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ABSTRACT 
Entamoeba histolytica is an invasive intestinal amoeba morphologically 
indistinguishable from Entamoeba dispar, a closely related organism that is not able to 
invade tissues. Differential diagnosis under conventional microscopy is therefore 
impossible. Reliable tools are needed for clinical diagnosis and for the reevaluation of the 
prevalence of infection with the invasive species worldwide. 
Monoclonal Antibody (MAb) 20/7D exhibited promising results when ascites was 
used to identify cultured isolates of E. histolytica by indirect immunofluorescence assays 
(IFA), and when used in a Faecal Antigen Capture Enzyme-Linked Immunosorbent Assay 
(FAC-ELISA) for laboratory diagnosis of amoebic dysentery and colitis. Here, further 
development of the assay was attempted to increase its sensitivity and use it for detection 
of asymptomatic carriers of E. histolytica. After purification and subsequent titration in 
ELISA, MAb 20/7D did not adequately distinguish between crude lysates of cultured E. 
histolytica and E. dispar trophozoites. MAb 20/7D reacted with a similar soluble antigen 
of E. histolytica and E. dispar, which confirmed previous observations in western blot 
analysis under non-reducing conditions. Therefore, the use of the FAC-ELISA for 
diagnosis in areas where E. dispar is endemic is probably not viable. A nucleic acid 
detection method was therefore developed. Polymerase Chain Reaction was used to 
amplify specific tandem sequences in the 24.5 Kb episome of E. histolytica and E. dispar. 
After PCR, internal sequences of digoxigenin-labelled PCR products were hybridized to 
specific biotin-labelled probes for E. histolytica or E. dispar and detected in Enzyme- 
Linked Immunosorbent Assay (ELISA). The Polymerase Chain Reaction Solution- 
Hybridisation Immunosorbent Assay (PCR-SHELA) was evaluated on samples from 
travellers returning from the tropics to Barcelona. The sensitivity and specificity were 98% 
and 100% respectively, when results were compared with microscopy. PCR-SHELA was 
also useful for differential diagnosis in cases of amoebic abscesses, amoebic dysentery, 
salmonellosis, ulcerative colitis and in asymptomatic carriage of E. histolytica. 
The new test gives sensitive and specific differentiation between E. histolytica and 
E. dispar in clinical specimens and it has proved successful in screening faecal samples in 
endemic areas for epidemiological purposes. 
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CHAPTER 1 
INTRODUCTION 
1.1 Amoebiasis 
The term "Amoebiasis" was adopted by the WHO expert committee in 1969 as "The 
condition of harbouring Entamoeba histolytica [(sensu lato)] with or without clinical 
manifestations" (WHO, 1969). In the past, the fact that many infected people never 
developed symptoms and spontaneously cleared the infection without treatment originated 
two hypotheses: one suggested, as originally proposed by Emil Brumpt in 1925, the 
existence of two species, one invasive and virulent and one morphologically identical and 
harmless. The second hypothesis pointed at E. histolytica as a commensal organism of the 
human colon with the potential to turn into an aggressive entity. Data collection to clarify 
the epidemiology and distribution of infection intensified, and in 1984 the WHO meeting 
of experts on amoebiasis officially acknowledged the magnitude of the world wide 
prevalence of amoebiasis: 480 million people were carrying the parasite, 10% of them 
developed invasive disease and from those, about 2% died (WHO, 1985). 
Unfortunately, the biochemical and molecular tools needed to confirm either of 
these hypotheses were unavailable for many decades but finally a redescription of E. 
histolytica Schaudinn, 1903 (Emended Walker, 1911) was published in 1993 by Diamond 
and Clark reviewing the biochemical, immunological and genetic evidence for the 
separation of Entamoeba histolytica sensu lato into two species and distinguishing the non- 
invasive species as E. dispar. The evidence presented proved that the earliest hypothesis, 
Emil Brumpt's proposal in 1925 of the existence of two species different only in their 
ability to produce disease in humans and kittens was correct (Diamond and Clark, 1993). 
Also, the inability of E. dispar to cause necrosis has been tested in hamsters, in which 
colonisation of the liver by trophozoites of E. dispar can cause local inflammatory response 
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without further invasion, with the development of an effective cellular immune response, 
that is responsible for the elimination of the trophozoites (Espinosa et al., 1997). 
Today, in its new sense, understanding that Entamoeba histolytica is the virulent 
species capable of further invasion, and Entamoeba dispar is the commensal species, the 
original definition of "Amoebiasis" remains and the disease is ranked as the second most 
important parasitic cause of illness and death after malaria in North and South America, 
Asia, Africa and Europe (WHO/PAHO/UNESCO, 1997). 
1.2 Taxonomy, life cycle and biology of Entamoeba histolytica sensu lato 
KINGDOM ANIMALIA 
SUBKINGDOM: PROTOZOA 
PHYLUM: SARCOMASTIGOPHORA 
SUBPHYLUM: SARCODINA 
SUPERCLASS: RHIZOPODA 
CLASS: LOBOSEA 
ORDER: AMOEBIDA 
SUBORDER: TUBULINA 
FAMILY: ENTAMOEBIDAE 
Levine et al., 1980 
The proposed life cycle for E. histolytica sensu lato remains so far unchanged. 
Dobell (1928) described the complete life history of what was probably a strain of E. dispar 
which had caused asymptomatic infection in primates. Parasites belonging to the complex 
E. histolytica/E. dispar are distributed worldwide, and infect via the faecal-oral route 
through contamination from one person to another when viable, mature quadrinucleated 
spherical cysts of 10-16 µm (average 12µm) are ingested. Whether the details of 
20 
Chapter 1 Introduction 
excystation from E. histolytica are identical to those for (probably) E. dispar is not certain, 
however, Dobell (1928) described excystation by the action of trypsin in the caecum or the 
lower part of the ileum, producing a quadrinucleate trophozoite from each cyst. The 
emerging trophozoite lives in close association with the bowel mucosa. After further binary 
fission, eight uninucleated trophozoites were released, each one ranging between 20 and 
40 pm in diameter. The organisms feed by phagocytosis of particulate matter and bacteria 
and by pinocytosis on liquid nutrients (Proctor, 1991). 
Encystation is stimulated when the trophozoites go into the faecal stream with 
production of a cyst wall, a distinct glycogen vacuole, formation of chromidial bars or 
chromatoidal bodies and nuclear division to four vesicular nuclei. Cysts are able to survive 
for long periods in a moist environment. Excretion of cysts by an asymptomatic carrier 
may reach up to a billion cysts per day, varying day to day in chronic carriers (Warhurst, 
1983). According to WHO/PAHO (1992) there are no animal reservoir hosts of E. 
histolytica/dispar, however, the organisms can infect several other hosts and can be found 
in monkeys (Beaver, et al., 1988), experimental infections have been established in dogs, 
cats, rats and many other species (Trissl, 1982). 
1.3 Morphology and ultrastructure 
The plasma membrane of E. histolytica trophozoites is trilaminar with a lipid 
bilayer covered by a glycocalyx (El Hashimi and Pittman, 1970), 20-30 nm thick that 
contains mucopolysaccharides (Feria-Velasco et al., 1972), lipophosphoglycan (LPG) 
(Bhattacharya et al., 1992), a polysaccharide containing N-acetylglucosamine repeated units 
identified as chitin (De la Vega et al., 1997), and cationic iron evenly bound over the 
surface (Lushbaugh and Miller, 1974). In addition, eighteen peptides and abundant lipids 
are also found in the membrane. The phosphonolipid, ceramide aminoethylphosphonate 
(CAEP) was isolated from the surface membrane of E. histolytica by Aley et al., (1980). 
It was also evident in this study that 50% of the total lipid content in the membrane are 
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ethanolamine-containing lipids. Cholesterol is the principal sterol found though E. 
histolytica is not capable of cholesterol de novo synthesis. It has been proposed that cellular 
debris and cells are the main source of cholesterol through phagocytosis (Lujan and 
Diamond, 1997). 
Trophozoites of E. histolytica present a high degree of pleomorphism and the use 
of scanning electron microscopy (SEM) has made it possible to study surface features such 
as the presence of lobopodia, endocytic stomata, filopodia and the uroid (Martinez-Palomo, 
1987). Trophozoite motility of E. histolytica is directional by means of pseudopod 
formation (lobopodia) or cellular translocation towards chemotactic signals; tubular 
extensions (filopodia) are associated with the uroid, which forms membrane invaginations 
of the cytoplasm located at the posterior end of attached trophozoites (Guillen, 1993). This 
structure accumulates cytoplasmic vesicules for exocytosis (McLaughlin and Aley, 1985) 
as an efficient way to eliminate capped substances such as toxic chemicals, anti-amoebic 
antibodies, complement or lectins (Guillen and Sansonetti, 1997). The presence of large 
amounts of actin that are not polymerized as microfilaments or microtubules has been 
detected (Martinez-Palomo, 1987). Its distribution in the trophozoite changes according 
to signal transduction from the environment, being involved in cell traction, capping and 
adhesion. It is located into the pseudopods (associated to myosin I) and in the posterior 
regions of motile amoebas (associated to myosin II). Those actomyosin complexes are 
important in adhesion of trophozoites to target cells (Guillen and Sansonetti, 1997). 
The cytoplasm contains the nucleus, vacuoles, membranous vesicles, glycogen and 
viruses (Diamond et al., 1972). Membrane-associated enzymes have been described but 
their specific localization is difficult due to the internalization processes constantly carried 
out in trophozoites. A lysosomal membrane bound pyrophosphatase (PPiase) non- 
dependent on Mg2+ has been demonstrated in E. histolytica and its role could be to function 
as a phosphotransferase in the glycolytic cycle. The presence of calcium-dependent 
thiamine pyrophosphatase (TTPase) in the membrane of vacuoles and vesicles located in 
the cytoplasm of E. histolytica suggests that the vacuolar system functionally replaces the 
22 
Chapter 1 Introduction 
Golgi apparatus and the smooth endoplasmic reticulum (McCaul and Bird, 1978). It derives 
from the internalization of plasma membrane portions by endocytosis or phagocytosis. The 
existence of different populations of vacuoles, according to the particular characteristics of 
the ingested materials has been suggested since macropinocytic, micropinocytic and 
autophagocytic vacuoles have been detected. Also, residual bodies (telolysosomes), 
primary (phagosomes) and secondary lysosomes (phagosomes containing hydrolytic 
enzymes) are present (Martinez-Palomo, 1987). Among the lysosomal enzymes detected 
there are phosphatases (alkaline phosphatase), glycosidases (ß-N acetylglucosaminidase), 
diverse proteinases, and RNAses. 
The lack of mitochondria (Rosenbaum and Wittner, 1970), is another remarkable 
characteristic of E. histolytica, with the fact that McLaughlin and Muller (1981) reported 
the isolation of a membrane-associated Ca-ATPase that suggests a regulatory function in 
the control of intracellular levels of Ca2+ (which in eukaryotic cells is done by the 
mitochondria). The function proposed for this enzyme is to maintain free high levels of 
pyrophosphate (PPi) needed for energy-dependent metabolic processes, and which is 
degraded by membrane-bound pyrophosphatases (McLaughlin et al., 1978). As a calcium- 
binding protein, calmodulin could be involved in the modulation of its activity 
(McLaughlin and Aley, 1985). 
The nucleus of E. histolytica possesses a central spherical karyosome of 0.5µm in 
diameter, surrounded by an achromatic capsule-like structure. It measures between 4 and 
7 µm in diameter, is surrounded by a thin achromatic double layered porous membrane, 
lined by evenly distributed small granules of chromatin. Those granules are involved in 
RNA synthesis and are found in contact or very close to each other (Diamond and Clark, 
1993). The DNA is distributed and synthesized through the nucleus. It is normally found 
extensively dispersed until prior to nuclear division, when it condenses around the 
endosome, arranged in chromosomes with sizes between 300 and 2000 kb (Valdes et al., 
1990). Ribosomal RNA (rRNA) or precursor rRNA is found in the periphery of the 
nucleus, surrounding the DNA, which is more centrally located (Albach, 1989). There are 
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between 175 to 200 copies of circular extrachromosomal DNA (24.5 kb each) per cell 
containing two inverted repeats (5.2 kb each) encoding ribosomal RNA (Bhattacharya et 
al., 1988, Bhattacharya et al., 1989, Huber et al., 1989). 
1.4 Metabolism 
Entamoeba histolytica is a model for the study of the metabolic processes in 
primitive eukaryotic cells and as such its metabolism diverges from most typically 
eukaryotic functions (Wöstmann and Bakker-Grunwald, 1993). Understanding those 
different metabolic features has been a very important issue for the design of effective 
strategies for diagnosis, treatment, prophylaxis and control of this protozoan parasite. 
It has been established that organisms belonging to the genera Entamoeba are not 
strictly anaerobic and that trophozoites are able to survive in low oxygen tensions and 
metabolise oxygen. Carbohydrates are the main source of energy for E. histolytica and in 
anaerobic conditions, the products of degradation are ethanol and carbon dioxide, 
meanwhile in the presence of oxygen, acetate is also formed (Weinbach and Diamond, 
1974). Other important features are the absence of cytochromes and the citric acid cycle 
(Weinbach and Diamond, 1974). 
Glucose uptake uses specific pinocytotic temperature-dependent mechanisms 
(Serrano and Reeves, 1975). Glucose is stored as glycogen and the existence of UDP- 
dependent enzymes such as phosphorylase, which could be involved in glycogen 
metabolism has been described. However, the mechanism of synthesis of glycogen is yet 
not clear since there is no evidence of any glycogen synthase (Takeuchi et al., 1979). The 
catabolism of glucose in E. histolytica differs from the process known for eukaryotic cells 
due to the presence of uncommon enzymes and the lack of allosteric regulation in 
glycolysis. Glucose can be converted directly into glucose-6-phosphate (G-6-P) either by 
glucokinase activity, or may be produced by glycogen degradation via (G-1-P) and 
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phosphoglucomutase (PGM). Since there is not glucose-6-phosphate dehydrogenase (G-6- 
PDH) present, it is assumed that the degradation of G-6-P is made through the Embden- 
Meyerhof pathway, instead of using the pentose phosphate shunt (PPP), also known as the 
hexose monophosphate shunt (HMPS) (McLaughlin and Aley, 1985). In the same way as 
glucose, galactose is also used as energy source by two UTP-dependent transferases: 
glucose- l-phosphate uridyltransferase (specific for glucose- l-phosphate) and hexose-1- 
phosphate uridyltranferase (Lobelle-Riche and Reeves, 1983). A distinctive feature of 
glycolysis in E. histolytica is the fact that it possesses a fully reversible PPi-dependent 
phospho-fructokinase (D-fructose 6-phosphate 1-phosphotransferase), which uses 
magnesium as a cofactor. PPi is used as an energy source, enabling the parasite to conserve 
ATP (Reeves et al., 1974; Mclaughlin et al., 1978). Phospho-enolpyruvate is obtained 
through the standard glycolytic process from fructose- l-6-diphosphate (F- 1,6-dip), but its 
further conversion into pyruvate is different: pyruvate phosphate dikinase, instead of 
pyruvate kinase catalyses the production of pyruvate with liberation of ATP. It is also 
important to note that although glycolysis is the main source of pyruvate, it can also be 
provided through the aerobic deamination of serine by serine dehydratase (Takeuchi et al., 
1979). 
The absence of lactate dehydrogenase, a means of recovering NAD from pyruvate 
+ NADH (Weinbach, 1981) in the organisms, made it possible to propose another route for 
the formation of pyruvate from P-enolpyruvate, providing also a source of NADPH to be 
used in reductive biosynthesis, protection against oxidative damage and cellular 
detoxification further along in the process by means of a oxaloacetate-malate cycle (Figure 
1.1) 
1 NADH NADP 
P-enolpyruvate + Pi + COZ ----ºOxaloacetate + PPi------- º Malate + NAD-------º Pyruvate + NADPH + CO2 
4------ 23 
FIGURE 1.1 Oxaloacetate-malate Cycle for Formation of Pyruvate. The enzymes involved in the 
process are: 1= P-enol-pyruvate Carboxy-transphosphorylase, 2= Malic dehydrogenase and 3= Malic 
Enzyme. 
25 
Chapter 1 Introduction 
Pyruvate degradation can be carried out aerobically or anaerobically in E. 
histolytica. Formation of acetate, ethanol and CO2 is possible by aerobic degradation. In 
anaerobic conditions, ethanol and CO2 are the only end products. Acetyl-CoA formation 
is common to both processes, via acetyl decarboxylation of pyruvate by a pyruvate 
synthase, which is similar to the pyruvate: ferredoxin oxidoreductase found in Trichomonas 
spp. The 2H- can be transferred to electron acceptors such as FMN, FAD or Ferredoxin 
(Figure 1.2). 
Pyruvate + CoA----------º Acetyl-CoA + CO2 + 2H- 
I- 
FMN, FAD or 
Ferredoxin 
FIGURE 1.2 Acetyl-CoA Formation by Pyruvate: ferredoxin Oxidoreductase (MacLaughlin and Aley, 
1985). 
Acetyl-CoA yields to the formation of acetate when with the intervention of an 
acetate thiokinase dependent on divalent cations (i. e. Mg+2, Fe+2 , or Mrt2 ), additional 
energy is obtained in the form of ATP (Figure 1.3). 
Mg +2 
Acetyl-CoA + Pi + ADP ----------º Acetate + CoA + ATP 
1---- 
FIGURE 1.3 Acetate Formation by Action of an Acetate Thiokinase on Acetyl-CoA 
Ethanol is the final product formed from the reduction of Acetyl-CoA to 
acetaldehyde by an acetaldehyde dehydrogenase (Lo and Reeves, 1978). However, It also 
can be produced in a lower proportion by means of a NADH: NADP+-dependent alcohol 
dehydrogenase (transhydrogenase) acting on free acetaldehyde. 
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1 2 
Acetyl-CoA + NADH -----º NAD + Acetaldehyde hemithioacetal ----- 1- Acetaldehyde + NADPH -----º Ethanol 
3 
NADH ----------º Ethanol 
FIGURE 1.4 Ethanol Formation: The main pathway involves two enzymes, 1= acetaldehyde 
dehydrogenase, and 2= NADH-alcohol dehydrogenase. The alternative pathway uses enzyme 3= NADPH- 
dependent alcohol dehydrogenase (Barret, 1997) 
One of the distinctive features of E. histolytica is the absence of catalases, 
peroxidases or any other enzymes (such as cytochromes) containing the heure group 
(Weinbach et al., 1976). However, the existence of iron (non-heme)/sulphur proteins has 
been confirmed as ferredoxin-linked (Weinbach et al., 1976; Reeves et al., 1980). The 
electron flow from reduced substrates starts from NADP+ to flavins (FMN), then to an 
iron-sulphur protein similar to ferredoxin, then ubiquinone. It is proposed that a high-redox 
potential electron carrier analogous to cytochrome c in the mammalian respiratory chain is 
also present in the parasite (Weinbach, 1981). The final electron acceptor is molecular 
oxygen, which is reduced to water, however this process remains to be clarified (Weinbach 
et al., 1978). The absence of catalase made unlikely the possibility for production of 
hydrogen peroxide, and the presence of an iron-containing superoxide dismutase (FeSOD) 
suggested a different intermediate (Saavedra-Lira and Perez-Montfort, 1996), although 
peroxidoxins (Tachibana et al., 1991, Reed et al., 1992) have recently been identified that 
could intervene in the removal of the H202 produced (McGonigle et al., 1998). Specific 
inhibitors for FeSOD have been proposed as an alternative for therapeutical use since 
human SODs are Cu/Zn and Mn- dependent (Bruchhaus et al., 1992). 
Nucleic acid synthesis in E. histolytica is under study, and so far it has been shown 
that there is synthesis of pyrimidine, but no de novo synthesis of purine bases, which may 
be done through salvage pathways from nucleosides with the intervention of nucleotide 
kinases for the synthesis of nucleotides. A de novo pyrimidine pathway was supported by 
the incorporation of orotic acid, the presence of aspartate transcarbamylase and no 
pyrimidine requirement for growth in culture. From uptake studies it has been concluded 
that cytosine, uracil, thymine, thymidine, guanine and hypoxanthine enter by passive 
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diffusion, meanwhile cytidine, uridine, adenine and guanosine enter via a carrier mediated 
system. For this system, four transport loci have been identified: two for purine uptake, 
adenine-adenosine, adenosine-guanosine (Booden et al., 1978). The other two sites are for 
pyrimidine uptake, uridine-adenosine (purine nucleoside) and uridine-cytidine. Also, 
hypoxanthine stimulates the uptake of uridine and cytidine (Albach, 1989). 
There is polyploidy in E. histolytica, with reports of up to 14n (Byers, 1986), with 
a total amount of nuclear DNA of 0.45 pg/cell, and a genome size of 5x 104. G+C ratio 
for E. histolytica has been reported to be 25% (Bhattacharya et al., 1998). The ribosomes 
(75S and subunits 55S and 35S) of E. histolytica are ribonucleoprotein (RNP) bodies 
grouped (polysomes) in the cytoplasm of trophozoites in an helical array (Kress et al., 
1971), when encystation is stimulated, they associate in crystalline aggregates generating 
the chromatoidal bodies (ribonucleoprotein bodies). 
Three species of rRNA, 25S, 17S and 5S are isolated from trophozoites. The 25S 
RNA is dissociated during nuclear processing into a 17S, a 16 and a 5.8S species. Two 
DNA-dependent RNA polymerases with specificity for denatured DNA are present, RNA 
polymerases I and II (Albach, 1989). 
1.5 Transmission 
The main factors involved in the transmission of parasitic infections in developing 
countries are poverty, low educational background, lack of home technology, maternal 
incompetence and ruralism (Mata, 1982). Defaecation near water supplies and 
indiscriminate squatting are important sources for transmission. Also, faecally 
contaminated food, and unhygienic irrigation practices result in high infection rates mainly 
in endemic areas. In developed countries, where good sanitation, education and water 
supplies are available to the majority of members in the community, increased risk of 
infection is linked to infected asymptomatic food handlers, institutionalized patients, 
immigrants and tourists returning from endemic areas. 
28 
Chapter 1 Introduction 
Like most epidemiological features of amoebiasis, most of the data are now known 
to refer to "E. histolytica/dispar". Mechanical vectors such as flies and cockroaches are 
important for the transmission of amoebiasis by transporting viable cysts or by 
contaminating food with their vomit or faeces (Warhurst, 1983). In addition, there is 
association between prevalence of invasive infections and movement of populations, 
overcrowding, poverty and ignorance in most developing countries. Intrafamilial spread 
(Spencer et al., 1981) is seen and transmission in groups living together is very common 
in mental institutions (Sexton et al., 1974; Spencer et al., 1977; Sargeaunt et al., 1982a) 
schools, and refugee camps (Gonzalez-Galvares et al., 1986). Also, contamination of fresh 
vegetables could account for E. histolytica infections, especially among tourists. 
Transmission of E. histolytica takes place when viable mature cysts are ingested. 
Trophozoites are not an important stage in transmission because of their inability to survive 
acid pH in the stomach. However, cyst carriers disseminate infection primarily through 
direct contamination from the digestive tract of one person to that of another person under 
poor conditions of personal hygiene. Experimentally it has been established that the 
infective doses is fewer than 2000 to 4000 cysts, with a prepatent period of 5 days and an 
average incubation period of six weeks for the development of symptomatology (Knight, 
1975). Once ingested, the cysts hatch in the intestine and the freed trophozoites are able 
to invade and cause dysentery in the susceptible host. Reports on identification of E. 
histolytica cysts during follow-up studies have shown that there are intervals of acute 
dysentery and cyst shedding among infected or convalescent individuals. During follow-up 
studies in asymptomatic cyst carriers, three stages were described, the chronic stable cyst 
shedder, the chronic intermittent cyst shedder and the short term cyst shedder, capable of 
autoeliminating the infection (Ruiz-Palacios et al., 1992). Those shedding periods are 
important in dissemination of the disease because cysts may be viable for 10 minutes on the 
surface of the hands (reviewed by Warhurst, 1983) and up to 45 minutes if they remain 
moist under the fingernails (Andrews, 1934). 
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1.6 Clinical Features of Entamoeba histolytica Infection 
Invasive disease is caused by Entamoeba histolytica with invasion of the mucosae 
by trophozoites which produces clinical manifestations with the potential risk of spreading 
to extraintestinal foci. Intestinal amoebiasis varies from mild manifestations with diffuse 
inflammation and microscopical damage, to more grave forms with different levels of 
ulceration (Trissl, 1982). The most important intestinal syndromes present in invasive 
amoebiasis are amoebic colitis, acute amoebic colitis (amoebic dysentery), fulminant 
colitis, amoeboma and appendicitis. However, amoebiasis as a general terminology also 
involves the asymptomatic intestinal infection by Entamoeba dispar, where trophozoites 
may cause slight irritation of the mucosa surrounding the trophozoite-multiplication area. 
The asymptomatic cyst passage is the most common presentation of amoebiasis. 
Acute amoebic colitis (amoebic dysentery) is characterised by 10-12 bloody stools 
per day, caused by the haemorrhagic inflammation of the mucosa, where oedema and 
infiltration by eosinophils and neutrophils is observed (Trissl, 1982), mucus and abdominal 
pain, without significant faecal leucocytosis. It must be differentiated from bacterial colitis 
or dysentery caused by Shigella sp., Salmonella sp., Helicobacter, Vibrio sp., Escherichia 
coli and Yersinia enterocolitica (Reed, 1992). The proctoscopy shows small ulcers on the 
mucosa and muscularis mucosae, with flask-like extension into the submucosa (Ravdin et 
al., 1988). Fulminant colitis occurs mainly in children, who suffer bloody diarrhoea, fever 
and abdominal pain. Appendicitis, colonic perforations, megacolon, and peritonitis are 
frequent complications of this syndrome with the presence of abundant infiltrates 
containing lymphocytes, histiocytes, and eosinophils (Trissl, 1982; Reed, 1992). 
Amoeboma is a complication of intestinal disease presented as a mass lesion in the caecum, 
ascending colon, rectosigmoid, transverse colon, or descending colon. It mimics colon 
carcinoma but responds rapidly to antiamoebic therapy and may even resolve spontaneously 
(Ravdin et al., 1988; Reed, 1992). 
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Councilman, Lafleur and Osler (1884) confirmed the pathology of amoebiasis and 
the relationship between intestinal amoebiasis and amoebic liver abscess and its 
complications (Councilman and Lafleur, 1978). The clinical syndromes present in 
extraintestinal disease include amoebic liver abscess, pleuropulmonary amoebiasis, 
peritonitis, pericardial amoebiasis, cerebral amoebiasis, cutaneous amoebiasis and 
genitourinary amoebiasis. Amoebic liver abscess is the most common of the extraintestinal 
syndromes and it is the major cause of morbidity and mortality due to amoebiasis 
worldwide (Ramos et al., 1986). E. histolytica probably reaches the liver by hematogenous 
dissemination from the intestine via the portal system. Once established, contact-dependent 
lysis of polymorphonuclear neutrophils by amoebae causes destruction of surrounding 
hepatocytes due to the release of toxic neutrophil constituents. The wall of the cavity 
consists of fibroblasts, macrophages and lymphocytes and the trophozoites are located 
within the wall. The cavity is usually filled with tissue debris, odourless and with a 
characteristic chocolate colour. Amoebae can be isolated with difficulty by culturing 
material from aspirates. Differential diagnosis with pyogenic abscess and hepatic 
carcinoma requires serological confirmation of antiamoebic antibodies and hemoculture to 
exclude Escherichia coli, Bacteroides spp., Klebsiella pneumoniae, Proteus spp., 
Enterobacter sp., Pseudomonas spp., Citrobacter spp., Staph.. aureus, and Strep.. pyogenes 
among others. 
Pleuropulmonary amoebiasis is the most common complication of amoebic liver 
abscess. It is found in 20-35% of patients and is the result of contiguous spread from the 
right lobe of the liver. The rupture of the liver abscess into the pleural cavity is the most 
serious pulmonary complication. Peritonitis is the second most common complication of 
amoebic liver abscess and occurs in 2%-7.5% of patients (Reed, 1992). Pericardial 
amoebiasis is the most serious complication of an amoebic liver abscess. Despite this, its 
presentation is infrequent (0.2%), more than two-thirds of patients who have amoebic liver 
abscess with pericardial involvement have abscesses of the left lobe of the liver (Reed, 
1992). Cerebral involvement in amoebiasis is seen in less than 0.1% of amoebiasis 
patients. In 50% of those patients there is an abrupt onset of symptoms and cerebellar 
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involvement or rupture within 12-72 hours is the cause of death. Genitourinary amoebiasis 
in its renal form can be the result of abscess rupture in the liver, hematogenous spread from 
the lesion in the liver or lungs or extension through the lymphatics. Cutaneous lesions are 
caused by fistulae from a liver abscess or rectocolitis. 
1.7 Invasive Markers in Amoebiasis 
Biochemical markers such as the agglutination of trophozoites with concanavalin 
A (Martinez-Palomo et al., 1973), high rate of erythrophagocytosis (Trissl et al., 1978a) 
and resistance to complement lysis (Reed et al., 1983) were the markers used to 
differentiate invasive from non-invasive isolates of E. histolytica. The criteria of direct 
association between the presence of E. histolytica and pathogenesis was modified when 
Sargeaunt et al. (1978) showed that the electrophoretic patterns (zymodemes) of the 
isoenzymes EC 2.7.1.1 hexokinase (HK); EC 5.3.1.9 glucose-phosphate isomerase (GPI); 
EC 1.1.1.40 L-malate dehydrogenase (decarboxylating) ME, and EC 2.7.5.1 phospho- 
glucomutase (PGM) from cultured E. histolytica differed depending on the clinical source 
of the strain (symptomatic or asymptomatic cases). After the analysis of the zymograms 
of thousands of isolates they characterized 24 zymodemes from which patterns of 
migration for HK and PGM were an indication of the pathogenic potential of the strains. 
These observations were corroborated by le Blanc (1992) who, using 12 isoenzymes 
(Alloenzymes) taxonomically classified pathogenic and non-pathogenic strains of E. 
histolytica. Results in the form of a dendrogram showed the existence of two groups within 
the "species". 
Evidence supporting the existence of only one species, suggesting that virulent 
behaviour relates to environmental conditions such as variations on bacterial flora in the 
intestine and in culture has also been produced, and Mirelman et al. (1986) and Andrews 
et al. (1990) reported the conversion of strains from non-pathogenic to pathogenic 
zymodeme and vice versa during the axenization process. Attempts to reproduce these 
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Clark and Diamond (1992) using several cloned strains including the "converted" isolates. 
Not only was there no conversion since the zymodeme patterns did not change, but the 
amplification and further digestions of the PCR products of the small subunit RNA genes 
with Xbal (Riboprinting) on the relevant isolates showed the original non-pathogenic 
restriction pattern (Clark and Diamond, 1991). 
Specific probes for pathogenic and non-pathogenic zymodemes based on the non- 
coding repetitive elements of the 23 kb episomal (extrachromosomal) DNA of E. histolytica 
have been used as invasive markers in clinical and epidemiological studies (Garfinkel et 
al., 1989). These probes were hybridised directly to the DNA by Bracha et al. (1990) and 
after PCR by Romero et al., (1992) and Acura-Soto et al., (1993) to identify the amoebal 
species in clinical isolates and in stool samples. Other gene sequences and antigens used 
as invasive markers, are the 125 kDa surface antigen (Edman et al., 1990), the 27 kDa 
cysteine proteinase (Tannich et al., 1991), the 30 kDa nuclear antigen (Tachibana et al., 
1991), and the Fe-superoxide dismutase (FeSOD) enzyme (Tannich et al., 1991), which 
reveal differences not only at genomic but also at the protein sequence level. Many of those 
markers are currently being successfully used as diagnostic tools and at present, E. 
histolytica and E. dispar have been acknowledged as two distinct species by the experts 
committee of WHO (WHO/PAHO/UNESCO, 1997). 
1.8 Mechanisms of Pathogenicity 
The cytolytic activity of E. histolytica has been studied in cultured cells and it 
involves four steps: adhesion, cytolysis, phagocytosis and intracellular degradation that 
combine different chemical and physical processes. After contact and binding, probably 
via the interaction of host cell carbohydrate residues with N-acetyl-D-galactosamine 
(GalNac) inhibitable lectin (Ravdin et al., 1988) on the surface of the trophozoites, and 
introduction of the peptide amoebapore (pore-forming peptide) into the membrane 
phospholipids of the host cell to form a water filled channel (Leippe et al., 1991; Leippe, 
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phospholipids of the host cell to form a water filled channel (Leippe et al., 1991; Leippe, 
1997), epithelial cells suffer a lowering of transepithelial resistance, detaching, distortion 
of microvilli and surface blebbing. As soon as the target cells are detached by amoebal 
filopodia, they are next distributed on the amoebic surface in patches clustering towards the 
uroid. Engulfment by phagocytic stomata then occurs, thus amoebae lyse target cells prior 
to phagocytosis (Ravdin and Guerrant, 1982). 
Amoebic colonisation and contact-dependent cytolysis of the host tissues involves 
lectin/adhesin-mediated mechanisms (Chadee et al., 1987; Ravdin and Guerrant, 1981; 
Rosales-Encina et al., 1987). The lectin-mediated effector has been identified in E. 
histolytica and E. dispar as a 260kDa membrane-associated glycoprotein, the galactose/N- 
acetyl-galactosamine (Gal/Ga1Nac) binding lectin, consisting of a transmembrane heavy 
subunit of 170kDa and a lipid-anchored light subunit of 35/31 kDa, linked by disulphide 
bonds (Petri et al., 1989a). The heavy subunit is encoded by a multigene family of five hgl 
genes and the light subunit is encoded by a family of lgl genes, both distributed in multiple 
loci among the genome. 
Human colonic mucins, with abundant Gal and GalNac residues are the main 
receptors for the amoebal lectin (Chadee et al., 1987) and monoclonal antibodies (MAb) 
raised against the heavy subunit of the lectin detected six different epitopes, with different 
effects on adhesion to target cells and mucins. Antibodies directed against epitopes 1 and 
2, which are present in E. histolytica and E. dispar enhanced adherence meanwhile 
monoclonal antibodies directed against epitopes 4 and 5 inhibited adhesion. Another MAb 
produced against epitope 6 inhibited adhesion to target cells but not to mucins. The 
enhancement phenomenon may indicate that some anti-lectin antibodies help during the 
colonisation of the host epithelium by activation of the lectin, thus evading the immune 
response. During the same study, 56.8% of 44 immune sera from patients with amoebic 
liver abscess inhibited adherence but interestingly, 36% of the remaining sera enhanced it. 
(Petri et al., 1990a; Petri et al., 1990b). 
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Contact-dependent lysis mechanisms involve the secretion of soluble factors that 
alter membrane stability. A family of pore-forming peptides (amoebapores), are 
responsible for part of the cytolytic effect of E. histolytica by changing the osmotic balance 
of nucleated cells and bacteria (Leippe et al., 1994; Leippe, 1997). Three isoforms, A, B 
and C corresponding to mature peptides of 77 aminoacids arranged in four a-helical 
domains connected by three disulphide bonds (Leippe, 1992) are present in E. histolytica 
and E. dispar in a ratio of 35: 10: 1 (Leippe, 1997), although E. histolytica activity is higher 
due to structural differences (Dodson and Petri, 1994). Domains 1 (residues 1-22) and 
especially 3 (residues 40-64) possess the pore-forming activity and the other two resemble 
globular proteins (Leippe et al, 1994). 
Amebapores are stored in vesicular compartments and are not released to the 
environment, unless activated by contact or due to amoebal lysis, however, no specific 
receptors are required (Leippe et al., 1995; Leippe, 1997). Together with the amoebapore, 
the mechanical aggressive mechanisms of the trophozoite's cytolytic action are 
complemented by the presence of several proteolytic enzymes that are probably used in the 
penetration of tissues, in degradation of exogenous substrates and in inflammation 
processes. Several cysteine (Thiol) proteinases have been isolated from extracts of 
axenically cultured trophozoites ranging between 16-96 kDa in molecular weight, which 
seem to be gene products in both E. histolytica and E. dispar, sharing a similar structure 
and function to those of mammalian cathepsins (Mclaughin and Faubert, 1977; Lushbaugh 
et al., 1984). As opposed to amoebapores, cysteine proteinases are secreted by exocytosis 
(Leippe et al., 1995) and their secretion is triggered and increased by the contact of the 
mannose-containing glycoproteins in the plasma membrane of trophozoites with receptors 
in bacteria or target cells (McKerrow, 1992). 
The proposed role of cysteine proteinases in invasion, (observed in cultured cells 
in vitro), is to reversibly round and detach cells from monolayers, without any lytic effect 
(Keene et al., 1986), resembling the function of cysteine proteinases found in macrophages 
and cancer cells. Studies of liver abscess formation in severe combined immunodeficient 
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(SCID) mice confirmed their role in amoebic abscess formation (Stanley et al., 1995). 
Also, their function in limiting the host's immune response seems to be related to their 
capacity to degrade specific IgG and cleave complement factor C3 into C3a and C3b and 
to degrade IgA, C3a, and C5a (Que and Reed, 1997). The major neutral proteinase, with 
a molecular weight of 56kDa was able to break down extracellular matrix, laminin, 
fibronectin and type I collagen (Keene et al., 1986; Li et al., 1995). Luaces and Barrett 
(1988) purified histolysin, a cysteine proteinase of Mr 26kDa by SDS/polyacrylamide gel 
electrophoresis or 29kDa by gel chromatography. Later, three different cysteine proteinases 
were identified by Reed et al. (1989) on gelatin substrate gel electrophoresis, with 
molecular weights of 56,40 and 30 kDa, the latter identical to the one identified by Luaces 
and Barrett (1988). Also a cysteine proteinase of 60kDa reported by Spinella et al., (1997) 
with different physicochemical characteristics to those reported previously could be the 
same 70kDa surface protease found by Avila and Calderon (1993). The 60kDa protease 
also resembles the CP5 isolated by Benkert et al., (1997) which seems to be present only 
in E. histolytica and that is membrane associated (Avila and Calderon, 1993; Spinella et al., 
1997; Benkert et al., 1997). 
At the molecular level, a multigene family of cysteine proteinases (acp or ehcp 
genes) have been identified in E. histolytica (Reed et al., 1993; Bruchhaus and Tannich, 
1996; Mirelman et al., 1996). Six genes (ehcpl -ehcp6) were identified by Bruchhaus et al. 
(1996) and the products of three of those genes (EhCP1, EhCP2 and EhCP5) were found 
to account for 90% of cysteine proteinase expression in E. histolytica. The sequences of 
three of those genes, acpl/ehcp3, acp2/ehcp2 (histolysainchistolysin) and acp3/ehcpl 
(amebapain) were first reported by Reed et al., (1993). The sequence of acpl was only 
35% and 45% homologous to acp2 and acp3 respectively, although acp2 and acp3 share 
85% homology between their sequences. Homologous sequences to those three genes have 
also been identified in E. dispar (Reed et al., 1993; Bruchhaus and Tannich, 1996), 
however, the level of their expression is 10 to 100 fold higher in the mRNA from E. 
histolytica (Tannich et al., 1991). 
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The conserved gene sequences of cysteine proteinases in E. histolytica and E. dispar 
resemble those of papain-cysteine proteinases and are translated in a similar way, as 
preproenzymes. Thus, the multiple number of gene products isolated suggest the possibility 
of different structures due to post-transcriptional processes during protein synthesis. 
However, it is not clear if the differences are due to different specific functions or activities 
(Que and Reed, 1997). 
Synthetic inhibitors of cysteine proteinases targeting intestinal forms have been 
proposed as possible chemotherapeutic agents for the treatment of amoebiasis. Also, the 
potential use of cysteine proteinases in diagnosis was highlighted by Reed et al. (1989) with 
an ELISA test using the 56 kDa proteinase which detected antibodies in 83% of patients 
with invasive amoebiasis and none in E. dispar infected subjects (Reed et al., 1989). 
Luaces et al., (1992) standardised an histolysain detection system in stool samples 
(ENZYMEBA) with a sensitivity of 87.5%, although it doesn't differentiate between E. 
histolytica and E. dispar infections (Luaces et al., 1992). Histolysain was also used in an 
ELISA for detection of circulating specific antibodies in 72.7% of patients with amoebic 
abscess, but also detected antibodies in 18.1% asymptomatic cyst carriers and 2.5% of 
healthy controls (Luaces et al., 1993). 
Among other important enzymes found in E. histolytica and E. dispar, a 
metalloproteinase, the Ca2+ dependent collagenase is located in electrodense bodies of 80- 
200 nm in diameter which are not surrounded by any membrane. This enzyme is not 
liberated into the culture medium and is activated only after contact with the collagen type 
I and Cat+, with the intervention of calmodulin (Munoz et al., 1984). Other components 
of the electrodense granules are Fe 2+/3+, Na+, Mgt+, K+5 P, S, Cl ; Pi and PPi. Phospholipases 
are also involved in the cytolytic processes in invasive amoebiasis, Said-Fernandez and 
Lopez-Revilla (1982) detected haemolytic activity related to phospholipase A in sonicates 
and homogenates of E. histolytica. Degradation of phospholipids produce free fatty acids, 
and lysophospholipids such as lysophosphatidylcholine, product of hydrolysis of 
phosphatidylcholine from membranes of the parasite (Said-Fernandez and Lopez-Revilla, 
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1982). Also, coding of haemolytic peptides has been reported within the ribosomal DNA 
inverted repeats in the extrachromosomal circular DNA from clones derived from E. 
histolytica genomic DNA (Jansson et al., 1994), and amplification of the 2.6 kbp 
haemolysin structural gene has been carried out from amoebic liver abscess samples 
(Zindrou, 1997). 
Two soluble components involved in the aggressive behaviour of the trophozoites 
are found in used culture medium, the first is a ß-N-acetyl-glucosaminidase whose role 
seems to be the disruption of glycoprotein holding the mucosal epithelial cells and also 
helps in the breakdown of ingested erythrocytes. The second is a chemotaxis inhibitor for 
monocytes (macrophage migration inhibition factor, MIF) which could be responsible for 
the local transient anergy present at the beginning of amoebic invasion (Kretschmer et al., 
1980). Studies in gerbils have shown that by modulation of the host immune system, 
trophozoites survive inflammatory reactions at infection sites affecting cell mediated 
immunity, namely macrophages and T-cells. Cell mediated activation of immunity during 
amoebic invasion induces T cell derived cytokines (IFN-y, IL-2 and TNF-ß) which in turn 
induce macrophage mediated cytotoxicity, involving the production of TNF-a to increase 
nitric oxide (NO) levels with 02 and H202 as cofactors (Campbell and Chadee, 1997). 
Trophozoites produce serotonin and neurotensin which promote loss of tissue fluid 
and red blood cells, generating vascular thrombosis, ischemia and necrosis of the intestinal 
epithelium. The trophozoites that are able to reach the blood stream and make contact with 
complement cleave C3 (by action of their cysteine proteinases), activating the alternative 
pathway by C3b. During the process, C3a is degraded, limiting anaphylaxis reactions and 
affecting the host inflammatory response (Reed, 1995). At the same time, at the 
extraintestinal site, the inflammation is absent or mild but necrotic processes do occur 
(Trissl, 1982). 
Delayed hypersensitivity is retarded and local down regulation of macrophage 
function is observed, either by inhibition of TNF-a production (via Prostaglandin E2 (PGE) 
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from the parasite and macrophages) or by modulation of T cell functions by amoebic 
proteins which suppress mitogenesis and induce production of interleukins 4 and 10 (IL-4, 
IL-10), known by their inhibitory effect on macrophage functions. Campbell and Chadee 
have recently proposed that soluble amoebic proteins induce production by macrophages 
of PGE2 and LTC4 (a pro-inflammatory mediator) and whose function is to reduce the 
ability of antigen presenting cells (APC) to present amoebic antigen to T cells, by reducing 
the expression of major histocompatibility complex class II molecules (MHCII), so no 
further macrophage activation occurs and formation of amoebic granulomas may be 
favoured by low levels of TNF-a (Campbell and Chadee, 1997). 
Although serum antibodies rise during amoebic invasion, they are not protective and 
frequent reinfections occur in endemic areas (Krupp, 1970; Ravdin and Guerrant, 1982). 
Many of the molecular mechanisms involved in the proposed downregulation of the 
immune system by E. histolytica are not yet clear mainly because the information available 
is fragmented, the identification of the specific amoebal components involved is required 
and more in vivo studies are needed to construct a complete picture of the inhibitory 
processes. 
1.9 Diagnosis 
The laboratory plays a key role in the diagnosis of invasive amoebiasis since, 
together with imaging diagnosis and colonoscopy, it confirms clinical findings in cases of 
fulminating colitis, amoeboma, peritonitis or liver abscess. It is also valuable when 
diagnosis by exclusion is carried out in entities such as inflammatory bowel disease 
(ulcerative colitis and Crohn's disease), carcinoma, and dysenteric syndromes caused by 
bacterial agents involving Shigella spp., Salmonella spp., Campylobacter jejuni, or 
Clostridium docile among others (Healy and Kraft, 1972; Tucker et al., 1975; Sanderson 
and Walker-Smith, 1984; Mhlanga et al., 1992; Chan et al., 1995). However, the frequent 
misdiagnosis due to lack of skilled personnel and delay in obtaining and providing 
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laboratory results are contributory factors to morbidity and mortality in amoebiasis 
(Krogstad et al., 1978; Yolken, 1982). Improvement in sensitivity and specificity in 
differential diagnostic tests is urgently needed and ideally, those diagnostic tests should be 
available in a flexible format for their application in large scale studies, especially in 
endemic areas. 
1.9.1 Microscopy 
The most common method for the diagnosis of amoebiasis is the direct examination 
of smears of freshly shed stools for the identification of trophozoites and/or cysts. Wet- 
mount examinations using physiological (0.85%) saline are useful for the identification of 
E. histolytica/E. dispar trophozoites according to their motility and the presence or absence 
of ingested erythrocytes (Gonzalez-Ruiz et al., 1994a). The size, nuclear characteristics and 
disposition of the chromatin in the cyst are diagnosed using Lugol's iodine. However, the 
difficulty in estimating the presence of the amoebic infection arises most commonly from 
low sensitivity due to failure to detect an organism during microscopical identification. 
Measurement by calibrated eyepiece micrometer permits the differentiation of cysts 
of E. histolytica/dispar from cysts of other related amoebas (E. hartmanni, E. coli, E. nana, 
and Iodamoeba butschlii) and from cells and other parasites (Gonzalez-Ruiz et al., 1991, 
Gonzalez-Ruiz and Bendall, 1995). Furthermore, in order to give an accurate result in the 
study of intestinal amoebiasis it may also be necessary to use several techniques in 
conjuction, including preservation in polyvinyl alcohol (PVA) or other fixatives such as 
10% formalin and Merthiolate-Iodine-Formalin (MIF). Also permanent staining, which 
detects the presence of trophozoites that are missed in concentration methods, are 
complementary diagnostic schemes. However, for successful identification, it is important 
to avoid the presence of substances such as antibiotics, laxatives or anti-diarrhoeals in the 
samples. These substances damage parasite morphology (Proctor, 1991). 
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The examination of trophozoites and cysts is the most important means of 
distinguishing between the different species of amoeba present in the gut when 
microscopical diagnosis is required. However, there are few key distinctive morphological 
features to be taken into account. For instance, trophozoites of E. hartmanni are similar in 
morphology and motility to those of E. histolytica/E. dispar, although the differential 
feature is their smaller size, measuring between 5 and 12 µm with an average between 8-10 
µm. Also, if trophozoites with ingested red blood cells are present in the sample, this gives 
certain identification of E. histolytica (Gonzalez-Ruiz et al., 1994a). Endolimax nana 
trophozoites, with a similar size (6-12 µm) are easily confused with those of E. hartmanni, 
however, their large, varibly-shaped karyosome is the distinctive feature. The cyst stage in 
E. hartmanni measure between 5-10 µm, spherical in shape with up to four nuclei identical 
to those of E. histolytica/E. dispar, however an overlap in size exists between cysts of E. 
histolytica/dispar and E. hartmanni in the 10-12 µm population. Cysts of Endolimax nana 
are 5-10 µm in size (average of 6-8 µm), with spherical or ovoidal shape and up to 4 nuclei 
with a large central karyosome each. 
E. coli trophozoites are large in size (15-50 µm), with rough vacuolar cytoplasm 
with blunt pseudopods and a nucleus that can be distinguished without staining. They give 
rise to spherical cysts with 8 nuclei when mature; abundant peripheral nuclear chromatin 
in granules of irregular size and uneven distribution are present. A cyst size of 15 gm and 
upwards and the number of nuclei are the main morphological distinctive features. 
In the case of I. buetschlii, trophozoites are 8-20 gm in size, with one nucleus 
containing a characteristic very large, centrally located karyosome. Cysts vary in size from 
5-20 µm, with an average of 10-12 µm, and this is the reason why they are sometimes 
confused with those of E. histolytica/E. dispar. However, their shape is usually irregularly 
ovoidal and in fresh specimens contain a single nucleus with a large karyosome without 
peripheral chromatin. In fresh specimens the cytoplasm usually contains a large, well 
defined glycogen vacuole which stains dark brown with Lugol's iodine. 
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Technical and parasite life cycle factors such as skill of the examiner and 
intermittent cyst excretion influence the sensitivity of microscopy. Those factors were first 
indirectly measured by Kershaw as early as 1946 when reviewing the diagnosis of 
amoebiasis on the basis of microscopical detection of positives. His results showed that 
when one stool sample was examined only 50% of the cases were diagnosed whereas after 
the examination of 8 to 12 samples it was possible to cover about 70-90% of the cases. He 
concluded that after the examination of three specimens, a high proportion of positives will 
remain undiagnosed (Kershaw, 1946). Stamm et al., (1957) studied the positivity of 
microscopical stool examination for E. histolytica/dispar cyst excretion in Pakistan, where 
45% of the positive individuals were detected in the third sample, reaching 67% in the sixth 
sample. Similarly, during a recent study, Hiatt et al., (1995) concluded that 10.4% of E. 
histolytica/dispar carriers required between 4 and 9 stool examinations before being 
diagnosed. Those studies support the use of auxiliary techniques such as the incorporation 
of concentration methods in order to improve diagnosis of most intestinal protozoa and 
helminth infections, especially when low numbers of parasites are present in the samples. 
Flotation with zinc sulphate is often used for the diagnosis of amoebiasis. The 
organisms are concentrated in the surface after centrifugation because the solution has a 
higher specific gravity (1.18) than the parasites. This technique is particularly useful in 
developing countries where costs and restrictions to the use of certain chemicals are 
important. A key advantage of this method is that after washing, the concentrated samples 
are suitable for culture since there is no fixative in the solution. However, the samples must 
be examined promptly in order to avoid cyst distortion and trophozoites are missed. 
Alternatively, a formol-ether method is also useful for concentration of eggs and cysts 
(Allen and Ridley, 1970), and the fixation facilitates the further staining of the sample for 
species differentiation. However, PCR amplification of samples concentrated by this 
method is very difficult, unless the pellet is washed immediately after concentration, and 
culture requires omission of the formalin fixative. 
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In the particular case of the diagnosis of intestinal amoebic infection, even after 
detection of cysts resembling E. histolyticaldispar by microscopy, discriminating between 
these species is now recommended, thus a specific detection system is required. To fulfill 
this need, a number of techniques are available, including in vitro culture of clinical 
specimens, from which the isolation of microorganism is attempted for further 
characterisation of strains in zymodemes. Also, a range of highly specific antigen, antibody 
and nucleic acid detection systems have recently been developed. 
1.9.2 In vitro Culture 
One of the most useful laboratory aids for the diagnosis of amoebiasis is the 
cultivation of stool samples and for future reference the term "Strain" indicates a laboratory 
grown population of amoebas isolated from a well characterised source (Trissl, 1982). 
Although cultivation is a time consuming procedure because the complex ecological 
relationships in the gut are difficult to mimic in the laboratory, the isolation of amoebic 
strains in culture permits their identification and provides protein extracts and nucleic acids 
for their classification into zymodemes and for molecular studies at the antigenic and 
genetic level respectively. Isolation of amoeba cultures directly from faeces requires the 
presence of the accompanying intestinal flora in the culture medium (xenic culture), where 
composition is not completely defined. Also, the addition of starch is necessary as a 
carbohydrate source, and the use of antibiotics keeps the balance between bacterial and 
amoebal populations allowing further subcultures. The most commonly used culture 
medium for isolation and mantainance of strains is Robinson medium (Robinson, 1968). 
It was devised as a polyxenic biphasic medium mainly based on Escherichia coli culture, 
enriched with horse serum, for the isolation and maintenance of Entamoeba spp. 
Intensive research in amoebiasis at all levels was stimulated when axenic cultures 
(no associated organisms required for growth) were developed in 1961 by Dr L. Diamond. 
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His TTY-S-CEEM25-diphasic medium containing a cell-free chick embryo extract and 
horse serum was the precursor of the TP-S-1 (Diamond, 1968) monophasic medium for 
mass cultivation of trophozoites. Chick embryo extract was not needed and adult bovine 
serum replaced horse serum. Once cultivation was available, the cryopreservation of strains 
became possible, and with it, the first reference strains were characterised. Growth 
efficiency in axenic cultures was improved by substitution of the ox-liver digest in TP-S-1 
by a mixture of yeast extract, iron, vitamin B 12, thioctic acid and polyoxyethylenesorbitan 
monooleate (Tween 80) in a new medium, TYI-S-33 (Diamond et al., 1978; Diamond, 
1980). However, gradual transfer from polyxenic to axenic conditions is necessary, since 
the process involves a long adaptation period and only virulent strains are likely to survive 
long term culture (Robinson, 1968). Although some axenic E. histolytica and a few E. 
dispar well characterised reference strains are available thanks to the process of 
axenisation, the problem of selection of "culturable" population remains. This could affect 
the many processes clarified by molecular studies, since their results could be an expression 
of phenomena due to the adaptive processes of the organism to culture and which might not 
represent the population composition in the host during the natural life cycle. An 
alternative approach to solve this problem from the molecular biological aspect is the study 
of uncultivated cyst-derived material. For this, it is necessary to establish a bank of samples 
or extracted nucleic acids from a wide range of geographical areas for further investigation. 
1.9.3 Zymodeme Characterisation 
The term "zymodeme" refers to a specific standard electrophoretic pattern of 
amoebic enzymes by which it is possible to group isolates. Reeves and Bischoff (1968) 
first studied electrophoretic patterns of five amoebic enzymes: Glucokinase (HK) EC 
2.7.1.1; Glucose-phosphate isomerase (GPI) EC 5.3.1.9; Phosphoglucomutase (PGM) EC 
2.7.5.1; Malate dehydrogenase (ME) EC 1.1.1.40; and NADP diaphorase (unclassified) to 
classify strains of Entamoeba species. 
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Comparison of the electrophoretic patterns of three enzymes: Glucose-phosphate 
isomerase (GPI EC 5.3.1.9), Phosphoglucomutase (PGM EC 2.7.5. l) and L-malate: NADP+ 
oxidoreductase (NIE EC 1.1.1.40) permitted the grouping of E. histolytica sensu lato into 
four groups according to the patterns found and based on those patterns, an association 
between the presence of a fast band in PGM and isolates from clinically symptomatic 
patients was established (Sargeaunt and Williams, 1978; Sargeaunt et al., 1978). Also, 
different patterns were found for E. hartmanni, Endolimax nana, lodamoeba buetschlii, 
Dientamoeba fragilis, E. moshkovskii (isolated from a crude sewage) some of which were 
know as the "Laredo" strains (isolated from man), E. invadens (isolated from snakes) and 
E. chattoni (isolated from monkeys). All these strains showed completely different patterns 
to those seen in strains of E. histolytica (Sargeaunt and Williams, 1979; Sargeaunt et 
al., 1980a). 
The use of zymodeme characterisation as a tool to describe the epidemiology of 
amoebiasis was first attempted by Sargeaunt et al., (1980b) in Mexico City. During this 
study the enzyme hexokinase (HK EC 2.7.1.1) was incorporated (Farri et al., 1980), where 
two bands of rapid migration were characteristic in pathogenic strains. Eleven zymodemes 
were described, and association of zymodemes II, VI, and XI to pathogenicity was 
established. Zymodemes were then formally defined as "a population of amoebae differing 
from a similar population in the electrophoretic mobilities of certain specified enzymes". 
Further studies of the epidemiology of amoebiasis in a rural area in Mexico 
(Sargeaunt et al., 1982b) revealed two new zymodemes: one pathogenic, XII and one non- 
pathogenic, XIII. A review of isoenzyme characterization of E. histolytica stated the 
presence of 14 zymodemes and established the isoenzyme patterns for other amoebae 
(Sargeaunt et al., 1982c). Also, new zymodemes (XI, XIX, and XX) were reported to be 
produced experimentally by Blanc et al., (1989) by mixing cultures of non-pathogenic with 
pathogenic zymodemes, and recently zymodeme XIX has been isolated from West Africa 
(Jackson and Suparsad, 1997) and Brazil (Barral de Martinez et al., 1995). The mixture of 
two pathogenic zymodemes (II and XIV) produced zymodeme XX with ay band in GPI 
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and PGM, also recently isolated by Gatti et al., (1997) from two institutionalised patients 
in a psychiatric hospital in northern Italy. All the patterns found were different for the 
different species and were recorded as standards for zymodeme determinations on isolates. 
However, Blanc and Sargeaunt (1991) found variability in the expression of the y and 6 
bands of GPI and PGM depending on the amount of starch used in Robinson's medium. 
When strains from zymodemes III, V, XI, XII and XX were cultured with low amount of 
starch (2-4 mg), the y band in PGM disappeared. Also, strains corresponding to 
zymodemes IV, V, VI, X, XII, and XVIII when cultured with 2-4 mg of starch lost their S 
band in the gels. The bands were expressed again in the gels when cultured with 12-15 mg 
of starch in Robinson's medium. In addition, intensity of the bands was directly 
proportional to the amount of starch in the culture medium, although a and ß bands of PGM 
and GPI never showed any variation. 
Later, Jackson et al., (1992) also reported a reduction from multiple to single 
banding patterns in the same two enzymes during axenisation of strains belonging to 
zymodeme XI, which changed to zymodeme II, both pathogenic, and strains belonging to 
zymodeme III became zymodeme I, both non-pathogenic, thus, there was no conversion 
from pathogenic zymodeme to non-pathogenic zymodeme or vice versa. Interestingly those 
results added to the controversy on the stability of zymodemes, which originated from the 
description of changes in isoenzyme patterns of non-pathogenic isolates during axenisation 
attempts by Mirelman et al., (1986) and Andrews et al., (1990). During the process, the 
associated bacterial flora from amoebic cultures was suppressed and replaced by irradiated 
bacteria. Changes in PGM and HK electrophoretic patterns were demonstrated (conversion 
from zymodeme III patterns to zymodeme II pattern), and a concomitant increment in 
virulence was observed. The converted strain reacted with the E. histolytica specific probe 
P 145, in contrast to the original culture which reacted with E. dispar specific probe B 13 3 
(Mirelman et al., 1986, Bracha et al., 1990). Reverse conversion was achieved by 
reassociating the original bacterial flora. The authors speculated about the probability that 
all E. histolytica strains contain copies of the same sequences in their genomes, but changes 
in conditions of growth may cause the amplification of different elements and express 
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modified amoebic components and behaviours, for example making them develop 
pathogenic characteristics. Those observations seemed to imply that sources of stress, such 
as adaptation to a new medium, exposure to antibiotics, and alterations in the bacterial flora 
in culture could induce expression of repressed genes or a post-translational process in 
proteins responsible for aggressive behaviour. However, the probability of selection of a 
previously existing but undetectable subpopulation in the original cultures was considered. 
Failure of several authors attempting to reproduce conversion following the 
methodology described in the original papers suggests artifactual results in the original 
studies (Clark et al., 1992, Jackson et al., 1992). A possible explanation for the switch in 
aggressive behaviour was cross-contamination of cultures and further experiments by Clark 
and Diamond (1993) demonstrated that the converted isolates were identical to the 
corresponding reference cultures and that as few as 10 pathogenic trophozoites were able 
to overgrow a non-pathogenic culture. This phenomenon was demonstrable by riboprinting 
after 72 hours in non-pathogenic cultures where bacterial flora was suppressed. Changes 
of isoenzyme patterns were evident after 11 subcultures. Thus, contamination of the non- 
pathogenic culture with pathogenic forms during the axenisation process seems to have 
been the source of such conversions and the doubts about the stability of zymodemes were 
dismissed. 
The relevance of the culture technique with zymodeme analysis for the differential 
diagnosis of amoebiasis was highlighted during a survey on the prevalence of amoebiasis 
in Mahe, an island belonging to the Seychelles. The results of this study confirmed the 
problem of both overdiagnosis and misdiagnosis of amoebiasis by microscopy when using 
culture and zymodeme analysis as gold standards. During a first screening, 24 samples 
were reported positive for E. histolytica by the resident laboratory, however, after quality 
control, only 50% were E. histolytica/E. dispar infections and after further culture and 
zymodeme analysis, only 8.3% (2/24) were true E. histolytica and 41.6% (10/24) were E. 
dispar. The lack of measurement of cysts was reflected in the report of the resident 
laboratory which included 20.8% (5/24) samples with E. hartmanni that were originally 
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identified as E. histolytica positive specimens by the microscopist (Sargeaunt, 1992). 
During a second screening, a different laboratory on the island reported 12 samples as 
positive for E. histolytica, from them, isoenzyme analysis identified 5 (41.6%) E. dispar 
infections, 6 (50%) E. hartmanni strains and one was D. fragilis. The results from the 
Mahe study revealed that from 313 stools cultured, 121 gave a positive culture, from which 
6.6% were identified as E. histolytica isolates, 33% were classified as E. dispar and 60.3% 
were positive for other intestinal amoebas. At this point it is necessary to note that the 
sensitivity of the culture technique is variable and when a culture does not grow it should 
not be necessarily assumed that it reflects a misdiagnosed sample. Nevertheless, the 
samples containing E. histolytica/dispar in the Mahe study (48/313) revealed a prevalence 
of 2.5% (8/313) for E. histolytica infections and 12.7% (40/313) for E. dispar infections 
after their confirmation by zymodeme analysis on the relevant cultures. Those 48 E. 
histolytica/E. dispar infections identified by microscopy masked 16.7% (8/48) true E. 
histolytica infections and, importantly, 83.3% E. dispar carriers, that would have been 
overdiagnosed as having E. histolytica. 
Polyxenic culture of specimens with zymodeme analysis is a very valuable tool and 
it is currently the gold standard technique for the classification of isolates as invasive or 
non-invasive strains. However, because zymodeme analysis is not a technique of routine 
use during clinical diagnosis of amoebiasis, it is only available in few reference laboratories 
through the world. The technique is expensive and not ideal, taking more than a week, the 
failure of some cysts to grow, and the loss of cultures before lysates can be made. 
Moreover, as mentioned above, selection of amoebic population occurs in the process of 
initial cultivation and subsequently in continuous culture. Added problems are the 
experience and skill required for the careful standardisation of cultures, manipulation of the 
protein lysates and interpretation of the electrophoretic patterns. 
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1.9.4 Antibody Detection 
Serology is one of the most useful tools for the diagnosis of extraintestinal 
amoebiasis and seroprevalence is a good global indicator of endemicity of invasive 
infection, especially when data on differential diagnosis are not available. The importance 
of techniques such as Enzyme-Linked Immunosorbent Assay (ELISA), radioimmunoassay 
(RIA), indirect immunofluorescence (IFAT) and indirect haemmagglutination (IHA) arises 
from the possibility to examine a large number of samples rapidly, with small amounts of 
serum and with reasonable sensitivity and specificity (Maddison, 1991). Although a wide 
variety of serological tests are currently successfully used in developed countries to detect 
extraintestinal amoebiasis, in 95% or more cases (Krogstad et al., 1978), the distinction 
between background levels of antibody in uninfected persons and raised levels in persons 
suffering from intestinal disease in endemic areas is difficult to assess due to the fact that 
antibodies can persist for 2 to 5 years or more after therapy (Krupp and Powell, 1971). 
Indirect haemagglutination uses erythrocytes sensitized with axenically cultured 
antigen. If present, antibodies react against and agglutinate the red cells. It has been 
reported to be positive in 87% to 95% of amoebic liver abscess and in 85% to 95% of 
patients with acute amoebic dysentery (Proctor, 1991). For indirect immunofluorescence 
(IFAT) methanol or acetone fixed trophozoites are incubated with patient's serum on a 
slide. Antibodies will bind to the trophozoites and the reaction can be detected with anti- 
immunoglobulins labelled with fluorescein. Vijayamma et al. (1981) evaluated this 
technique for the diagnosis of invasive amoebiasis. The test was positive in 96% of the 
patients with hepatic amoebiasis and in 73% of those with amoebic dysentery. The test was 
not useful in cases of amoebic colitis, in which only 15% of the cases had positive reaction 
with low titres. When compared to indirect haemagglutination, Carvalho et al. (1991) 
found IFAT to be equally sensitive to IHA in individuals with E. histolytica trophozoites. 
The test was positive in 75% of the individuals, confirming previous reviews (Healy, 1971). 
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ELISA is one of the most sensitive and specific techniques used in the diagnosis of 
hepatic amoebic abscess. The test can be performed without sophisticated technology and 
can be read visually or by colorimeter. Highly skilled personnel are not necessary and the 
test can be adapted to use microquantities of reagents and serum. Crude extracts (Aguirre 
et al., 1991a, Restrepo et al., 1996; Kraoul et al., 1997), the purified adhesin from axenic 
cultures of E. histolytica reference strains (Abd-Alla et al., 1992, Braga et al., 1996) and 
recombinant proteins (Stanley et al., 1990, Lotter et al., 1993) are among the different 
sources of antigen used. 
One of the ELISA techniques that has incorporated the use of a novel antigen is the 
detection of IgG raised against the heavy subunit of the galactose-inhibitable adherence 
lectin for the diagnosis of invasive amoebiasis. The protein was affinity purified from 
axenic cultures of E. histolytica, using a mixture of five mouse monoclonal antibodies. 
Although sensitivity was found to be 94% and specificity is 90%, it does not differentiate 
between past and present infections (Abd-Alla et al., 1992). Also, as opposed to the use 
of crude antigen where a greater number of epitopes are exposed to the sera tested, using 
one antigen limits the response measured. Nevertheless, the advantage of systems using 
recombinant technology is that such systems eliminate the need for massive culture of this 
fastidious organism. The problem could be solved by the use of a mixture of different 
recombinant antigens. 
Commercial tests for the detection of anti-E. histolytica antibodies are available. 
Kraoul et al., (1997) evaluated an indirect hemagglutination (IHA Amoebiasis kit, Fumouze 
Diagnostics, France), a latex agglutination (LA Bichro-latex kit, Fumouze Diagnostics) and 
a rapid enzyme immunoassay kit based on the standard ELISA format (EIA, Amibiase 
Serologie, LIVID, California). A population of 143 sera were screened, including 43 sera 
from patients with diagnosis of hepatic amoebiasis, 33 sera from patients diagnosed with 
a hepatic disease different from amoebiasis and 67 healthy individuals. The highest 
sensitivity was achieved with the IHA kit (97.6%), with a specificity of 97%; the positive 
predictive value was 93.3% and the negative predictive value was 98.9%. However, EIA 
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was 100% specific and sensitivity was 93%, with a positive predictive value of 100% and 
a negative predictive value of 97.1%. LA specificity was compared against the EIA results 
and it was found to be 95%, with a sensitivity of 90.7%. The lowest positive and negative 
predictive values were scored by this test, 88.6% and 95.9% respectively (Kraoul et al., 
1997). 
The use of EIA was considered of advantage for sample processing (20 minutes) 
and simplicity. Although costs are higher than IHA and LA, they are reduced when the 
number of samples to process increases, making it ideal for its use in endemic areas for the 
diagnosis of hepatic amoebiasis. Dot-ELISA, is a variation of the standard ELISA 
microwell format that was developed by Kumar et al., (1983). This test uses nitrocellulose 
sheets as the matrix to which the antigen is applied. The advantages of this technique are 
the reduction of incubation times compared to conventional ELISA and that predotted 
sheets can be stored for up to three months making them available for field use. 
The comparison of two recently standardised serological tests (including a 
recombinant antigen) with an EIA in which the antigen was a standard crude soluble extract 
(SA-EIA) of E. histolytica was carried out in South Africa by Lotter et al., (1995). The P1- 
EIA test is based on a recombinant surface protein of E. histolytica and the latex 
agglutination test (M-LA) uses a membrane fraction as the antigen covering the polystyrene 
beads. After testing 76 patients with proven invasive amoebiasis and 91 control subjects 
with no amoebiasis but other conditions comprising lung and liver disease, cancer, 
gastroenteritis, and other abdominal or general diseases, the sensitivity of M-LA and P 1- 
EIA were 96.1% and 86.1% respectively whereas specificity was 92.3% and 96.7% 
respectively. The SA-EIA assay had the best sensitivity at 97.4% although its specificity 
was lowest at 62.5% due to detection of high antibody titres in the control group. 
Persistence of antibodies after treatment was measured with the P 1-EIA test in 16 
patients with amoebic liver abscess and high antibody titres at admission. All patients 
except one tested negative or slightly positive after a5 month follow up period (Lotter et 
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al., 1995). The clearing of anti-Pl specific antibodies could indicate the possibility of using 
this test in endemic areas, however, it is necessary to test considerably more samples 
against other crude antigen preparations such as whole lysates of cultured trophozoites. 
1.9.5 Antigen Detection 
The difficulty of sensitive and specific detection of E. histolytica in faecal samples 
has led to the development of many antigen detection methods using solid phase 
immunoassays. Root et al., (1978) used an immunochemical method involving a rabbit 
polyclonal IgG conjugated to enzyme able to detect as little as 0.22 gg/ml of amoebic 
protein. However, freezing resulted in the loss of reactivity of the sample and non-specific 
background was increased after storage of the samples for 24 hours at 4°C. Some non- 
specific reaction was due to the presence of peroxidase activity in the sample, pigments 
masking the enzyme reaction and unidentified cross reacting components. Additionally, 
the long incubation times with the sample and with the conjugate were perceived to be 
disadvantageous for mass screening of samples. Later, during a survey in Mexico city, the 
test revealed a prevalence of infection of only 4.4%, compared to 10.6% detected by 
microscopy (Randall et al., 1984). With hindsight, however, no doubt a proportion of the 
infections diagnosed microscopically as "E. histolytica" were E. hartmanni, or E. dispar. 
The use of a multilayer ELISA by Grundy (1982) brought a new possibility for the 
development for the detection of E. histolytica antigens in stool samples. This ELISA used 
a rabbit anti-E. histolytica capture antibody and a human anti-E. histolytica 
immunoglobulin as the detecting antibody. The sensitivity of the test was 0.15-0.3 µg/ml 
E. histolytica protein, equivalent to 1 trophozoite. The test did not react with faeces 
containing E. histolytica cysts. This was probably due to the antigenic differences between 
cysts and the trophozoites used to produce the capture antibody. In 1987 the system was 
modified in order to detect cyst passers excreting low numbers of parasites (Grundy et al., 
1987). The system used specific sheep anti-E. histolytica immunoglobulins as the capture 
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step and rabbit anti-E. histolytica IgG as the detecting antibody. The conjugate was sheep 
anti-rabbit immunoglobulin coupled to horseradish peroxidase. A slightly different 
approach with the capture ELISA format was followed by Baumann and Gottstein (1987) 
with a double-antibody sandwich ELISA for the detection of detergent-solubilized E. 
histolytica antigen in stool samples using rabbit hyperimmunoglobulins for the capture and 
the detection steps. This assay was reported to have a sensitivity of 93% and a specificity 
of 93%. The results of this test were not affected by the repeated freezing and thawing of 
the samples nor by their storage for several months. However, the assay was able to detect 
only trophozoites, probably due to the different antigenic determinants released during the 
solubilizing procedure, with the cysts being more resistant than trophozoites. 
Among the currently commercially available tests for antigen detection in faeces, 
ProSpecT EIA (Alexon Inc., Sunnyvale, CA) is widely used for detection of E. 
histolytica/E. dispar infections by detecting an "E. histolytica-specific" antigen (EHSA), 
with a sensitivity of 78% and a specificity of 99% when compared to microscopical analysis 
(Ong et al., 1996). Further evaluation of this test revealed a 35% sensitivity when 
compared to microscopy of faecal samples (Benzeguir and Kettis, 1997). The test was also 
evaluated with samples from 469 German travellers returning from endemic areas. In this 
study, the sensitivity of the test was 90.3% while by microscopy only 87.1 % of cases were 
detected (Jelinek et al., 1998). However, although the sensitivity of the ProSpecT EIA is 
better than microscopy, this test does not differentiate E. histolytica from E. dispar and as 
such is useful for screening purposes only. 
Antigen detection using monoclonal antibody technique is an attractive approach 
for the diagnosis of amoebiasis. One of the advantages of using these antibodies is the fact 
that they can be selected against a group of antigens to achieve a high level of specificity 
and sensitivity. Once the cell line secreting the antibody is obtained, it should be immortal 
and a constant source of monoclonal antibody. However, monoclonal antibodies often have 
low affinity constants rendering assays insensitive. It is therefore necessary to choose for 
affinity as well as for specificity. The use of enzyme immunoassays incorporating 
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antibodies for the detection of antigens in body fluids is becoming more widespread. The 
increased specificity provided by the monoclonal antibody is linked to higher sensitivity 
due to the enzyme-substrate amplification stage. 
Ungar et al., (1985) developed an indirect enzyme-linked immunosorbent capture 
assay for the detection of E. histolytica in human faeces using a monoclonal antibody for 
the capture step and immune rabbit sera for detection. The test had a 82% sensitivity and 
98% specificity. This capture assay could detect both cysts and trophozoites even if the 
samples were frozen. The use of monoclonal antibodies has the advantage of bulk 
production but the structural lability of the antibody produced makes it difficult to keep 
them attached to solid phase surfaces. 
Strachan et al., (1988) reported a technique using monoclonal antibody in 
immunofluorescence. The advantage of this technique was the possibility to distinguish 
between pathogenic and non-pathogenic E. histolytica quickly (2 days) compared to 
diagnosis by isoenzyme tests. The disadvantage of this assay was the necessity to establish 
cultures from the stools in order to obtain trophozoites to be tested. Only 50% of the stools 
cultured in this study were positive. Tachibana et al., (1990) produced the monoclonal 
antibody 4G6 that reacts only with pathogenic strains of E. histolytica and identified an 
invasive-specific antigen with a molecular weight of 30 kDa which is used for diagnosis 
in cultures. 
Gonzalez-Ruiz et al., (1992) produced a monoclonal antibody capable of identifying 
invasive strains of E. histolytica by immunofluorescence. When assayed by western blot, 
it reacted with an 84 kDa antigen in pathogenic strains and with an 81 kDa antigen in non- 
pathogenic strains. The fact that this antibody recognises only invasive strains by IFA on 
methanol fixed amoebas suggests that this epitope is detected only under non-denaturing 
conditions in invasive strains and it is present but non exposed in non-pathogenic strains. 
Also recently, detection of the galactose and N-acetylgalactosamine inhibitable adherence 
lectin of E. histolytica and E. dispar has been made available in the form of two 
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commercially available tests, Eh/Ed CELISA with Mabs detecting epitopes 1 and 2 and the 
specific E. histolytica CELISA test uses Mabs against epitopes 3 to 6 to detect the adhesin 
of E. histolytica (Cellabs, Cat. Ref. KE1 and KE2 respectively). 
1.9.6 Nucleic Acid Detection 
Molecular biological technology has been used to distinguish pathogenic from non- 
pathogenic strains of E. histolytica by means of techniques involving the use of DNA 
probes and the Polymerase Chain Reaction (PCR) in the same assay. The advantages of 
these techniques are their sensitivity (<200 trophozoites) and specificity since with 
appropriate stringency conditions, no cross reactions with other amoebae are present 
(Bracha et al., 1990). Moreover, Samuelson et al., (1989) reported direct detection of E. 
histolytica in faeces using a DNA probe. Specific applied molecular biological techniques 
in faecal material provide more accurate information of the organisation in the infecting 
population because the problem of culture media selection pressure is avoided. Garfinkel 
et al. (1989) isolated non-coding repetitive elements from the 23 kb extrachromosomal 
episome of E. histolytica and reported two DNA probes: one (P133), specific for non- 
pathogenic forms and the second (P 145) specific for pathogenic strains. Comparison of the 
DNA sequences showed only 44% identity, giving support for high genomic differences 
between pathogenic and non-pathogenic E. histolytica. 
At approximately the same time, the detection by two single copy cDNA probes 
representing homologous genes in two strains of E. histolytica, one pathogenic (cEH-P 1) 
and the other non-pathogenic (cEH-NP 1) was reported by Tannich et al., (1989). DNA 
sequence analysis on these particular sequences together with the comparison of their 
predicted amino acid sequences showed 12% evolutionary divergence in structure. These 
findings support the hypothesis of 2 genetically defined species in E. histolytica. 
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Studies on homologous cysteine proteinases of E. histolytica by Tannich et al., 
(1991) revealed a 16% divergence in the nucleotide sequence when pathogenic and non- 
pathogenic subspecies were compared. Support for the hypothesis of the existence of two 
morphologically indistinguishable species in E. histolytica was also provided by Clark and 
Diamond (1991). When studying the multicopy ribosomal RNA genes (on episomal DNA) 
of the two forms they found that they were distinct with an estimated genetic distance 
between the small subunit rRNAs of pathogenic and non-pathogenic strains of 2.2%, 
comparable to differences found between human and mouse rRNA. Also, 15 pathogenic 
strains of E. histolytica isolated worldwide had identical riboprints. Cruz-Reyes et al. 
(1992) confirmed the hypothesis of Clark and Diamond (1991) when performing a 
fingerprint analysis of total DNA from E. histolytica isolates by probing with recombinant 
ribosomal DNA sequences amplified by PCR. 
1.10 Treatment 
Amoebicides (drugs for the treatment of amoebiasis) are divided into three 
categories namely luminal, systemic and mixed amoebicides. Luminal amoebicides are 
characterised by their low absorption in the lumen: diloxanide furoate (Furamide), the 
halogenated 8-hydroxyquinolines diiodohydroxyquin (lodoquinol) and 
iodochlorohydroxyquin (Clioquinol or Enterovioform); also antibiotics such as 
erythromycin, tetracycline and paromomycin (Humatin) are able to eliminate luminal 
forms. Systemic amoebicides, which include emetine, dehydroemetine and chloroquine 
(Aralen) are used to eliminate tissue forms (invasive trophozoites) and are less effective 
against luminal forms. Mixed amoebicides such as the nitroimidazole derivatives 
metronidazole (Flagyl), tinidazole (Fasigyn), and ornidazole (Tiberal) are effective against 
both luminal and systemic forms, however because their rapid absorption, their 
effectiveness against luminal forms is reduced and they are normally administered in 
association with a luminal amoebicide (Webster, 1990; Saavedra-Lira and Perez-Montfort, 
1996). 
56 
Chapter 1 Introduction 
The most widely used drug is metronidazole (1-[2'-hydroxyethyl]-2-methyl-5- 
nitroimidazole), a 5-nitroimidazole whose broad spectrum of protozoal and antimicrobial 
activity includes the treatment of trichomoniasis, amoebiasis and giardiasis as well as 
serious entities caused by anaerobic bacteria (Bacteroides spp., Clostridium spp., 
Fusobacterium spp., Peptococcus spp., Peptostreptococcus spp. and Eubacterium spp. ). 
The mode of action of the drug is based on the reduction of the drug by pyruvate: ferredoxin 
oxidoreductase to give a toxic free radical. The capacity of the intermediate products to 
oxidize the DNA causes strand breakage, loss of the helical structure by interaction with 
guanines and cytosines and cellular death in bacteria (Coulson, 1995). 
Acute amoebic colitis is treated with 750 mg of metronidazole three times daily for 
5-10 days, orally or intravenously. Side effects of metronidazole are nausea, vomiting and 
abdominal discomfort. Alcohol ingestion must be avoided when taking metronidazole 
because of the uncomfortable side effects caused by inhibition of the enzyme alcohol 
dehydrogenase (disulfiram effect). The possibility of mutagenic and carcinogenic effects 
has been proposed after positive results were seen in the Ames Salmonella mutant test and 
in animal models. Early reports from Legator et al., (1975) detected mutagenic activity 
(using the Ames test) in urine of patients after 6 days of treatment. Studies by Rustia and 
Shubik (1979) where metronidazole induced hepatomas, mammary and pulmonary tumours 
in noninbred rats after prolonged treatment seemed to confirm those results. In addition, 
studies from Ostrosky-Wegman et al., (1994) used biomarkers of cell proliferation in 
lymphocyte cultures of individuals treated with metronidazole and found an increase in 
lymphocyte proliferation after treatment. However, Beard et al, (1979) found no 
appreciable increase of cancer in humans after the use of metronidazole, and Friedman & 
Shelby, (1989) did not notice a rise in the incidence of tumours. 
The controversy remains today since implication of metronidazole as a dangerous 
agent is difficult due to the large latency periods between exposure, clinical manifestations 
and detection bias in the cancer studies. 
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During treatment of amoebic colitis it is important to continue the course of 
treatment with luminal agents since metronidazole reaches lower conentrations in the 
lumen. Although its mechanism of action is not yet known, the most common luminal agent 
is diloxanide furoate, with an efficacy rate higher than 90%, given 500 mg orally three 
times daily for 10 days. Among the 8-hydroxyquinolines used as luminal amoebicides, 
lodoquinol (Diiodohydroxyquin) is also used, 650 mg three times a day orally for 20 days 
but must be avoided in patients with hepatic failure or iodine allergy. Doses exceeding 2 
g per day for long periods are associated with subacute myelo-optic neuropathy (SMON) 
(Webster, 1990). Aminoglycoside antibiotics such as Paromomycin are administered over 
5-10 days in doses of 1.5 g per day or three doses of 25-35mg/kg/day in children. 
In cases of extraintestinal amoebiasis, metronidazole remains the treatment of 
choice. Cure rates greater than 95% are reached when the drug is given for 5-10 days. 
Other drugs such as chloroquine, emetine and its less toxic derivative, dehydroemetine are 
used for the treatment of severe invasive intestinal and extraintestinal amoebiasis but their 
use is restricted to cases where nitroimidazoles are ineffective or contraindicated. Emetine 
blocks the synthesis of proteins in the trophozoite by inhibiting the transfer of peptidyl- 
tRNA in the ribosome from the aminoacyl to the peptidyl site. Some of its adverse effects 
involve the cardiovascular and neuromuscular systems, the central nervous system and the 
gastrointestinal tract (Webster, 1990). 
Although little is known about resistance to drug treatment in amoebiasis and there 
are only a few reports on treatment failure, emetine resistant strains have been produced in 
vitro. Those strains exhibit the same characteristics found in mammalian tumour cells with 
multidrug resistance phenotype (MDR), which are resistant to multiple chemotherapeutic 
drugs and overexpress a P-glycoprotein which increases drug efflux. Cross-resistance to 
hydrophobic anti-amoebic drugs such as colchicine, iodoquinol and diloxanide is one of the 
features of the amoebic emetine-resistant mutants, and six P-glycoprotein-like genes with 
40-41 % homology to human mdr genes have been characterised (Descoteaux et al., 1992; 
Gomez et al., 1996). Therefore, the emergence of wild populations of E. histolytica 
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carrying mdr genes must be considered as a potential problem for the future control of 
invasive amoebiasis. 
New anti-amoebic compounds based on the energy metabolism of E. histolytica are 
under development. Inhibitors such as gossypol, particularly targeting alcohol 
dehydrogenase and malic enzyme, and several bisphosphonates, inhibitors to the PPi- 
dependent enzymes phosphofructokinase and pyruvate phosphate dikinase are being tested. 
Compounds, with few toxic effects, could offer a safer alternative for the treatment of 
invasive amoebiasis (Saavedra-Lira and Perez-Montfort, 1996; Byington et al., 1997). 
1.11 Epidemiology and Control 
Assessing the epidemiology of amoebiasis in the world is a difficult task due to the 
technical difficulties and because many of the previous studies on the transmission 
dynamics of amoebiasis were based on the observation of cyst excreting individuals, the 
majority of whom were probably harbouring E. dispar. Problems in the estimation of 
prevalence are related to the lack of clear case definitions and homogeneous methodology 
for the diagnosis in the different studies, selection bias in the populations sampled, and 
inability to easily identify invasive strains. For this reason, previous reports on prevalences 
of cyst excretion are to be re-evaluated using new differential diagnostic tools in order to 
separate E. histolytica from E. dispar infections. Based on the review of the prevalences 
and incidences of amoebiasis from 1970 to 1985, Walsh (1986) concluded that despite the 
fact that in the population infected with E. histolytica sensu lato, prevalence remained the 
same during this period of time, the growth of the population reflected an increase in the 
incidence of infection. From 500 million people infected, 38 million developed invasive 
disease and from those, about 40 thousand died. Simplistically, we can deduce that 90% 
of infections were probably due to E. dispar and the remaining 10% of infections were due 
to E. histolytica. This remains to be confirmed using modem techniques. 
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Prevalences of amoebiasis in endemic areas remain stable and mortality is low. 
However, morbidity causes a great economic impact in poor populations in terms of 
production and it is directly related to their daily subsistence income. The patterns of 
infection and disease for E. histolytica differ from other intestinal protozoa, for example, 
it has been observed that susceptibility to clinical amoebiasis increases with age, so that 
adults are ten fold more susceptible to develop invasive disease compared to children, and 
males are more likely to develop invasion than females (Bundy, et al., 1992). However, 
because of their role in the household, females seem to be the source of infection to 
children (Bray and Harris, 1977; Ruiz-Palacios et al., 1992). 
Improvement in water supply availability, together with sanitary education and 
adequate excreta disposal may reduce transmission but longitudinal studies with 
homogeneous methodology and good control of confounding variables must be designed. 
The presence of E. histolytica cysts in the environment is difficult to demonstrate although 
cysts are able to survive moist environments, and, remain viable in water supplies, 
seawater, faeces, night soil, sewage and crops contaminated through irrigation with 
contaminated water or night soil. However, cysts are sensitive to desiccation, which 
reduces their viability on the surface of vegetables to three days in dry conditions or less 
than one day in the environment under dry, hot weather. Vegetables are made safe by 
soaking them in water at 55 °C, vinegar for 30 minutes (Warhurst, 1983). 
The most effective method for the control of the transmission of parasitic diseases 
is the sanitation of water at high temperature. Heating water at 60'C for 1 minute or at 
55'C for 10 minutes ensures total destruction of cysts, however, cysts survive longer in 
water at lower temperatures. Cysts are also eliminated by chlorination of water in the form 
of 3 mg/L of free chlorine residual ie. after the specified contact time of 30 minutes, there 
is 3mg/L free chlorine remaining. However, the process is again temperature dependent and 
normally requires higher conentrations or longer contact times than those used to eliminate 
faecal bacteria (Warhurst, 1983). For the latter, only 0.5 to 1 mg/L residual chlorine is 
needed for 30 minutes. 
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Treatment of cyst excretors is one of the proposed approaches for the control of 
amoebiasis. Mass treatment has been applied in some endemic areas, with a rapid 
reduction in prevalence. However, reinfection rates are high and this approach must be 
carefully considered under the knowledge that 90% of infections are due to E. dispar and 
the risk of invasive amoebiasis in those carriers is very low (Ruiz-Palacios et al., 1992). 
Drug pressure is also an important factor for the emergence of drug resistant populations 
of parasites, which could create greater public health problems. 
The improvement of quality of life (housing, sanitation and education) is the holistic 
approach suggested for the success of parasitic control programmes. However, those 
measures are only effective with an adequate infrastructure for primary health care at the 
community level (Mata, 1982). Mathematical modelling in amoebiasis is useful to predict 
the effect of potential intervention. A theoretical model proposed by Knight (1975) 
suggests that an improvement in hygiene will halve transmission in a population with a 
50% prevalence of amoebic infection if applied for more than 10 years, meanwhile mass 
treatment will not be effective if transmission remains constant. 
The identification of virulent organisms is an important target to improve the cost- 
effectiveness of treatment and to propose prophylactic measures and control strategies for 
E. histolytica infection. New diagnostic strategies and estimation of infection prevalences 
are needed for the evaluation of the epidemiology and distribution of E. histolytica and E. 
dispar in endemic and non-endemic areas. Also, only after carefully planned long term 
prospective studies will it be possible to establish effective intervention measures for the 
control of amoebiasis. Other intervention strategies such as a vaccine have been proposed 
for the control of amoebiasis and protection studies with the galactose-specific adherence 
lectin of E. histolytica suggest that a recombinant vaccine is likely to be available in the 
future (Petri and Ravdin 1991, Zhang and Stanley, 1997, Stanley, 1997) 
As in many other parasitic infections, the factors influencing the worldwide 
distribution of amoebic infection remain unclear. From a universal point of view, it is 
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known that the interaction of factors such as the environment, human behaviour and 
parasite biology affect the epidemiology and transmission of parasites. For instance, 
limiting faecal-oral transmission by encouraging improvements in hygiene habits in food 
handlers, specially women and girls, and linking the hygiene campaigns to availability of 
good quality water supplies and soap would lower the rate of parasite transmission. 
However, it is also desirable to readily identify reinfections through epidemiological 
surveillance programmes in endemic areas. Research on the environmental, sociocultural 
and behavioural factors relevant to amoebiasis is needed. 
1.12 Aims of the Project 
1. To confirm the data on prevalence of intestinal amoebic infection in two areas believed 
to be endemic in Colombia, using routine microscopy of stool samples, culture and 
serology. 
2. To evaluate the potential of MAb 20/7D to be incorporated as a tool for the differential 
diagnosis of amoebiasis in endemic areas. 
3. To standardise a PCR system for the sensitive and specific differential diagnosis of 
amoebiasis in clinical samples. 
4. To evaluate PCR-SHELA as a tool for differential diagnosis of amoebiasis in endemic 
and non-endemic areas. 
5. To propose effective research targets in endemic and non-endemic areas according to 
the new data obtained from the evaluation of new differential diagnostic tools. 
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CHAPTER 2 
GENERAL METHODS 
2.1 Microscopy of Stool Samples 
Two smears of approximately 2 mg of each fresh stool sample were prepared on a 
microscope slide. The smear at one end of the slide was made in isotonic saline solution 
(Appendix 1) and the smear at the other end was stained with one drop of Lugol's-iodine 
solution (Appendix 1). Each smear was covered with a 22x22 mm glass cover slip. The 
sample was examined by microscopy with lOX and 40X objectives for the presence of 
trophozoites in the saline side of the slide and for the presence of cysts and ova on the 
Lugol's iodine half. All cysts of amoebas were measured with an ocular micrometer to 
ensure the quality of the diagnosis. 
2.2 Zinc Sulphate Concentration Method 
Three serial samples from each subject were pooled and approximately lg was 
diluted in 14 ml of a saturated zinc sulphate solution prepared in water (density 1.18) and 
centrifuged at 1500 rpm for 15 minutes. A cover slip was then carefully placed over the 
liquid surface on each centrifuge tube and after one minute it was transferred to a glass slide 
with a drop of Lugol's iodine (Faust, et al., 1938) and each sample was examined for the 
presence of cysts. 
2.3 In Vitro Culture of Trophozoites 
2.3.1 Axenic Culture of Entamoeba histolytica Trophozoites 
Axenic trophozoites of Entamoeba histolytica, ( strain HM I -IMS S) were grown 
in TYI-S-33 medium (Diamond et al., 1978a. See Appendix 1) in 12 ml flat sided Nunc 
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culture tubes (Nunc 1-56758A) at 37°C and growth was checked every 24 hours using an 
inverted microscope until confluent growth was achieved. These cultures were then chilled 
on an ice bath for 20 minutes in order to detach the trophozoites, centrifuged at 200xg for 
10 minutes at 4'C, and the pellet was resuspended in fresh medium and distributed into 25 
cm2 cell culture flasks. The medium in each flask was replaced every 48 to 72 hours until 
the growth became confluent. For antigen preparations, the trophozoites were harvested 
by centrifugation, and the pellets were washed in chilled PBS pH 7.2 (Appendix 1), 
repeating the procedure 3 times. These cells were then counted using an improved 
Neubauer haemocytometer, adjusted to lx106 trophozoites/ml and the pellets were stored 
at -70°C. 
2.3.2 Polyxenic Culture (Robinson, 1968) 
About 50 mg of each faeces was added to a culture bottle containing a saline agar 
slant, 0.1 ml of 0.5% erythromycin (Sigma E-6376), approximately 10 mg of rice starch 
(BDH), and 2 ml of primary Robinson's medium (Appendix 1). Each culture was incubated 
for 24 hours at 37'C before the supernatant was removed and replaced by secondary 
Robinson's medium (Appendix 1). After a further 24 hours incubation, each supernatant 
was discarded and an aliquot of the sediment was examined microscopically for the 
presence of trophozoites after addition of Lugol's iodine. When positive, subcultures were 
made three times a week in secondary Robinson's medium and an average of 5 sediments 
per isolate were pooled before expanding. Each pool was transferred into a 25 cm2 cell- 
culture flask and filled with liquid Robinson's medium (Appendix 1), incubated at 37'C 
for 48 hours and chilled in ice-water bath for 20 minutes. After centrifugation at 200xg for 
10 minutes at 4°C, the trophozoites were washed 3 times in PBS pH 7.4 and cells were 
counted in haemocytometer. Pellets were processed according the corresponding antigen 
preparation. 
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2.4 Isoenzyme Characterisation of Isolates 
Starch gel electrophoresis was used to separate specific isozymes (hexokinase, HK 
EC 2.7.11; glucose-phosphate isomerase, GPI EC 5.3.19; L-malate dehydrogenase, ME EC 
1.1.1.40; and phospho-glucomutase, PGM EC 2.7.5.1) by size and charge and therefore to 
classify different isolates of E. histolytica and E. dispar as described by Sargeaunt et al. 
(1978). The variation in protein structure of these enzymes indirectly reflects the presence 
of genetic differences among organisms. The advantage of using enzymes for the 
classification of isolates is the specificity of their substrates, yielding specific migration 
patterns. 
2.4.1 Lysates for Starch Gel Electrophoresis 
Lysates were prepared from a minimum of WO' 105 trophozoites per ml. After 
centrifugation at 200xg for 5 minutes, the supernatants were discarded and the pellets were 
diluted with 20 µl of lysis buffer which contained protease inhibitors (Appendix 1) and then 
immediately transferred to liquid nitrogen. 
2.4.2 Starch Gel Electrophoresis 
4.3 g of electrophoresis starch (BDH) was dissolved in 43 ml of the corresponding 
tank buffer (Appendix 1) in a round-bottomed flask. This mixture was stirred while being 
heated to boiling temperature. The mixture was then degassed and 40 ml was spread onto 
each glass plate and allowed to cool for 20 minutes. Meanwhile, each of 4 tanks was filled 
with 800 ml of the corresponding tank buffer (Appendix 1) and two sponge (plastic) wicks 
were soaked in the same buffer. The cooling plate was put in the tank and connected to 
the tap. Embroidery cotton boiled in water and dried on filter paper was cut into threads 
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for sample application. When ready, slots were made in the gel and the lysates were 
thawed. Threads were saturated in these samples and placed with forceps in the slots (one 
thread for one sample) ensuring that they were below the gel surface. Each gel was then 
placed in the tank, and the wicks were then adjusted to ensure that a good contact between 
the buffer and the gel was obtained. A thin glass plate was placed crosswise onto each gel 
plate and a thick glass cover was placed covering the gel plates. Each gel was subjected 
to a constant current of 20 mA (240 V) for 3 hours while each gel was cooled by the 
circulation of tap water at approximately 15 °C. 
2.4.3 Substrate Preparation for Isoenzymes 
After electrophoresis, each gel was stained with a specific substrate in the dark. ME 
was developed by incubation with a mixture containing malate, NADP, phenazine 
methosulphate (PMS) and the tetrazolium salt, MTT. The NADPH2 formed by the 
enzymatic reaction, in the presence of PMS (hydrogen carrier), reduced the MTT to a blue 
insoluble formazan which was deposited at the sites of ME activity. 
GPI was stained by a similar method by employing fructose-6-phosphate, glucose-6- 
phosphate dehydrogenase (G6PD) (linking enzyme), NADP, PMS and MTT. Glucose-6- 
phosphate formed at the sites of PGI activity, then reacted with the NADP in the presence 
of the G6PD to form NADPH2 and then reacted with PMS to reduce the MTT to formazan 
(Bagster and Parr, 1973). 
PGM was developed using glucose- l-phosphate, glucose 1-6-diphosphate, NADP 
and glucose-6-phosphate dehydrogenase (see above). HK was identified by its ability to 
convert glucose to Glucose-6-phosphate with conversion of added Adenosine 5'- 
Triphosphate into Adenosine diphosphate. Glucose-6-phosphate dehydrogenase is the 
linking enzyme to convert G6P into 6-phosphogluconate. This reaction produces NADPH2 
and MTT is converted into formazan through the link with PMS. 
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2.5 Cryopreservation of Trophozoites 
Trophozoite cultures were centrifuged at 700 g for 5 minutes and most of the 
supernatant was discarded and the pellet was resuspended (in the remaining amount of 
supernatant) to a concentration of 2x 106 trophozoites per ml. 0.5 ml aliquots were 
distributed into 1.2 ml cryovials (Nalgene, Sigma V-4757) and an equal volume of 
cryoprotectant solution (15% v/v Sigma D-5879 dimethylsulphoxide, in MRC Ringer) was 
added and mixed. After equilibration at room temperature for 15 minutes, these vials were 
then transferred to a Union Carbide BF5 freezing plug in position F and then placed in the 
neck of a LR-35-9 cryobank overnight, to slowly cool (at 1 °C per min. ) the samples to 
-50°C. The vials were then transferred into liquid nitrogen. 
For retrieval, each vial was placed in a water bath at 37'C until thawed and its 
content was immediately transferred into a 12 ml flat-sided plastic test tube filled with pre- 
warmed complete culture medium and incubated at 37°C for 24 hours. Then, the used 
medium was decanted carefully and replaced with fresh complete medium. Observation 
under the inverted microscope to confirm confluent growth was done every 24-48 hours. 
2.6 Estimation of the Protein Concentration of Lysates 
Protein concentrations were estimated according to the bicinchoninic acid (BCA) 
protein Assay Reagent (Pierce 23223) into microtiter plates. BCA reagents A and B were 
mixed at a proportion of 1/50 and 200 µl volumes were added to wells in an ELISA plate. 
Duplicate wells with standards of 1,0.5,0.25,0.125,0.0625 and 0 mg/ml of Bovine Serum 
Albumin (Sigma A-4503) in PBS were used and 10 pl of either standard or culture lysate 
were added to the freshly prepared BCA working reagent. Plates were sealed with 
cellotape, incubated at 37°C for 30 minutes and Optical densities (ODs) at 570 nm were 
determined with a Dynatech MR 700 microplate reader and protein concentrations were 
calculated from the standard curve. 
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2.7 Trophozoite Antigen Preparations 
2.7.1 Antigen Preparation for Rabbit Immunisations 
Entamoeba histolytica Well-IMSS trophozoites were grown axenically in TYI-S-33 
(TPS-1) medium as described in 2.3.1. Approximately 1x106 trophozoites were washed 
three times at 200xg for 10 minutes in sterile PBS pH 7.2 (Appendix 1). After the third 
wash, the supernatant was discarded and the pellet was immediately resuspended in 0.25 
ml of PBS and diluted 1: 1 in complete Freund's adjuvant (Sigma F-5881). The antigen was 
homogenised with the help of a1 ml syringe, 21 gauge needle. 
2.7.2 Antigen Preparation for ELISA Plates 
Trophozoites of the strain HIVII-IMS S were axenically cultured as described in 
2.3.1. The trophozoites were diluted 1: 10 in sterile distilled water (hypotonic shock), 
freezed and thawed three times and finally centrifuged at 700 g for 10 minutes. The protein 
content of the supernatant was determined by the bicinchoninic acid (BCA) Protein Assay 
(Pierce 23225) using dilutions of bovine serum albumin (BSA Sigma A-4503) as standards. 
The protein concentration of lysates was adjusted to a stock concentration of 6 mg/ml, 
dispensed in aliquots of 0.2 ml, lyophilized and stored at -20'C until used. 
2.7.3 Antigen Preparation for IFAT Slides 
Control slides for immunofluorescence were prepared from axenically grown E. 
histolytica reference strain (BM-IMSS) and from polyxenic E. dispar reference strain 
(SAW 1734). The axenic cultures were placed in ice-cold water bath for 20 minutes and 
centrifuged at 200 g for ten minutes. The culture medium was discarded and the pellet was 
washed for 10 minutes twice with PBS at 200 g. The pelleted amoebae were resuspended 
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in PBS, giving a final concentration of 10-20 trophozoites per field when a drop of 20 µl 
was observed under the microscope using the 40X objective. The slides were air dried and 
fixed in methanol for five minutes and stored at -20'C with desiccant until used. 
Supernatants of polyxenic Robinson's cultures were collected avoiding disturbing 
the starch layer, they were centrifuged and washed as previously described for the axenic 
strain. Then, the same protocol followed with the invasive trophozoites from axenic 
cultures was applied to the non-invasive trophozoites derived from polyxenic cultures. 
2.8 Detection of Anti-E. histolytica Specific Antibodies in Human Sera by ELISA 
The ELISA methodology for detection of anti-E. histolytica antibodies was the 
following: 
Immulon II ELISA plates were coated with l00µl of a 1: 5000 dilution of stock 
antigen in carbonate-bicarbonate buffer pH 9.6 (coating buffer, Appendix 1), for a final 
protein concentration of 1.2pg/ml. The plates were incubated overnight at 4°C and the 
unbound antigen was eliminated by three washings with PBS- 0.1% Tween 20 during 3 
minutes each time. Then, the plates were dried and stored at -20'C with desiccant until 
used. 
For the test, 200µ1 of 0.5% Casein in PBS were used to block the plates for 1 hour 
at 37°C and the excess was eliminated by washing with PBS-T as previously described. 
100µl of serum diluted 1: 100 according to previous chequerboard were added to each well 
and incubated for 1 hour at 37°C. The unbound antibodies were washed 3 times for 3 
minutes with PBS-T. 100µ1 per well of Goat anti-Human Polyvalent Immunoglobulins- 
peroxidase conjugate (1/5000 in PBS-T) were incubated for 1 hour at 37°C. The excess 
of conjugate was washed with PBS-T as previously described. The substrate was prepared 
in citrate-phosphate buffer pH 5.0,20 mg of orthophenylene diamine (OPD) and 20µl of 
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30% hydrogen peroxide were added to 50 ml of buffer. 100µ1 were added to each well and 
the plate was incubated 20 minutes in the dark at room temperature. The enzymatic 
reaction was stopped by addition of 50µl of 2.5N HCI. The Optical Density was read at 
492 nm. 
2.9 DNA Extraction Using Phenol-chloroform Method 
The protocol described below has been modified from Romero et al., 1992: 
1. Approximately lg of faeces were resuspended in 3 ml of PBS (liquid faeces should not 
be diluted). 
2. The samples were lysed using three freeze/thaw cycles by immersion in a mixture of dry 
ice/ethanol followed by immersion in a water bath at room temperature. 
3.1 ml of the lysate was centrifuged for 1 minute at 6500 rpm in a microcentrifuge and the 
supernatant was transferred to a new tube to which an equal volume of lysis buffer and 10 
, ug of Proteinase K were added and the mixture was incubated overnight at 37°C (this 
incubation was later changed to 2 hours at 55 °C). 
4. The mixture was then divided in 500 , ul aliquots, to which an equal volume of water- 
saturated phenol (Cat. No. RP3024 Rathburn, UK) was added and mixed by inversion. The 
suspension was then centrifuged at 14000 rpm in a microfuge for 5 minutes. The upper 
layer of each was transferred to a new tube and the phenol extraction was repeated. 
5. The supernatants were then extracted with a mixture of 1: 1 phenol: chloroform. The 
mixtures were centrifuged at 12000 rpm for 5 minutes and the upper layer of each was 
taken. 
6. Extraction with chloroform was followed by centrifugation at 12000 rpm for 5 minutes. 
The upper layers was then tranferred to an eppendorf tube. 
7. Then, two volumes of 100% ice-cold ethanol plus 5041 of 3M sodium acetate solution 
were added, followed for an incubation at -70°C for 10 minutes. 
8. Centrifugation for 30 minutes at 14000 rpm followed, and the supernatant was 
discarded. 
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9. Then, 1 ml of 70% ice-cold ethanol was added, followed for a centrifugation at 14000 
rpm for 5 minutes. The supernatant was discarded and the DNA was air dried. 
10. The DNA was then redissolved in 50, ul of sterile distilled water. 
11. Concentration of DNA was determined by spectrophotometry at 260 nm and the DNA 
was checked by electrophoresis using 0.8% agarose gels. 
12. The DNA stocks were stored frozen at -20°C. Dilutions for use were stored at 4°C. 
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CHAPTER 3 
AMOEBIASIS IN COLOMBIA 
3.1 History of the Problem 
Intestinal protozoal infections such as amoebiasis and giardiasis are particularly 
endemic in some Latin American countries due to their socioeconomical conditions and 
cultural features, which are linked to a high frequency of transmission. Amoebiasis is an 
important cause of morbidity and mortality in Mexico and as a result, Mexico is one of the 
countries with pioneering and accurate studies on the biology and epidemiology of 
amoebiasis in Latin America. An average of 10-20% of the mexican population are 
asymptomatic carriers of E. histolytica/E. dispar (Martinez-Palomo, 1986) and according 
to Walsh, approximately 5% of the population develop symptoms and produce an antibody 
response yearly (Walsh, 1986). Antibodies in the mexican population can be detected in 
all age groups, predominantly in school children (Sepulveda, 1980), with high frequences 
of amoebic rectocolitis in children younger than 5 and in adults older than 20 years (Pardo- 
Gilbert, 1971). In the case of Colombia, fewer reports on the prevalence of amoebic 
infection are available; the first national survey on morbidity carried out by the Ministry of 
Health between 1965 and 1966 identified 3656 infected subjects out of a sample population 
of 15426 individuals, with an overall prevalence of 23.6% for E. histolytica/E. dispar 
infection (MINSALUD, INS, 1969). 
After a second national survey carried out between 1977 and 1980, the overall 
prevalence had dropped to 12.1 % (Corredor, 1980). No differential diagnosis between E. 
histolytica/dispar and E. hartmanni, nor serological test were included in either study. 
Those reports reflect the prevalences of intestinal infection with parasites in the population, 
but the degree of morbidity caused is difficult to assess when indirect but specific tools 
such as antibody measurement or antigen detection systems are not incorporated in the 
studies. 
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Investigations carried out previously in different geographical areas of Colombia 
reveal common characteristics to those reported for other countries such as variable 
prevalence according to geographical area and variation with the health status of the 
population studied, with mental hospital based-studies recording higher prevalences than 
those reported for other hospitals (Tables 3.1 and 3.2). 
TABLE 3.1 E. histolytica/E. dispar INFECTIONS DIAGNOSED BY MICROSCOPY IN COLOMBIAN 
HOSPITALS** 
STUDY HEALTH 
FACILITY 
PREVALENCE LOCATION 
Botero, 1957 Outpatients Clinic 8 Medellin Antio uia 
Botero et al., 1958 Mental Hospital 18.4 Medellin Antio uia 
Botero and Restre o, 1959 Mental Hospital 13 Medellin Antio uia 
Faust, 1958 Outpatients Clinic 11.1 Cali (Valle) 
Faust, 1958 Mental Hospital 40.3 Cali (Valle) 
Krupp, 1970 Outpatients Clinic 62 Cali (Valle) 
Valencia and Alban*, 1960 Outpatients Clinic 34.4 Bo otä Cundinamarca) 
Los Andes University, 1989§ Outpatients Clinic 7.4 Ibague (Tolima) 
* Diagnosed by rectosigmoidoscopy sample 
**Modified from Duque and Zuluaga, 1962 
§ Unpublished data 
TABLE 3.2 PREVALENCE OF CLINICAL AMOEBIASIS IN COLOMBIA BY SEX 
STUDY DIAGNOSIS SEX RATIO 
(% M: F) 
AGE 
GROUP 
(YEARS) 
CASES 
Salazar and Valencia, 1962 Amoebic Colitis 46: 54 NR 846 
Bravo, 1964 Hepatic Amoebic Abscess 80: 20 13-62 88 
Bravo, 1965 He atic Amoebic Abscess 50: 50 0-12 22 
Garcia and Acufia, 1966 Hepatic Amoebic Abscess 93: 07 4-70 44 
Du ue*, 1968 Hepatic Amoebic Abscess* 42: 31 0-80 220 
Zuliani and Garcia*, 1970 Amoebic Colitis* 50: 50 0-12 20 
Saravia et al., 1978 Hepatic Amoebic Abscess 75: 25 16-80 20 
Varela et al., 1990 Hepatic Amoebic Abscess 94: 06 24-65 16 
*Autopsy Material 
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Unfortunately, methodological differences in the screening, including number of 
samples examined, age of the sample, intermittent cyst excretion, overdiagnosis by 
confusing E. hartmanni with E. histolytica/dispar, and the use or not of different 
concentration methods, are also confounding factors that complicate interpretation of 
results (Table 3.3). 
TABLE 3.3 E. histolytica/E. dispar PREVALENCE* OF INFECTION IN THE GENERAL 
POPULATION IN COLOMBIA 
STUDY PREVALENCE LOCATION 
Duque and Zuluaga, 1958 24.6 Medellin (Antio uia) 
Duque and Zuluaga, 1958 50 Choc6 (Choc6) 
Faust, 1958 33.5 Cali (Valle) 
Carvajal et al., 1995 36 Buenaventura (Valle 
Restre o, 1962 55 Leticia (Amazonas) 
Diaz and Ospina, 1961 ** 28.1 Bo otä (Cundinamarca) 
A delo, 1987 12.9 Bo otä (Cundinamarca) 
A delo et al., 1993 3 Bo otä (Cundinamarca) 
* Prevalences reported include E. hartmanni 
**Bravo, 1964 
Host and parasite related factors both contribute to the epidemiology and 
distribution of the disease and greatly influence the seroepidemiology of invasive 
amoebiasis. Among the host related factors, age, sex and nutritional status of the carrier 
determine morbidity (Kretschmer, 1990). Although invasive intestinal involvement is the 
first step required for extraintestinal amoebic infection, the failure of circulating antibodies 
produced during previous infections to protect against reinfection, and the initial delay in 
immune response during the invasive extra-intestinal stage make the establishment of new 
foci possible (Sepulveda, 1982; Gilter and Mirelman, 1986). Once invasive trophozoites 
attach to the host cell by means of the galactose-inhibitable lectin (Petri et al., 1989b), 
cysteine proteinases degrade the extracellular matrix producing the typical "flask shaped 
ulcer", surrounded by an acute initial inflammation, where polymorphonuclears, mast cells 
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and monocytes liberate lysosomal enzymes, proteases, histamine and cathepsins (Martinez- 
Palomo, 1987). Local anaphylactic reactions seem to contribute to the pathology of 
intestinal amoebiasis. The increase in permeability observed during intestinal invasion 
could in part be due to the release of neuroactive substances by mast cells, that degranulate 
when activated by IgE-amoebic antigen complexes (Trissl, 1982). 
As previously described (Chapter 1), untreated acute intestinal amoebiasis often 
evolves to extraintestinal involvement, particularly hepatic abscess. Invasive amoebic 
infection in children (Tables 3.2 and 3.4) does not exhibit sex predilection but is often 
mortal due to perforation (Bravo, 1964; Zuliani and Garcia, 1970; Trissl, 1982). In 
contrast, adult males (Table 3.2) suffer more frequent hepatic involvement, but mortality 
rates are low (Alvarez-Alva and Loza-Saldivar, 1971). Pregnancy and malnutrition 
predispose to depressed immunological status, which, together with inoculum size and 
virulence of the strain are also implicated in the extent of the damage in the host (Trissl et 
al., 1978b; Kretschmer, 1990). 
Although no differential diagnosis between E. histolytica and E. dispar was carried 
out, a parasitological survey by Faust in a poor ward in Cali (Valle, South West Colombia, 
Figure 3.1) highlighted the relationship between high prevalence of infection and a 
predominantly carbohydrate based diet (yucca, plantain, rice and potatoes) in the population 
studied (Faust, 1958). Diamond reviewed the influence of iron and nutritional immunity 
and relates the high prevalence of amoebiasis to increased ingestion of iron in the diet and 
malnutrition, which enhances susceptibility to invasion by depletion of the immune system. 
In his review, Diamond suggests that the observation of a higher prevalence of disease in 
adult males also indicates the involvement of an hormonal component (Diamond, et al., 
1978b; Diamond, 1982). 
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TABLE 3.4 E. histolytica/E. dispar PREVALENCES OF INFECTION FOR CHILDREN IN COLOMBIA 
STUDY AGE 
RANGE 
PREVALENCE LOCATION 
Cardona and Raad*, 1987 0-14 8.1 Manizales (Caldas) 
Los Andes Universi *§, 1989 0-12 22.6 Medellin (Antio uia) 
Los Andes Universi *§, 1989 0-18 18.3 Iba e (Tolima) 
Trujillo and Vargas, 1990 0-7 2.4 Iba e (Tolima 
A irre et al., 1991a 0-12 7.5 Bo otä (Cundinamarca) 
Duque et al., 1994 0-18 6.2 Bo otä (Cundinamarca) 
* Prevalences including E. hartmanni 
§ Unpublished data 
Recent epidemiological studies are not available in Colombia and amoebiasis was 
reported to be endemic in the country based in observed prevalences of infection covering 
different geographical areas (Table 3.3). According to the reports on invasive disease 
(Table 3.2), between 1960 and 1965 Garcia-Torres and Acura studied 44 clinical records 
corresponding to hepatic amoebiasis cases from the Hospital San Juan de Dios and the 
Santa Marta clinic (Instituto de Seguros Sociales) in Santa Marta, located in the North 
Atlantic coast (Figure 3.1). In this study, the distribution of cases according to sex was 
93% of males and 7% of females with only 4.5% of patients under 20 years of age and 
61.3% of cases in the age range between 20 and 49 years. Alcoholism and malnutrition 
were present in 38.6% of the patients and 52.3% suffered dysentery previous to the abscess 
(Garcia-Torres and Acufia, 1966). Also, a report on fatal amoebiasis by Duque (1968) 
reviewing 220 cases of invasive amoebiasis on autopsy material collected in three 
university hospitals in the country (153 cases in Medellin, 38 cases in Bogota, 25 cases in 
Cali and 4 cases from Bucaramanga) shares many common features. The ratio of males to 
females in this study was 65%: 35% and the higher frequencies of infection were 20.9% 
among children between 2 and 5 years of age, and 31.4% among adults between 21 and 40 
years. 
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The author describes malnutrition and immunosuppression-associated diseases 
(digestive candidiases and pulmonary aspergillosis) in 7.7% of patients, 5.4% of them were 
children. All the children in the study (73) and a third of the adults (49) were malnourished 
and 15.6% of the female cases were related to pregnancy, puerperium or abortion (Duque, 
1968). 
At the same time as the introduction of metronidazole as the therapeutic agent 
against amoebic infection, serological tests were included in the diagnosis of invasive 
amoebic infection at most of the university hospitals in the country, and the first reports are 
those from the University Hospital in Cali. Indirect haemagglutination test (IHA) was used 
to evaluate antibody levels before and after treatment of amoebiasis by Krupp (1970) in 
asymptomatic carriers and patients with invasive disease. From 168 subjects with amoebic 
colitis, 81% had positive titres of antibodies which persisted for six months, although 
reinfections (40%) made it difficult to continue the follow-up study. In the group with 
extraintestinal amoebiasis (31 patients), 87.1 % were positive with titres that persisted for 
the six month follow up study and in this group also, the high titres of antibody did not 
prevent reinfections. The serological study of cyst passers (75) revealed 9% positives, and 
among 118 healthy controls 7% had antibodies. No relation was found between antibody 
level and age, sex and concurrent bacterial or parasitic infections (Krupp, 1970). Some 
time later, Saravia et al. (1976) collected a series of 40 cases with probable diagnosis of 
hepatic amoebic abscess in patients attending at the same hospital from 1972 to 1974. The 
comparison of serological diagnosis by indirect hemagglutination (IHA), agar gel diffusion 
(AGD), latex agglutination (LA), and counterimmunoelectrophoresis (CIE) techniques 
indicated that although IHA was the most sensitive (92%) and specific (97%) technique, 
AGD with a sensitivity of 89% and a specificity of 97% was simple and easily accessible 
to small laboratories, with the only disadvantage of the time delay in obtaining the results. 
An alternative proposed was the counterimmunoelectrophoresis, with a sensitivity of 75% 
and a specificity of 97%. The authors highlighted the simplicity and rapid results of LA 
that together with its high sensitivity (92%) and specificity (94%), make the kit ideal for 
the hospital format, however, the costs were excessive for the hospital budget. 
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FIGURE 3.1 POLITICAL DIVISION OF COLOMBIA 
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Also during 1976, a different evaluation of serology was carried out by Restrepo et 
al. in Medellin using complement fixation (CF), AGD, IHA, and LA in patients with 
hepatic abscess, acute amoebic colitis, and asymptomatic cyst carriers. Complement 
fixation was positive in 93% of asymptomatic cyst passers, 94% of patients with amoebic 
colitis and 90% of patients with probable amoebic abscess. Although sensitivity in cases 
of hepatic abscess was 90% and in colitis cases was 94.6%, specificity was only 50%, 
detecting asymptomatic cyst passers and healthy controls as positive. Clearly complement 
fixation is of limited use in endemic areas for invasive amoebiasis (Restrepo et al., 1976). 
Results with AGD revealed a better specificity (100%) sacrificing sensitivity, which 
was 65% for hepatic abscess cases and 54% for amoebic colitis, detecting antibodies in only 
3% of asymptomatic cyst passers. In this study LA detected antibodies in 60% of the cases 
of acute amoebiasis, 70% of cysts passers, 83% of abscess cases and 20% in healthy 
controls. Sensitivity was 72% and 86% for hepatic abscess cases, with a specificity of 83%. 
Specificity for IHA was 83%, with 84% sensitivity in cases of colitis and 83% in patients 
with hepatic abscess. 
The specific detection of IgG anti-amoebic antibodies by the ELISA technique using 
a crude lysate of axenically cultured trophozoites permits the serological evaluation of a 
great number of samples in short time, with the possibility of automation in hospitals. A 
retrospective study of 19 cases of clinically diagnosed hepatic amoebic abscess collected 
from 1987 to 1990 in two university hospitals in Bogota (Varela et al., 1990) is the first 
report of its use in diagnosis by exclusion in Colombia. Invasive amoebic infection was 
confirmed by a significant rise in antibody response measured by the ELISA test in 16 
cases. The use of ELISA was a valuable tool for the differential diagnosis in the 3 
remaining patients, who were believed to have pyogenic abscess, where clinical 
manifestations and echography were not clear. Those three patients had a negative amoebic 
ELISA result and good response to treatment with antibiotics, confirming the pyogenic 
origin of the abscesses. 
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A further valuation of the ELISA technique for the diagnosis of hepatic amoebic 
abscess was carried out by Aguirre et al., (1991b) with 71 sera collected during the four 
previous years in Bogota. This study reported a sensitivity of 95% with 100% specificity 
when analysing 59 sera from patients with amoebic abscesses and 12 sera from patients 
with other aetiologies such as cancer, pyogenic abscesses, and cysts of the liver. Positive 
predictive value was 100% and negative predictive value was 80%. It was recommended 
to test at least two samples from different days in cases in which the first result is negative. 
A comparison between ELISA and CIE was published by Restrepo et al., (1996) with sera 
from 30 patients with suspected hepatic amoebic abscess of the liver, 30 patients with 
symptomatic amoebic colitis and 50 healthy controls. ELISA detected all cases of amoebic 
liver abscess (27) and did not react in 3 cases of abscess later classified as from bacterial 
origin. In comparison, CIE detected 20 cases of amoebic liver abscess, with no cross 
reactivities in pyogenic cases. Both tests were highly sensitive in cases of amoebic abscess 
(100% and 88% respectively) and 100% specific when evaluated against abscesses from 
bacterial origin. However, for amoebic colitis CIE was negative in all cases, only three had 
a level of antibodies detectable by ELISA and none of the healthy controls was positive by 
either test. 
Serology has been shown in Colombia and other endemic areas (Trevino et al., 
1997) to be valuable in the hospital environment as a confirmatory test for the evaluation 
of extraintestinal amoebiasis, when used together with other diagnostic aids such as X rays, 
ultrasonography, gammagraphy, and fluoroscopy. However, the results of the previous 
studies confirm observations that only low and non-specific levels of antibodies are present 
in the early stages of intestinal invasion, although serology can be a good measure of 
exposure to amoebic invasion. Microscopy is however not useful for the detection of 
carriers of E. histolytica sensu stricto, emphasising the need for antigen detection systems 
or nucleic acid detection systems able to make a differential diagnosis between carriers of 
E. dispar and individuals carrying E. histolytica. 
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3.2 MATERIALS AND METHODS 
The first step in the study is to identify and confirm some endemic areas (Ibague in 
the Tolima department and La Mesa, in Cundinamarca) for intestinal infection with E. 
histolytica/dispar, with the further purpose of collecting material to be used during the 
different stages of the project. 
3.2.1 Description of the Study Area at Ibague 
The first step of the project was to determine the exact situation of amoebiasis in 
places that in the past have been designated as endemic for E. histolyticalE. dispar. The 
pilot study was developed at Ibague, capital of the department of Tolima (Figure 3.1), 
which covers a population of 1,150,080 inhabitants. This city is situated 4°27' latitude 
North and 75 ° 15' longitude West, in the Andean zone, 1285 m above sea level, with an 
average temperature of 24.1 °C, a mean Relative Humidity of 73.7% and a bimodal rain 
pattern corresponding to April-May and October-November. 
This part of the research project was carried out at the biology laboratory in the 
Department of Biological Sciences at the University of Tolima, with the agreement of the 
academic authorities for a study which included obtaining blood samples on a voluntary 
basis. Subjects were asked their consent for venipuncture. 
The area of Ibague was selected for the study because a previous screening on 
school children in 1989 exposed a prevalence of 15.6% for E. histolytica/E. dispar by 
microscopy of stool samples (Universidad de los Andes, 1989 unpublished data). Also, 
according to the university health authorities, an outbreak of invasive amoebiasis was 
observed in the student's residency at the university in 1987, which was understood to 
indicate that invasive strains were circulating among the population and a new 
parasitological and serological survey in the form of a pilot study was necessary to 
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determine prevalence of infection. Also, further parasitological surveys were carried out 
in La Mesa, in the department of Cundinamarca and in different areas of Santafe de Bogota, 
the capital to the same department applying the modifications to the sampling methodology 
which were the result of the pilot study. 
3.2.2 The Community and the Population in the Study at Ibague 
3.2.2.1 Subjects 
At Ibague, two groups of subjects, one consisting of 127 students (Group I), with 
ages between 5 and 18 years at secondary school "Carlos Lleras Restrepo" (Figure 3.2), 
choosen because of the precarious sanitary facilities present. The school is located in El 
Salado ward, one of the poorest semirural wards outside Ibague. The second group of 
subjects consisted of 181 university students and staff from Tolima University (Group II), 
with age ranging between 19 and 85 year olds. 
3.2.2.2 Sample Collection 
A short talk covering basic information on what intestinal parasites are and simple 
hygiene routines to avoid their transmission was given to each class prior to requesting 
volunteers for the study. Also the methodology for the collection of the sample was 
explained, with extra marks being offered by the biology teacher to those who completed 
the study. The same information was given at a meeting with parents of students at the 
school, explaining the arrangements made with the local health authorities for the treatment 
of those students carrying pathogenic parasites. 
Each volunteer was given a sample container, together with simple worded 
instructions on how to collect the material. Immediatly after the collection of the first 
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sample, volunteers were issued a new container labelled with the corresponding number of 
the subject in the study, until completion of three samples per subject was achieved. At the 
school, stool samples were collected from 6: 30 am to 7: 30 am in every class room during 
two weeks and transported to the laboratory at the university within the following hour. 
FIGURE 3.2 SCHOOL SANITARY FACILITIES AT IBAGUE 
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Advertisement for the collection was done two weeks before through the welfare 
office at Tolima University, consisting of posters being displayed throughout the university 
campus. The questionnaire and methodology for sample collection were the same as used 
for the school but the results were reported to the welfare office and those students 
requiring treatment were referred to the university health services. Samples from the 
university population were collected from 8 am to 11 am at the laboratory during two 
weeks. The processing of the samples started immediately after arrival in batches of 10 for 
microscopy. A pool of the three samples from each volunteer was concentrated with zinc 
sulphate and examined by microscopy with Lugol's iodine. Results were registered into an 
Epi Info 5.1 database. 
All E. histolytica/dispar microscopically positive samples were cultured in primary 
Robinson's medium (Appendix 1), which was replaced by secondary Robinson after 24 
hours. Sediments were examined for positivity using Lugol's iodine after 48 hours (Figure 
3.3) and cultures with a negative sediment were discarded after 96 hours. 
Blood samples were taken from volunteers when the third stool sample was 
obtained. Standard radial vein puncture was carried out using 10 ml syringes. After 
removing the clot, centrifugation at 700 g for 10 minutes separated the serum, followed by 
inactivation of the complement at 56°C for 30 minutes in a water bath. Sera were stored 
at -20'C until transported to the reference laboratory in Bogota, where serology was carried 
out during the following weeks. Sera were tested by ELISA test in duplicate wells and the 
cut off for each plate was calculated by adding two standard deviations to the mean of three 
duplicated pools of negative sera. 
3.2.3 La Mesa, Department of Cundinamarca. Description of the Area 
La Mesa is situated in the department of Cundinamarca (Figure 3.1) 4'3 8' latitude 
North and 74'28' latitud West, with an average temperature of 22'C and an altitude of 
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1,198 m. Being located in the Tequendama province of the Department of Cundinamarca, 
the total population of the municipality was estimated to be 19,132 persons in 1993 from 
whom, only 2,639 had potable water and from those, 1,954 had a proper sewage system 
(Departamento Administrativo de Planeacion, Gobernacion de Cundinamarca, 1995). 
3.2.4 The Community and the Population Screened at La Mesa 
3.2.4.1 Subjects 
At La Mesa, 138 subjects were tested in three different locations: "Futuro Juvenil", 
the local charity which runs an orphanage housing 56 children and granted permission for 
the parasitological survey but restricted information on age and clinical 
background of the children. A voluntary collection was carried out at the "Departamental" 
Secondary School, which is one of the 4 secondary schools at La Mesa covering a total 
population of 1,935 students. Students in their fifth year of secondary school were asked 
to provide samples, from which 53 provided stools. The remaining 29 subjects tested were 
patients attending the Hospital Pedro Leon Alvarez and from whom at least one stool test 
each was submitted. 
3.2.4.2 Sample Collection 
Authorities were contacted at the orphanage "Futuro Juvenil" in order to obtain stool 
samples from the children residing in their location at La Mesa. An informal talk on basic 
hygiene technique to avoid parasite transmission, stressing the need of an adequate sample 
collection was given to the staff in charge. Written instructions and the corresponding 
containers were provided, and three consecutive samples were obtained and further 
transported to the Hospital Pedro Leon Alvarez, where all the samples were processed as 
described in 3.2.2 
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FIGURE 3.3 A. POLYXENIC ROBINSON'S CULTURE SYSTEM. 
FIGURE 3.3 B. POSITIVE CULTURE (Lugol's iodine) 
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Parental permission was requested at the Colegio Departamental prior to sample 
collection for which a talk was given during the previous Saturday to the start of the 
collection. On the following Monday, a short talk to each class and instructions with the 
containers were provided for the first sample. After the first sample was obtained, a 
labelled container for the sample was given, and the same system applied for the third 
container. 
Results were reported in writing to the staff in charge for the arrangement of a 
consultation with the general practitioner at the hospital. Stool samples produced by 
patients at the hospital were included in the study. No blood samples were collected at La 
Mesa. 
3.3 RESULTS 
3.3.1 Ibague, Department of Tolima 
As the pilot study, this screening was to provide information not only on the 
prevalence of amoebiasis in the population, but in the feasibility of the application of the 
methodology proposed. 
A total of 308 serial stool samples were collected and examined by microscopy 
during the field trip to Ibague (Tolima). 127 samples were collected in the secondary 
school (Group I) and 181 were collected at the university (Group II). 
The population consisted of 42.5% females and 57.5% males (Figure 3.4), with a 
distribution of 50.4% females (64) to 49.6% males (63) in group I and 37% females (67) 
to 63% males (114) in group II, for a total of 131 females and 177 males in the study. 
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FIGURE 3.4 SEX RATIO(%) 
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n') c 
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In relation to age distribution, group I consisted of individuals between 5 and 18 
years of age, and group II covered individuals between 19 and 85 years of age. The most 
densely populated age groups were the 13-15 year olds in group I (81/127), 63.8% of the 
school population tested, and the 22-24 year olds in group II (56/181), corresponding to 
30.9% of the university population (Figure 3.5). 
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FIGURE 3.5 AGE DISTRIBUTION OF THE 
POPULATION AT IBAGUE 
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3.3.1.1 Microscopy 
High prevalences of intestinal parasitism were found in the two groups studied at 
Ibague, where Blastocystis hominis was the most common protozoan found, with a 
prevalence of 80.5% in the overall population, 79.5% subjects (101/127) from group I and 
81.2% subjects (147/181) from group R. Only 8.4% of persons were found negative for all 
of the parasites investigated. From them, 3.1% (4/127) were in group I and 12.1% (22/18 1) 
belonged to group II (Figure 3.6). 
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FIGURE 3.6 MICROSCOPY OF STOOLS (%) 
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The result of prevalence presented for E. histolytica/E. dispar was 22.8% (29/127) 
in group I. From them, 20.7% (6/29) had trophozoites without red blood cells on direct 
examination with isotonic saline. Similarly, the prevalence of E. histolytica/E. dispar in 
group H was 28.1% (51/18 1), and from them 9.8% (5/51) were carrying trophozoites only 
but also without red blood cells. No significant difference in prevalence was found 
between groups I and II (Chi square, Yates Corrected 0.85, p=0.35). The overall prevalence 
of E. histolytica/E. dispar infections was 26% (80/308), from which, 13.7% (11/80) had 
only trophozoites without ingested red blood cells. Because no haematophagous 
trophozoites were observed, and all the subjects were asymptomatic, none of those 
infections was classified as amoebic colitis, however, some of the subjects were found later 
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to have high titres in the serology test and those results were reported to the University. 
The overall prevalence of E. hartmanni in the population was 9.4% (29/308), with 5.5% 
of those infections in Group I (7/127) and 12.1% (22/181) in Group H (Figure 3.7). Again, 
no significant difference in the prevalence was found between both groups (Chi square 
3.12, Yates corrected, P=0.077). However, 13 out of the total of 29 infections (44.8%) were 
concurrent in patients carrying E. histolytica/dispar. 
FIGURE 3.7 PREVALENCE OF E. hartmanni & 
L. histolytica/E. dispar INFECTIONS 
AT IBAGUE 
E. h/E, d 
L hartmanni 
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Giardia intestinalis was found in a high proportion of samples (17.9%), however, 
prevalence in group I was doubled at 25.2% (32/127) when compared to 12.7% (23/18 1) 
in group II, which represented a significant difference between both groups (Chi square 
7.11, Yates Corrected, p= 0.0076). Of those infected with Giardia intestinalis, 10.9% 
individuals (6/55) had trophozoites in their faeces during the direct exam with isotonic 
saline. 
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Other protozoal infections in descending order of prevalence were 50% overall for 
End. nana, represented in 74 infections in the group I (58%) and 80 infections (44%) in 
group II, with a significant difference between both groups (Chi square 5.36, Yates 
corrected, p=0.02). E. coli was present in 45% of the individuals in group I (57/127) and 
in 25% of individuals in group II (45/181), where a significant difference was also found 
(Chi square Yates corrected 12.6, p= 0.0003), for an overall prevalence of 33.1% for in the 
population. 24% of the population tested was infected with I. buetschlii, 40 individuals 
(31.5%) in the group I, and 34 (19%) individuals in group II, with a significant difference 
between group I and group II (Chi square Yates Corrected 5.93, p=0.014). Ch. mesnili was 
present in 6.8% of the population, 13 in group I (10%) and 8 in group II (4%), but no 
significant difference in prevalence for both groups was found (Chi square Yates corrected 
3.11, p=0.077). 
Among the helminths, eggs ofA. lumbricoides were found in 5 individuals in Group 
I and in 3 individuals in group H, for an overall prevalence of 2.6%; T trichiura, was found 
in 7 subjects in the group I in contrast to 2 subjects in group II, for an overall prevalence 
of 2.9%. The differences in prevalences found between groups I and II for A. lumbricoides 
were not significant (Fisher exact test p=0.19) and although the difference was significant 
for T trichiura infections, (Fisher exact test p=0.028), the low prevalence found probably 
due to the concentration method used (flotation) might not reveal the real prevalences for 
helminth eggs. 
Hookworm infections were found in two individuals in group I and in two 
individuals in group II, for a global prevalence of 1.3%. Eggs of E. vermicularis were found 
in one individual in group I only, which corresponds to a prevalence of 0.3% (Figure 3.8). 
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FIGURE 3.8 HELMINTH INFECTIONS 
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The retrospective analysis of the microscopy results at Ibague showed a high degree 
of polyparasitism when comparing the overall results between groups I and II. In addition, 
only 8% of the population (3 individuals in group I and 25 individuals in group II) shed 
three negative samples. Faecally transmitted parasites are evident in both groups, with 
prevalences for G. intestinalis significantly higher in school children than in university 
students. E. coli, I. buetschlii, and End. nana were also found in high prevalence. A visit 
to the sanitary facilities at the school, where some toilets did not flush, floors were 
contaminated with urine and no toilet paper, paper towels or soap were available, may be 
relevant. The housing conditions in El Salado area varied from inadequate with no sanitary 
facilities to rudimentary with basic sanitary facilities and partially treated drinking water. 
It is likely that lack of basic hygiene education contributes to intrafamilial transmission of 
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parasites, with people failing to wash their hands after visiting the toilet. Also, a 
contributory factor is the fact that although health authorities advise boiling any water used 
for drinking and food preparation purposes, these guidelines are seldom followed. 
Differences in prevalence of infection with E. histolytica/E. dispar among sexes 
were not significant, 35 females out of a total of 131 were infected (15/64 in group I and 
20/67 in group II), compared to 45 infected males (14/63 in group I and 31/114 in group II) 
among a total of 177 in both locations studied. Although at Ibague infection rates slightly 
increased with age, affecting 23.4% of females younger than 19 (15/64) and 29.8% females 
older than 19 (20/67), this did not represent a significant difference (Chi square 0.40, p= 
0.527). However, infected females are an effective vehicle for the spreading of infection 
since normally they are responsible for food preparation and as food handlers, they play an 
important role in transmission. Though not significant either, the same trend was noted for 
males, with 22.2% of males infected among the school students (14/63) compared to 27.2% 
males infected in the university population (31/114). (Figure 3.9). 
FIGURE 3.9 E. histolyticar/dispar 
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Similarly, no increment in the prevalence in relation to age is evident when 
analysing infections in the different age groups (Chi square for linear trend 0.413, p=0.520; 
Figure 3.10). When three groups including the individuals up to 27 years of age (5 to 15 
year olds, 16 to 21 year olds and 22 to 27 year olds) were compared, no significant 
differences in prevalence were found (Chi square 0.078, p=0.78). When a second 
comparison was carried out with the individuals over 22 years of age (22-27 year olds, 28- 
45 year olds and 46-85 year olds), no significant differences were shown either (Chi square 
0.075, p=0.78). The analysis after separating the population in two groups, from 5 to 27 
year olds and from 28 to 85 year olds confirmed that there was no significant difference in 
prevalence of infection with E. histolytica/E. dispar among this population in relation to 
age (Chi square 0.05, p=0.818). 
Retrospective studies on the influence of the number of samples examined in the 
detection of new parasitic infections by microscopy were carried out for the two potentially 
most prevalent pathogenic protozoa found, E. histolytica/dispar and G. intestinalis with the 
results from Ibague. 
FIGURE 3.10 E. histolytica PREVALENCE 
OF INFECTION BY AGE GROUP AT IBAGUE 
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After the first stool sample the prevalence of infections with E. histolytica was 13%, 
with detection of 50% of the carriers (40 positives). After the second examination, the 
prevalence rose to 20.8%, thus a further 30% (24 new infections) was detected and with the 
third examination (16 new infections, Figure 3.11), the "final" prevalence detected by 
microscopy reached 26% (80/308). This change was statistically significant (chi square for 
linear trend=16.269, p=0.00005) and justifies the screening of consecutive samples from 
the same subject. 
FIGURE 3.11 INFLUENCE OF SAMPLE NUMBER 
FOR E. histolytica/E, dispar DETECTION 
BY MICROSCOPY. IBAGUE SAMPLE 
THIRD SAMPLE 20% 
------- ----------- SECOND SAMPLE 30% 
FIRST SAMPLE 50% 
40 
PROPORTION OF NEW INFECTIONS DETECTED 
A similar situation was observed when assessing the prevalence of G. intestinalis 
according to the sample number tested, 45.4% (25/308) of carriers of G. intestinalis were 
detected during the first exam, 25.4% (14/308) new infections were detected during the 
second sample, bringing sensitivity to 70.8% and the "remaining" 29.1% (16/308) 
infections were detected after the third sample (Chi square for linear trend 12.15, 
p=0.00049). 
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G. intestinalis infections were concentrated in the population younger than 22, with 
41 (74.5%) infections of the total of 55 in the overall population (Figure 3.12). When this 
prevalence was compared to the prevalence found in the group of people older than 22 
(13/152), the difference in prevalence was significant (Chi square 15.53, p= 0.00008). 
However, no significant differences (Chi square for linear trend 0.00 1, p=0.971) were found 
when comparing the prevalences between the first three groups (5-12 years old, 13-15 years 
old and 16-21 years old). Similarly, no significant difference in prevalence (Chi square for 
linear trend 1.233, p=0.266) was found among the groups where individuals older than 22 
were classified (22-27 years old, 28-33 years old, 24-45 years old and 46-85 years old). 
FIGURE 3.12 G. intestinalis PREVALENCE. 
POSITIVE SUBJECTS ACCORDING TO AGE GROUP 
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The former results indicate that the sensitivity of the microscopical analysis is 
directly proportional to the number of samples examined (Kershaw, 1946; Stamm, 1957; 
Mathur and Kaur, 1973). However, the possibility of missing some recently acquired 
infections must be taken into account because zinc sulphate, as other concentration 
methods, fails to concentrate trophozoites. Also, large, dense structures are missed, 
therefore, the possibility is that some light helminth infections were not detected, which 
may explain the relatively low levels of helminth infections reported. 
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3.3.1.2 Cultures 
Eighty samples found positive for E. histolytica/dispar by microscopy were cultured 
and although 48 sediments were positive after the first 24 hours, 20 survived to the sixth 
subculture and only 8 were characterised by hexokinase. All strains showed slow banding 
patterns for hexokinase, characteristic of non-invasive strains (Figures 3.13A and B). 
'Po 
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FIGURE 3.13 A. Hexokinase Profiles on Cultures from Ibague. Lane 1: Axenic Control HM1- 
IMSS, Fast Migration, E. histolytica. Lane 2: Polyxenic Control SAW 1734, Slow Migration, E. 
dispar. Lane 3: Culture 28, Negative. Lane 4: Culture 32, E. dispar. Lane 5: Control CIMPAT 
Culture LFS, E. histolytica. Lane 6: Culture 72, E. dispar. Lane 7: Culture 160, E. dispar. Lane 
8: Control CIlVIPAT Rosa, E. histolytica. 
98 
Chapter 3 Amoebiasis in Colombia 
K 
!' inrlýusa+:.; +arsý++"h1F -: ý.:. ý.... -. +. ýý. ý,...., ý. xý - ý..... ..:. s.: Y wtlC. ' 
ik . 
, '' 
ýt. 
I 
FIGURE 3.13B. Hexokinase Profiles on Cultures from Ibague. Lane 1: Axenic Control HMI-IMSS, Fast 
Migration, E. histolytica. Lane 2: Polyxenic Control SAW 1734, Slow Migration, E. dispar. Lane 3: 
Control CIMPAT culture LFS, E. histolytica. Lane 4: Culture 169, E. dispar. Lane 5: Culture 186, E. 
dispar. Lane 6, Culture 189, E. dispar. Lane 7 Culture 28, E. dispar. Lane 8: Control CIMPAT Rosa, E. 
histolytica. 
3.3.1.3 Serology 
Serum samples were obtained from 114 out of 127 subjects in Group I and from 140 
individuals out of 181 in Group II, giving a total 254/308 (82.5%) subjects tested by 
serology. In group I, 16/114 (14%) subjects had antibodies against E. histolytica in 
serology by ELISA. In group II, 28/140 (20%) subjects were positive by ELISA for anti-E. 
histolytica antibodies. No significant difference of the positivity for anti-E. histolytica 
antibodies between the two groups was found (Chi square 1.17, p=0.2789). The overall 
positivity at Ibague was 44/254 (17%) individuals by ELISA, which indicates that this 
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proportion of the population is or has been in contact with invasive strains. From 80 
individuals infected with E. histolytica/E. dispar, 14 had positive serology and in 6 of them 
trophozoites were present, although without phagocytosed red blood cells (Table 3.5). 
These findings do not guarantee that they are E. histolytica sensu stricto carriers, but the 
association of trophozoites and high ELISA titre could suggest the presence of an invasive 
strain. 
TABLE 3.5 SEROLOGY RESULT ON E. histolytica/dispar POSITIVE SUBJECTS AT IBAGUE 
SAMPLE ID SEROLOGY 
OD 492 nm 
CYSTS TROPHOZOITES 
41 0.586 - + 
131 0.441 - + 
145 0.596 - + 
150 0.300 + + 
153 0.270 + - 
162 0.339 + - 
181 0.306 + - 
199 0.380 + - 
206 0.513 + - 
216 0.300 + - 
224 0.333 - + 
249 0.398 + - 
272 0.637 + - 
306 0.329 + + 
OD: Optical Density 
Mean Break Point: 0.262, Calculated as the average of the cut off points of nine plates 
Cut off Values: Mean of pooled negative sera in each plate +2 Standard Deviations (SD) 
Positive serology was found in 15% (16/109) of the females and in 19% (28/145) 
of the males in the population studied, not significant difference (Chi square 0.03, p= 
0.864). However, the sex distribution of these 44 positive individuals is 36% females to 
64% males (Figure 3.14). 
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FIGURE 3.14 GENDER DISTRIBUTION AMONG 
SEROLOGY POSITIVE INDIVIDUALS 
IBAGUE SAMPLE 
FEMALES 
MALES 
64% 
When analysing the presence of a positive serological response to E. histolytica 
antigen according to age group, 9 individuals out of 84 (10.7%) were positive in the group 
of 5-15 years old, 11 of 53 (20.7%) in the group of 16-21 years old, 11 out of 57 (19.2%) 
in the group of 22-27 years old, 4 out of 18 (22.2%) in the group of 28-33 years old and 2 
out of 19 (10.5%) in the group of 46-85 years old (Figure 3.15). Although the highest 
percentage of positives (30%) was found in the group of 34-45 year olds (7/23), no 
significant association between age and presence of antibodies was found (Chi square for 
trend 1.675, p= 0.1956). 
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Individuals with other parasites but no E. histolytica in their faeces and a positive 
serology by ELISA 26/44 (60.5%) and those with no parasites 4/44 but with positive 
serology (9.3%) possibly suffered past invasive intestinal or extraintestinal infections since 
serology remains positive for up to 5 years (Krupp and Powell, 1971). Also, it is possible 
that light infections with the parasite were not detected in the stools of those individuals. 
A specific detection system is necessary to discriminate E. histolytica from E. dispar in 
stool samples. 
FIGURE 3.15 E. histolytica SEROLOGY 
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3.3.2 Field Work at La Mesa, Department of Cundinamarca 
46-85 
After the field trip to Ibague, it was decided that new material was to be collected 
in a new location with similar population and geographical conditions. From the pilot study 
it was evident that not many invasive strains were circulating among healthy carriers and 
consequently, the probability of finding invasive strains would increase by testing material 
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from symptomatic patients at hospitals in addition to the carriers in the general population. 
A second field trip to La Mesa involved testing 138 subjects, 50.7% (70) of which were 
males and 49.3% (68) females from the orphanage, the secondary school and the hospital 
(Figure 3.16). 
FIGURE 3.16 GENDER RATIO(%) 
LA MESA SAMPLE 
FEMALES 
49.3 
MALES 
50.7 
3.3.2.1 Microscopy 
The microscopy on the samples read at La Mesa resulted in high prevalences for 
amoebic infections such as 20.3% (28/138) of samples positive for E. histolytica/dispar, 
10.1% with E. hartmanni (Figure 3.17), and in 5.8% (14/138) of cases both parasites were 
present. 
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FIGURE 3.17 PREVALENCE OF E. hartmanni & 
E. histolytica/E, dispar INFECTIONS 
AT LA MESA 
E. h/E. d 
E, hartmanni 
E. h: E. histolytica 
E. d: E. dispar 
E. nana was found in 36.2% (50/138) of the samples, and I. butschlii was present 
in 26.8% (37/138). The most prevalent parasites were E. coli in 43.5% (60/138), and BI. 
hominis with a prevalence of 69.6% (96/138). Other protozoa found were G. intestinalis 
in 16.6% (23/138) of the population tested, Ch. mesnili, 20.3% (28/138) and in a lower 
proportion, T hominis in 2.2% (3/138) of samples; and at La Mesa, 18.8% (26/138) of the 
138 subjects tested were negative for intestinal parasites (Figure 3.18). 
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FIGURE 3.18 MICROSCOPY OF STOOLS 
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E. h/E. d 
hartmanni 
, cam 
L butschlii 
. nand 
intestinalis 
BL hominis 
Ch. mesnili 
L hominis 
Negative 
Among the infections with helminths, the most prevalent was A. lumbricoides, 
found in 9.4% (13/138) of subjects, 2.2% were carrying T. trichiura (3/138), or hookworm; 
2 (1.4%) were found infected with H. nana (Figure 3.19). The low number of infections 
found may be due to the concentration method used (flotation), and the results might not 
reflect the real prevalences of helminth infections at La Mesa. 
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FIGURE 3.19 PREVALENCE (%) OF HELMINTH 
INFECTIONS AT LA MESA 
EGGS OF HELMINTHS 
lumbricoicies 
T. trichiura 
Hookworm 
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Prevalence of infection with E. histolytica/E. dispar was not significantly different 
(Chi squareYates corrected 0.70, p=0.401) between the samples taken from the 
symptomatic patients from the hospital (8/29) than in the samples collected at the 
orphanage and at the school (12/56 and 8/53 respectively) at La Mesa. However, for future 
screenings, close contacts of individuals found carrying E. histolytica will be included in 
the screenings. This might reveal the subjects source of infection in the households, thus 
their diagnosis and treatment could help to reduce transmission. 
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When analysing the prevalence of infections according to sex, 17 females out of a 
total of 68 were found infected with E. histolytica/E. dispar as compared to only 11 from 
a total of 70 males screened at La Mesa (Figure 3.20). The difference is not statistically 
significant (Chi square 1.310, p=0.2525), but as discussed previously, it is important 
because mainly females are in charge of food handling in their households, which is one 
of the main factors influencing the transmission of intestinal parasites. 
FIGURE 3.20 E histolytica/dispar 
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3.3.2.2 Cultures 
Fourteen cultures were successful after samples of 28 E. histolytica/dispar 
microscopically positive individuals were cultured in Robinson's medium. The 
microscopy-positive individuals according to location were distributed as follows: 8 came 
from the school, 12 from the orphanage and 8 from the hospital. Hexokinase 
characterisation showed slow non-invasive pattern of migration in starch gels, and once 
again no invasive strains were isolated. 
3.4 DISCUSSION 
Socio-economical conditions in Colombia have improved steadily during the last 
40 years, however, poverty remains the most crucial factor responsible for the regional 
disparities in the quality of life. According to the Departamento Administrativo Nacional 
de Estadistica (DANE), the national percentage of poor people fell from 45.6% in 1985 to 
37.2% in 1993. From the 33.1 million people censused in 1993, almost 20% (6 million) 
had an income below the subsistence level (less than 1 USD/day) and of these, 4.5 million 
lived in rural areas. Malnutrition affects 10% of children under five, with an infant 
mortality rate of 37 per 1000 for 1992 (PAHO, 1995). About 3 million (10%) of the 
population in the country lack access to safe water (World Bank, 1995), accounting for 
51,024 hospital cases of enteritis and other diarrhoeal infections in 1994 (DANE, 1996). 
During the same year, parasitic intestinal infections were the second cause of morbidity in 
the department of Cundinamarca, with 34,482 cases from a total of 1,046,497 morbidity 
cases registered by the Servicio Seccional de Salud de Cundinamarca. 
The introduction of over the counter antiparasitic treatments in Colombia during the 
seventies is believed to have dramatically influenced the prevalences of intestinal parasites, 
with a marked reduction in morbidity and mortality caused by these entities (Robles, 1995), 
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although transmission rates (reflected in reinfections and prevalences of polyparasitism) 
continue to be high (Agudelo et al., 1993; Duque et al., 1994; Carvajal et al., 1995). Also, 
the slight improvement in socioeconomical and sanitary conditions of the population may 
explain the difference in prevalences for E. histolytica/E. dispar among recent and earlier 
studies, although the high prevalences of other intestinal parasites found still indicates the 
need for educational campaigns and a greater effort on the development of economical but 
improved alternatives for sanitation in the country. 
The prevalence of Bl. hominis brings to attention the ongoing discussion about its 
pathogenicity. The problem has been actively investigated during the last fifteen years 
because large numbers of pleomorphic dividing trophozoites have been found in patients 
suffering from diarrhoea (Zierdt, 1991; Zaman, 1996), however other studies have 
concluded it is a commensal organism. The results of the present study show no association 
between Bl. hominis and diarrhoeic faeces, although the characteristic polymorphism was 
present, and large spherical trophozoites (20-40 pm) were frequently observed in 
Robinson's cultures. Trophozoites of Bl. hominis have a higher multiplication rate than E. 
histolytica and competition interfered with the amoebic growth causing the death of many 
cultures. Contamination was eliminated by two washings of the cultured amoebas in 
distilled water for 10 minutes and transfer of the pellets to fresh culture medium. 
The controversy surrounding Bl. hominis shares many features in common with the 
E. histolytica/E. dispar case. The asymptomatic cyst carrier and several symptomatic states 
have been identified, consisting of self-limited gastroenteritis in some cases, and chronic 
gastroenteritis in others, where metronidazole is the drug of choice for treatment (Levy et 
al., 1996), however, in resistant cases emetine, trimethoprim-sulfamethoxazole and 
pentamidine are claimed to be useful (Zierdt, 1991; Zaman and Zaki, 1996). A link 
between Bl. hominis infection and autoimmune-related disorders such as irritable bowel 
syndrome (Nagler et al., 1993; Hussain et al., 1997), arthritis (Kruger et al., 1994) and 
urticaria (Armentia et al., 1993) has been reported. 
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The presence of "pathogenic" strains with variable virulence, and "non-pathogenic" 
strains is supported by studies on animal models (Zierdt, 1991; Moe et al., 1996), variation 
in polypeptide, isoenzyme patterns (Mansour et al., 1995), and serological characterisation 
(Muller, 1994). Consequently, variation among human isolates has been shown by 
immunological and DNA hybridization tests, suggesting that different species may infect 
the same host. Sequencing of the small subunit of ribosomal DNA has provided evidence 
that Bl. hominis is an unusual Stramenopile, which comprises a complex of mitochondria 
containing organisms including unicellular and multicellular protists (Silberman et al., 
1996). As a result, the laboratory diagnosis of Blastocystis hominis represents a new 
challenge for the design of "pathogenic"-specific diagnostic methods. 
The need for improved diagnostic techniques, incorporating differential diagnosis 
between entities such as E. histolytica and E. hartmanni on one hand and between E. 
histolytica and E. dispar on the other is evident. In a recent study on the quality of 
diagnosis for amoebiasis carried out in 58 laboratories in different areas of Bogota, Guhl 
et al. (1996) found that only one laboratory used a micrometer eye piece, 95% of the 
laboratories failed in recognising cysts and/or trophozoites of E. histolytica/dispar and 81 % 
of the total failed to diagnose E. coli cysts in spiked faeces. 
The accurate diagnosis of amoebiasis relies on the improvement of the methodology 
for the analysis of microscopically positive samples with new diagnostic targets, where 
detection is based not only in sensitive and specific procedures, but also on targets stable 
enough to permit samples collected in the field to reach reference laboratories. Ideally, 
such procedures should be applied on the faecal sample directly, avoiding the problems of 
selection during culture. As an example, although all microscopically positive samples 
from Ibague and La Mesa were cultured in Robinson's medium, very few strains were 
isolated because of the difficulty of maintaining and transporting cultures in the field. At 
Ibague, the high number of positive samples required high volumes of materials and culture 
media. Also, the procedure of examining each of them for positivity was time consuming 
and most of the strains did not survive long term culture. A further disadvantage of 
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cultured material is the possibility of selection of populations, which for example influences 
the results on true prevalences of mixed infections. In terms of the lysates for isoenzyme 
analysis, protein extracts are not stable except under cryopreservation, and the intensity of 
the banding pattern varies depending on the media components, influencing interpretation 
of results. 
Antigen and nucleic acid detection systems seem to be the most appropriate 
candidates for differential diagnosis in the future. The field work in Colombia was a 
valuable source of information and material. Some of the cultures collected and 
characterised during the field work were used to standardise and evaluate procedures 
involving antigen detection with monoclonal antibody 20/7D in Chapter 4 and DNA 
amplification using Polymerase Chain Reaction (PCR) and ELISA in Chapter 5. 
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CHAPTER 4 
DETECTION OF ENTAMOEBA HISTOLYTICA USING MONOCLONAL 
ANTIBODY 20/7D 
4.1 INTRODUCTION 
Producing an assay which can distinguish between E. histolytica and E. dispar 
species has been one of the main lines for amoebiasis research. Monoclonal antibodies 
(MAbs) have been the first choice as diagnostic tools when incorporated in IFA or ELISA 
tests. For this purpose, a series of MAbs have been generated against E. histolytica (Table 
4.1). Among the most interesting assay formats proposed, Bhaskar et al., (1996) used a 
rapid, single step immunochromatographic test in which MAb AC55 was conjugated to 
colloidal gold to detect the presence of E. histolytica/E. dispar antigen in faeces as a dot in 
nitrocellulose strips, with a sensitivity of 97.6% and a specificity of 92.6%. Application 
of this format to specific detection of E. histolytica would be valuable. 
TABLE 4.1 ENTAMOEBA ANTIGEN DETECTION WITH MONOCLONAL ANTIBODIES 
MAb ID ANTIGEN Eh Ed LOCATION REFERENCE 
116 Li o hos ho 1 canPG + - S Mirelman et al., 1997 
EH3023 150 kDa, Gal//GalNao-lnhibitable lectin + - S, I Tachibana et al., 1997 
AC55 14 kDa, 21 kDa + + I Bhaskar et al., 1996 
NICED 11 22 kDa, 29 kDa + + ND Se to et al., 1993 
Eh208C2-2 122 kDa, 115 kDa, 111 kDa, 65 kDa + + S, I Wonsit et al., 1992 
4G6 30 kDa, Peroxidoxin + - I Tachibana et al., 1990 
7F4,8C12 170 kDa + - S Petri et al., 1990a 
NA Serine Rich Antigen + + S Stanley et al., 1990 
22.5 ND + - I Strachan et al., 1988 
EH403 96 kDa ND ND S Torian et al., 1987 
NA 50 kDa, 25 kDa ND ND S Ortiz et al., 1986 
Eh: E. histolytica. Ed: E. dispar 
S: Surface. I: Intracellular 
NA: Not Available 
ND: Not Determined 
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Also among those commercially available, the surface serine-rich antigen-specific 
MAb (Stanley et al., 1990) has been used for clinical diagnosis (Optimum S kit, Merlin 
Diagnostica, USA). However, since most of the epitopes on this particular and other 
antigens are shared by E. histolytica and E. dispar, this test is therefore not specific. The 
most advanced kits currently available employ a mixture of MAbs specific for the surface 
adhesin of the parasites and are distributed by either TechLab or Cellabs as the Entamoeba 
test and the E. histolytica specific test (Haque et al., 1995). Since the latter test is able to 
distinguish Entamoeba histolytica sensu stricto infections but the presence of E. dispar can 
only be determined if the Entamoeba test is positive with a negative result in the E. 
histolytica specific test, each sample should ideally be typed with both kits. 
According to the manufacturers of the Techlab E. histolytica kit, the sensitivity and 
specificity of the test are 92.6% and 96.7%, respectively when evaluated against cultures. 
Two further evaluations using clinical samples from Bangladesh have, however revealed 
sensitivities of 85% and 86% respectively for antigen detection when compared with 
microscopy of faecal samples (Haque et al., 1998; Haque et al, 1997). The literature 
included with the test reports a sensitivity of 100% and a correlation of 84% when the 
Entamoeba test is compared to culture and/or PCR. These two tests are presently the best 
available for the fast confirmation of E. histolytica sensu stricto infection. However, since 
E. dispar is diagnosed only by deduction, and most infected people carry E. dispar, 
deduction is a problem because the E. histolytica test is of low sensitivity, thus this limits 
the use of the kits for epidemiological studies. Furthermore, an independent evaluation 
determined that the limit of detection for the E. histolytica test was 1000 trophozoites/well, 
which is approximately 100 times less sensitive than PCR when compared to the specific 
amplification of the small subunit of rDNA (Mirelman et al., 1997). 
MAb 20/7D which was able to distinguish invasive from non-invasive strains in 
clinical isolates was described in 1992 ( Figures 4.1 and 4.2). 
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FIGURE 4.1 DETECTION OF E. histolytica BY IFA WITH MONOCLONAL ANTIBODY 20/7D. 
POSITIVE REACTION 
FIGURE 4.2 DETECTION OF E. dispar by IFA WITH MONOCLONAL ANTI130DY 20/71). 
NEGATIVE REACTION 
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The characterisation of MAb 20/7D was performed on lysates of axenic E. 
histolytica reference strains and on invasive clinical isolates from Colombia and it was 
shown to recognise a protein in the range of 81 and 84 kDa in western blot assays from 
axenic or polyxenic cultures, respectively (Gonzalez-Ruiz et al., 1992a). Although MAb 
20/7D also reacted faintly with a homologous protein in lysates of E. dispar, the results of 
the IFAT testing on a further 107 cultured isolates allowed a 100% correlation with the 
zymodeme analysis of strains, which corresponded to isolates from different geographical 
areas in Bangladesh, Mexico and Colombia (Gonzalez-Ruiz et al., 1992c). The ability of 
MAb 20/7D to recognise an analogous antigen in lysates of E. dispar suggested that a 
common antigen was present in both species, at a lower level in E. dispar. However, MAb 
20/7D was then tested for its ability as an antigen detection system applied directly in faecal 
samples for diagnosis of amoebic dysentery. Thus, the initial evaluation of an antigen 
detection ELISA system (Faecal Antigen Capture ELISA, or FAC-ELISA) using affinity 
purified rabbit polyclonal antibodies (capture step) and MAb 20/7D-containing ascitic fluid 
for the detection step was performed with 108 stool samples from Bangladesh (Gonzalez- 
Ruiz et al., 1994b). The FAC-ELISA system detected 13 out of 15 E. histolytica infections. 
There were no false positives in the remaining 93 samples composed of 32 E. dispar 
carriers, 33 samples from patients with other parasites different from E. histolytica or E. 
dispar and 28 true negative samples (i. e. no parasites found). The corresponding sensitivity 
and specificity values were 87% and 100% respectively. In order to compensate for high 
background signals, this test employed a control of commercially available non-immune 
rabbit IgG. The optical densities (ODs) of these controls were then subtracted from the OD 
readings obtained from the test samples. The cut off value was calculated by the average 
of these controls plus three standard deviations. Optical densities >0.035 were considered 
positive. 
The encouraging results described above suggested the possibility of further 
developing the test and it was the aim of the work described in this chapter. One of the 
modifications proposed was to substitute the use of ascites by the purified MAb in the 
FAC-ELISA in order to improve the sensitivity of the test. Also, to evaluate further the 
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dynamics of the individual components of the FAC-ELISA system for the detection of E. 
histolytica infections and their differential diagnosis from E. dispar. All the work on the 
evaluation of MAb 20/7D was performed under the advice and supervision of Dr Andrew 
Falconar, who carried out all animal procedures. 
4.2 MATERIALS AND METHODS 
MAb 20/7D cell line was first grown and re-cloned followed by the production of 
ascitic fluid. This IgGI MAb was then purified using a Protein-G Sepharose column 
(Sigma, UK). Then, the immunoaffmity column was prepared using purified MAb 20/7D 
and this column was used for immunoaffinity purification of cell lysates of E. histolytica 
and E. dispar trophozoites. The positive fractions were identified by protein assay, and the 
further identification of the target proteins obtained from lysates of parasites was carried 
out in dot-blot assays using either rabbit polyclonal antibody or the purified MAb 20/7D. 
The selected fractions were pooled and the E. histolytica and E. dispar proteins were then 
compared by SDS-PAGE under non-reducing conditions with subsequent western blot 
analysis. 
The proteins were also tested by ELISA using E. histolytica-immune rabbit serum 
and MAb 20/7D. Capture-ELISA for the detection of the purified E. histolytica and E. 
dispar proteins was then performed using affinity purified rabbit IgG specific for E. 
histolytica antibody in the capture step, and MAb 20/7D as secondary antibody. The results 
were then evaluated to assess the feasibility of the assay for use in differential diagnosis. 
4.2.1 Hybridoma Culture 
One cryopreserved vial of hybridoma 20/7D containing 1x 106 cells/ml was removed 
from liquid nitrogen, thawed in a 37'C water bath, wiped in 70% (v/v) ethanol and 
transferred to a category H laminar flow cabinet. The cells were slowly diluted in 10 ml of 
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serum-free RPMI (Roswell Park Memorial Institute) 1640 medium (Appendix 1), washed 
by centrifugation at 700 g for 10 minutes, resuspended in 10 ml of growth medium and 
transferred to a 25 cm2 culture flask (1-63371 Nunc, DK). This flask was incubated at 37'C 
in air containing 5% CO2 until the cells were confluent. Subcultures were established by 
gently resuspending the cells in fresh complete RPMI medium (Appendix 1) and transferred 
to new culture flasks. Once the new cultures were 70% confluent, the cells were cloned. 
4.2.2 Cloning of Hybridoma Cells 
For cloning, mouse peritoneal mononuclear cell feeder layers (provided by Dr 
Falconar) at 1x 104 cells/ 100, u1 of RPNH complete medium (Appendix 1) were added to each 
well of 96 well tissue culture plates. These plates were then incubated at 37'C overnight. 
MAb 20/7D hybridomas were then gently removed from the flasks, counted using a 
Neubauer haemocytometer and diluted in growth medium to obtain 160 hybridoma 
cells/ml. Then, 0.9 ml of the cell suspension were added to 0.9 ml of growth medium, to 
give a final concentration of eight hybridoma cells/200µl. l00µ1 of serial two fold dilutions 
were transferred into columns of the previously prepared 96 well microtitre plate which 
contained the cell-feeder layers to give 8 cells/ well in column 1,4 cells/well in column 2, 
2 cells/well in column 3, and 1 cell/well in columns 4 and 5. 
After incubation for 7 days at 37°C with 5% CO2,100µl of fresh medium was 
added to each well and the wells were examined for hybridoma growth. Wells in columns 
4 and 5, which contained single colonies were marked, and when they reached 50% 
confluency, these supernatants were assayed for MAb by IFA. Wells which secreted 
antibodies were transferred to 24 well plates and when these were 50-80% confluent, these 
clones were subcloned as described above. The MAb producing clones were then expanded 
into 80 cm2 flasks for freezing and ascitic fluid production. 
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4.2.3 Screening of 20/7D Subclones by Immunofluorescent Assay (IFA) 
12-well immunofluorescence slides (polytetrafluorethene-coated slides, Hendley, 
PH-001) which contained methanol-fixed trophozoites of polyxenic E. dispar SAW 1734 
and axenically cultured E. histolytica HMI-IMSS or N IH-200 were used to test the MAb 
20/7D cell-culture supernatants for E. histolytica specificity by IFA. Supernatants from the 
MAb non-producing myeloma cell line Sp2/O-Agl4 (Shulman et al., 1978) (kindly 
provided by Dr A. Gonzalez), were used as negative controls for IFA. For the test, 10 µl 
of two fold dilutions (1/2 to 1/64) from each cell-culture supernatant was added to each 
well and slides were incubated in a humid chamber for 30 minutes. After washing for five 
minutes in PBS pH 7.2,10 µl of a 1/500 dilution of fluorescein-conjugated goat anti-mouse 
IgG(H+L) (115-016-062, Jackson ImmunoResearch Laboratories, USA) diluted in 1/ 10,000 
dilution of Evans blue were added to each well. After incubation for 30 minutes in humid 
chamber, and washing in PBS pH 7.2 for five minutes, the slides were allowed to dry and 
were mounted in glycerol buffer (1000-4 Sigma, UK) under a cover slip. Positive 
specimens were identified using an immunofluorescence microscope (Diaplan Leitz, 
Germany). 
4.2.4 Screening of 20/7D Subclones by ELISA 
MAb 20/7D-secreting cell-culture supernatants which were positive in the IFA were 
tested by ELISA using a crude lysate of E. histolytica HM1-IMSS trophozoites. For the 
ELISA, 96-well ELISA plates (Immulon 2, Dynatech, UK) were coated with 100 µl of 1.2 
µg/ml of protein in sodium carbonate-bicarbonate buffer pH 9.6 (coating buffer, Appendix 
1), previously found by titration to be the optimal antigen concentration. The plates were 
incubated overnight at 4'C in a humid container. Unbound antigen was removed by 
washing with PBS which contained 0.05% v/v Tween 20 (PBS/T, Appendix 
1). The plates 
were then dried by blotting on to paper towels and stored at -20°C with 
desiccant for up to 
one month. 
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Before use, these plates were then blocked using 100µl/well of 1% gelatin/PBS and 
incubated for 1 hour at 37°C in a humid container. After washing 3 times with PBS/T, 
three-fold serial dilutions of each MAb cell-culture supernatant were prepared in PBS/T 
containing 0.25% gelatin (PBS/T/G) and these plates were then incubated for 1 hour at 
37 °C. After six washes with PBS/T, 100 µl of a 1/1500 dilution of horse-radish peroxidase 
conjugated goat anti-mouse IgG antibody (A-2304, Sigma, UK) diluted in PBS/T/G were 
added to each well and these plates were incubated for 1 hour at 37°C in a humid chamber. 
After washing, 100 µl of OPD-H202 substrate prepared in citrate/phosphate buffer pH 5.0 
(Appendix 1) was added to each well. The plates were then incubated at room temperature 
for 20 minutes, before the reactions were then stopped by addition of 50p i/well of 2.5M 
H2SO4 and the absorbance was read at 492 nm (MR700, Dynatech microplate reader, UK). 
4.2.5 Cryopreservation of Myeloma Cells, and Hybridomas 
Approximately 2x 106 cells of each MAb 20/7D hybridoma cell-line were 
resuspended in 1.8 ml of ice-cold foetal calf serum which contained 10% v/v dimethyl 
sulphoxide (DMSO) (D-4540, Sigma UK). Two 1 ml aliquots were distributed in cryovials 
(Nunc, DK) and slowly the vials were frozen to -70'C (-1 'C/min) before being transferred 
to liquid nitrogen. 
4.2.6 Production of 20/7D Ascitic Fluid 
Groups of 20 eight week old female BALB/c mice were injected intra-peritoneally 
(i. p. ) with 0.5 ml of pristane (2,6,10,14-tetramethyl pentadecane) (Sigma, UK) followed by 
the i. p. injection of 2x 106 hybridoma cells contained in 0.5 ml of PBS (pH 7.2) 10-14 days 
later. After 14-28 days, ascitic fluid was collected from these animals using an 18 gauge 
hypodermic needle, clarified by centrifugation for 10 minutes at 700 g and the supernatants 
were then stored at -40'C. 
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4.2.7 Production of Immunoaffinity Columns 
4.2.7.1 MAb 20/7D Purification 
MAb 20/7D was purified from ascitic fluid using a 5m1 Protein G-Sepharose Cl 4B 
fast flow column (P-3296, Sigma, UK). For this, 20 ml of ascitic fluid were diluted to 50 
ml in THE buffer (loading buffer, Appendix 1) and allowed to bind overnight at 4'C. After 
washing the column with 500 ml of TNE, bound MAb 20/7D was eluted with 0.1 M 
glycine/HC1 pH 2.5 and 2 ml fractions were immediately neutralised with 2S0µ1 of 2M 
Tris-HC1 buffer, pH 8.0 and stored at -20°C. 
4.2.7.2 MAb 20/7D Immunoaffinity Column 
Purified MAb 20/7D was adjusted to a protein concentration of 5 mg/ml (5 ml) in 
coupling buffer (Appendix 1) by reduced pressure dialysis against three 1 litre changes of 
coupling buffer. 1g of cyanogen bromide-activated Sepharose 4B (Pharmacia, UK) was 
then washed with 500 ml of 1 mM HCl (pH 3.0) at 4°C. The MAb 20/7D was then added 
and coupling was allowed to proceed overnight at 4°C in a5 ml polypropylene tube on a 
rotating mixer. After draining the coupling buffer, the excess binding sites were blocked 
using 0.2M glycine in 10mM Na2HPO4 pH 8.0 for 2 hours in a rotating mixer at room 
temperature. The coupled Sepharose was then transferred to a5 ml polypropylene column 
and subjected to five high and low pH alternations using 0.1 M acetate buffer containing 
0.5M NaCl pH 4.0 and coupling buffer (pH 8.5) to remove the excess uncoupled protein. 
The column was then stored at 4°C with PBS which contained 0.02% w/v sodium azide. 
4.2.8 Immunoaffinity Purification of Proteins 
1x 106 trophozoites of axenic E. histolytica and polyxenic E. dispar cultures were 
lysed using 0.5% v/v Nonidet P-40 (NP 40) diluted in THE which contained a mixture of 
protease inhibitors (Appendix 1) to minimise protein degradation. After incubation 
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overnight at 4'C, these lysates were diluted with 50 ml of loading buffer (TNE, Appendix 
1) and passed through the MAb 20/7D immunoaffinity column overnight at 4 °C. After 
washing with 500 ml of THE which contained protease inhibitors, the bound antigens were 
eluted using 0.05M diethylamine/TNE (pH 11.3) and 2 ml fractions were immediately 
neutralised with 250 µl of 2M Tris-HC1 pH 7.0. 
4.2.9 Dot-ELISA for Detection of E. histolytica and E. dispar Proteins in Eluates 
Nitrocellulose (NC) membranes were soaked in PBS pH 7.4 and dried at room 
temperature. From each fraction 24l were applied as dots on 5mm grids on the 
nitrocellulose membranes and were dried at room temperature. Each membrane also had 
antigen (21u1) control dots corresponding to Bovine Serum Albumin (1 mg/ml stock), 
conjugate diluent (PBS-3% casein), faecal diluent (50% FCS/0.02% NaN3/0.3% PBST, 
Appendix 1) and E. histolytica and E. dispar antigens (1.2 mg/ml each). Non-specific 
binding sites were blocked by incubation with PBS-casein 3% for 15 minutes. After 
washing with PBST, either immune rabbit serum 1: 100 or purified monoclonal antibody 
diluted 1: 50 in PBS-3% Casein were added to the membranes in plastic bags and incubated 
for 30 minutes at room temperature. A final wash with PBS-T eliminated unbound 
antibodies. 
The corresponding peroxidase labelled conjugates containing goat anti-rabbit IgG 
or goat anti-mouse IgG were incubated for 15 minutes at room temperature. After washing 
with distilled water, the substrate (10 ml of PBS-T containing 10 41 of a3 mg/ml 4-chloro- 
1-naphthol stock in methanol and 10 , ul of 
30% hydrogen peroxide) was incubated with the 
membranes in a plastic bag for 15 minutes at room temperature. Then the membranes were 
washed in distilled water to stop the reaction. The results were read positive when a purple 
dot was seen. 
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4.2.10 Polyacrylamide Gel Electrophoresis (PAGE) 
Discontinuous SDS-PAGE (Laemmli, 1970) was performed using a minigel 
apparatus (Mini-Protean II, 165-2940, Bio-Rad Laboratories Ltd., UK). An 8% w/v 
polyacrylamide resolving gel and a 3.4% w/v stacking gel were prepared (Appendix 1). 
Both gels were allowed to polymerise for 1 hour at room temperature. Purified protein and 
culture lysate samples (81u1) were mixed with 2 µl of 5X sample buffer (without 2- 
mercaptoethanol) and bromophenol blue (2, u1 of 0.2% bromophenol blue w/v in 50% 
glycerol/water, Appendix 1). After heating the samples (100'C for three minutes in a 
boiling water bath), 10µl of each sample was loaded/well. Molecular weight standards of 
the proteins (MW-SDS-200. Sigma, UK) were added to the outer wells to calculate the 
relative Mr (Appendix 1). 
The proteins were separated using 200 V (constant voltage). The gels were then 
either stained to reveal all proteins or the proteins were transferred directly onto 
nitrocellulose membranes for immunoblot analysis (western blot assay, see 4.2.10). For 
staining, the gels were initially fixed using a mixture of 40% methanol and 14% acetic acid 
in water (Appendix 1) for half an hour before being stained with the 0.25% w/v Coomassie 
blue R250 solution (Appendix 1) for 1 hour. Destaining was then performed using 5% 
methanol and 7.5% acetic acid in water until sufficient contrast was obtained. 
4.2.11 Western Blotting 
After electrophoresis the gels were immersed in 1X blotting buffer (Appendix 1) 
together with six (8.5 cm2 x 5.5 cm2) Whatmann 3MM filter papers. These papers were 
used to "sandwich" a sheet of 0.2 gm pore size nitrocellulose (401-196, Schleicher & 
Schuell, Germany) next to the gel. Semi-dry electroblotting of the proteins was performed 
at 160mA/gel (Sartoblot H-S, SM 17556, Sartorius Ltd., UK) for 30 minutes at room 
temperature. The membranes were then air-dried, blocked overnight with 3% w/v skimmed 
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milk (Cadbury, Marvel, UK) in PBS that contained 0.02% NaN3 (PBS/T/M) at room 
temperature. After washing three times with PBS/T, a 1/200 dilution of purified MAb 
20/7D was allowed to react with the membrane in a sealed plastic bag overnight on a 
horizontal shaker (Mk VII, LH Engineering Co., UK). After washing the membranes three 
times with PBS/T, a 1/2,000 dilution of goat anti-mouse IgG conjugated with horse-radish 
peroxidase (A-2304, Sigma, UK) in PBS/T/M was allowed to react for one hour at room 
temperature. After three washing steps, diaminobenzidine/4-chloro-l-naphthol substrate 
(Appendix 1) was added and allowed to react for 10 minutes at room temperature. The 
reaction was stopped by washing the membranes with distilled water and residual enzyme 
activity was destroyed with 0.01M H2SO4 for 10 seconds before the membranes were 
thoroughly washed with distilled water. 
4.2.12 Generation of Rabbit Anti-E. histolytica Specific Polyclonal Antibodies 
Two male New Zealand White (NZW) rabbits were initially bled from the marginal 
ear vein and the blood was allowed to clot at room temperature for 20 minutes. The clot 
was detached and centrifuged at 700 xg for 30 minutes at 4'C and the serum was 
collected. This pre-immune serum was checked for absence of antibodies against E. 
histolytica and as negative control in IFA and ELISA assays. Each animal was then 
immunised intramuscularly with 1x106 axenically cultured trophozoites of E. histolytica 
strain HIVII-IMS S in a total volume of 0.5 ml of Freunds complete adjuvant (FCA, F-5881 
Sigma, UK). These animals were then boosted with the same dose of antigen emulsified 
in Freund's incomplete adjuvant (FIA, F-5506 Sigma, UK) every two weeks for four 
months. Blood samples were obtained before each antigen boost and aliquots of each 
serum sample were mixed with an equal volume of glycerol and stored at -20'C. 
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4.2.13 Titration of Rabbit Polyclonal Anti-E. histolytica Specific Antibodies 
ELISAs were performed using E. histolytica lysate as described for MAb 20/7D (see 
4.2.4), except that the bound rabbit IgG was identified using a 1/5,000 dilution of goat anti- 
rabbit IgG conjugated with horse radish peroxidase (HRP) secondary antibody (111-036- 
003, Jackson's ImmunoResearch, USA). 
4.2.14 Affinity Purification of Rabbit Polyclonal Anti-E. histolytica Specific 
Antibodies 
IgG from the rabbit serum samples (see 3.2.10) were precipitated by the addition 
of an equal volume of ice-cold saturated ammonium sulphate [(NH4)2SO4] solution (pH 
7.4). After continuous stirring for two hours at 4'C, the mixture was then centrifuged at 
5000 g for 10 minutes at room temperature. The pellet was then washed twice with 50% 
saturated ammonium sulphate solution and then dissolved in half of the original volume of 
distilled water. These samples were then transferred into dialysis tubing which had a 12.4 
kDa cut-off value (D-9777 Sigma, UK) and dialysed overnight against 25 mM Tris/HC1 
which contained 70 mM NaCl pH 8.8. 
Then a column of DEAF/Trisacryl (Reactifs IBF, Villeneuve la Garenne, France) 
was packed and equilibrated in 25 mM Tris/HC1 which contained 35 mM NaCl (TN) pH 
8.8. The precipitated rabbit IgG was diluted with an equal volume of 25 mM Tris/HCl pH 
8.8 and added to the column at a flow rate of 1 mu min. This column was washed with TN 
buffer and elution was then performed using 25 mM Tris/HCl which contained 100 mM 
NaCl pH 8.8. Twenty, 2 ml fractions were then collected and any remaining proteins were 
finally eluted with 25 mM Tris/HCl which contained 500 mM NaCl pH 8.8. The fractions 
that contained the protein were identified using a BCA protein assay (see 2.6), pooled and 
then dialysed overnight at 4'C against 0.15M NaCl solution and stored at 4'C with 0.02% 
w/v 3mM NaN3. The rabbit IgG was further purified using Protein A coupled Sepharose 
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6MB (P-6649 Sigma, UK) column. After loading the IgG in TN buffer pH 7.8 and washing 
with 500 ml of this buffer, the bound IgG was eluted using 0.2 M glycine/HC1 pH 3.0 and 
one ml fractions were immediately neutralised with 200 µl of 1M Tris/HC1 pH 7.6. The 
purified IgG was then stored at -20'C. 
4.2.15 Capture ELISA (FAC-ELISA) Using E. histolytica and E. dispar Spiked Stool 
Samples 
4.2.15.1 Preparation of Samples 
Stool samples found to be negative for any intestinal parasites by microscopy with 
concentration were pooled and diluted in PBS which contained 0.02% w/v sodium azide, 
0.3% v/v Tween 20 and 50% foetal calf serum (PBS/T/FCS) as described previously 
(Gonzalez-Ruiz et al., 1994b). 1x106 trophozoites (approximately 1.2 mg protein/ml) of 
freshly harvested E. histolytica (BM-IMSS) and E. dispar (SAW 1734) reference strains 
were lysed by three freeze/thaw cycles using liquid nitrogen. These suspensions were then 
centrifuged at 35 00 g for 10 minutes at 4'C, and the supernatants were diluted to I/ 100 (12 
µg protein/ml) and to 1/500 (2.4 pg protein/ml) PBS/T/FCS with or without the negative 
faeces. 
4.2.15.2 Test Procedure 
ELISA plates (Immulon 4, Dynatec, UK) were coated (50 , d1well) with a 10 µg/ml 
solution of purified rabbit anti-E. histolytica IgG (see 4.2.13) in carbonate-bicarbonate 
buffer pH 9.6 (coating buffer, Appendix 1) and incubated overnight at 4'C. After three 
washings with PBS/T, the plates were blocked for 1 hour at 3 7'C using 200 µl/well of I% 
w/v gelatin/PBS. After three washings, 100 µl of the Entamoeba spiked faecal samples 
were added to duplicate wells and the plates were incubated for 2 hours at room 
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temperature. After washing 5 times with PBS/T, 100 pl/well of purified MAb 20/7D 
diluted to 1/3000 in PBS/T which contained 0.25% w/v gelatin and 50% FCS 
(PBS/T/G/FCS) were added and the plates were incubated for 2 hours at room temperature. 
After washing with PBS/T, 100 µl/well of goat anti-mouse conjugated with peroxidase (A- 
2304 Sigma, UK) diluted 1/1000 in PBST/G/FCS were added and the plates were incubated 
for 1 hour at 37 °C. After washing the plates, bound antibodies were identified by the 
addition of 100 µl/well of o-phenylene diamine substrate (OPD) in citrate/phosphate buffer 
pH 5.0 (Appendix 1) and the plates were incubated for 30 minutes in the dark. The 
reactions were then stopped by the addition of 50 µl/well of 2.5M HC1 and the absorbance 
was determined at 492 nm (MR700, Dynatec, UK). 
4.3 RESULTS 
4.3.1 Selection of Monoclonal Antibody 20/7D Clones 
Four subclones of MAb 20/7D (4A9,3C6,1E2, and 1H2) were positive by both 
IFAT against methanol-fixed E. histolytica and E. dispar trophozoites (see 4.2.3), and 
ELISA against crude lysates of E. histolytica HM1-IMSS (Table 4.2). Each of these 
produced higher MAb titres than the original uncloned parent cell-line. Each of these 
subclones was then further subcloned to obtain 3 to 7 stable hybridoma cell-lines, for a total 
of 18 antibody-producing hybridomas (Lot 1). The logarithm of the 50% end point titre of 
antibody from each cell-line is registered in Table 4.2. 
Nine of the hybridomas (Lot 2, Table 4.2) were selected for subculture on the basis 
of their growth rate, then their antibody titres were confirmed by ELISA using crude lysates 
of E. histolytica antigen as above (Figures 4.3 A and B). 
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TABLE 4.2 SELECTION OF MAb 20/7D SUBCLONES USING AN E. histolytica LYSATE 
1st 
SUBCLONE 
2nd 
SUBCLONE 
Logo Tf, 0 CCSN 
(Lot 1 
Logo T50 CCSN 
(Lot 2) 
4A9 B3 1.67 1.41 
B6 1.71 1.41 
D1 1.62 1.42 
E4 1.5 1.43 
H4 1.44 --- 
3C6 D9 1.44 --- 
G10 1.42 --- 
F4 1.59 1.44 
1E2 Al 1.36 --- 
B7 1.42 --- 
1E2 C5 1.86 1.78 
H2 1.4 --- 
1H2 B4 1.5 --- 
C9 1.67 --- 
D1 1.62 --- 
D4 1.6 1.76 
E1 1.6 1.72 
E8 1.57 --- 
F4 1.6 1.78 
MAb 20/7D PRECLONED 0.916 --- 
CCSN: Cell Culture Supernatant. 
Log, 0T50: Logo 50% End-Point Titre 
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Figure 4.3A CLONED LINES SUPERNATANT 
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The specificity of supernatants of hybridomas 4A9-B6,4A92-D 1,1 E2-C 5,1 H2-D4, 
and 1 H2-F4 was examined by comparison of their antibody titres with E. histolytica and 
E. dispar crude antigens by ELISA (see 4.2.4). Supernatants from uncloned 20/7D cell-line 
and hybridoma l H7.4 secreting specific anti-dengue virus non-structural-1 protein 
(Falconar et al., 1994) monoclonal antibodies were used as positive and negative controls 
respectively (Table 4.3). 
TABLE 4.3 SPECIFICITY OF MAb 20/7D SUBCLONES 
HYBRIDOMA ID Log10T50 CCSN 
E. histolytica 
ANTIGEN 
Log10T50 CCSN 
E. dispar 
ANTIGEN 
Log10T50 ASCITES 
E. histolytica 
ANTIGEN 
PRECLONED 
20/7D 
0.916 0.8 --- 
4A9-B6 1.42 0.92 3.02 
4A9-DI 1.36 0.92 --- 
1E2-C5 1.58 0.954 3.5 
I H2-D4 1.4 0.92 3.36 
1H2-F4 1.46 0.89 --- 
2'2.5* NT NT 4.5 
1H7-4 NEG. NEG. --- 
Log 10T: Logo of 50% End Point Titre 
CCSN: Cell Culture Supernatant 
*Specific for E. histolytica in IFA (Strachan et al., 1988) 
Although the supernatants of all five hybridomas also reacted with E. dispar 
antigen from polyxenic cultures, their reaction towards E. histolytica antigen was 
approximately 3 to 4 times stronger than with E. dispar antigen (Table 4.3). Subclones 
4A9-B6, IE2-C5 were selected for ascites production (Table 4.3, column 4) because of 
good growth rate and high level of antibody secretion. Cell-line 1 H2-D4 had a very slow 
growth rate, but its antibody titres were also high when tested by ELISA, therefore it was 
also selected for ascites production (Figures 4.4 A and B). 
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Figure 4.4A TITRATION OF MAb 20/7D 
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4.3.2 Purification of Monoclonal Antibody 20/7D 
Hybridomas 4A9-B6, I E2-C5 and I H2-D4 were injected into pristane-primed 
Balb/c mice (see 4.2.6). The antibody activity of the corresponding ascites was measured 
with E. histolytica crude antigen by ELISA using ascites 22.5, as positive control (Table 
4.3, column 4 and Figure 4.5). Hybridoma 22.5 (kindly provided by Dr J. Ackers) is 
specific for E. histolytica and it has been used for diagnosis of invasive isolates in IFA 
(Strachan et al., 1988). Ascites 4A9-B6 and 1 E2-C5 were selected for affinity purification 
of MAb 20/7D. Ascites l H2-D4 was found to slightly cross react with E. dispar 
trophozoites by IFAT and was not considered for affinity purification. 
Figure 4.5 ASCITES TITRATION 
USING E. histolytica HM1-IMSS ANTIGEN 
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4.3.3 E. histolytica and E. dispar Protein Purification 
The protein identified by monoclonal antibody 20/7D was obtained from both E. 
histolytica and E. dispar immunoaffinity columns. The 20 fractions collected in each case 
were analysed by Dot-ELISA using the MAb 20/7D and rabbit anti-E. histolytica IgG for 
protein detection. The fractions containing the peak of protein were each pooled before 
being incorporated in further assays. Both the purified MAb 20/7D and the purified rabbit 
IgG antibody reacted with E. histolytica and E. dispar lysates. This was later confirmed 
when the isolated proteins were used as antigens to coat microtiter plates for ELISA (4.3.5). 
4.3.4 SDS-PAGE and Western Blotting of Specific Proteins 
Lysates of E. histolytica and E. dispar were compared with the corresponding 
purified proteins by Western blot analysis after denaturating, non-reducing SDS-PAGE 
electrophoresis (Figure 4.6). Interestingly, the proteins in the lysates of E. histolytica 
(Lane 1) and E. dispar (Lane 3) had relative Molecular Weights of 79 kDa and, both 77 and 
70 kDa respectively while the immunoaffinity purified proteins from each were 89 kDa (E. 
histolytica, Lane 2) and 89 kDa and 82 kDa (E. dispar, Lane 4). 
MAb 20/7D also weakly identified multiple bands of approximately 132,58,54, 
52 and 50 KDa in the E. histolytica lysate and of 98,56,55,53,52,49 and 48 kDa in the 
E. dispar lysate. The differences between the relative molecular weights of the impure and 
purified protein may therefore have been caused by partial proteolysis (truncation) of the 
proteins in the lysates. 
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FIGURE 4.6 Western Blot Analysis of E. histolytica and E. dispar Lysates and 
Immunoaffinity Purified Proteins Using MAb 20/7D. 
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Lane 1: E. histolytica Lysate (Axenic), where a protein of approximately 79 kDa reacted 
with MAb 20/7D. Lane 2: E. histolytica Pure Protein, where a protein of 89 kDa reacted 
with MAb 20/7D. Lane 3: E. dispar Lysate (Polyxenic) showing the reaction of MAb 
20/7D with bands at 77kDa and 70 kDa. Lane 4: E. dispar Pure Protein reacted with 
bands at 89 kDa and 82 kDa. 
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4.3.5 Titration of E. histolytica and E. dispar Lysates and Immunoaffinity Purified 
Proteins Using MAb 20/7D 
Three-fold dilutions of purified MAb 20/7D starting from 1/30 were titrated with 
the E. histolytica and E. dispar culture lysates (Figure 4.7) and purified proteins (Figure 
4.8) used as the antigens in ELISA. 
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The purified MAb 20/7D reacted with both lysates, but its titre (10910 t50) against the 
E. histolytica lysate was approximately three times higher than that against the E. dispar 
lysate (Figure 4.7). In contrast, when ELISA plates were coated with the same 
concentration (10µg/ml) of each of the purified proteins, MAb 20/7D showed a higher titre 
and higher maximum absorbance values against the E. dispar antigenO0910 t50 : 3.7) than 
the E. histolytica antigen O0910 t50 : 3.4) (Figure 4.8). 
These results may indicate that there is between three and ten times more protein 
in E. histolytica than in E. dispar in the lysates and although the molecular weight 
differences between the lysates and the pure proteins should be taken into account for the 
evaluation of these results, Gonzalez-Ruiz et al. (1992a) also reported differences in the 
molecular weights of the protein depending on the culture conditions of the trophozoites 
(81 kDa for axenic trophozoites and 84 kDa for polyxenic trophozoites) in the lysates of 
E. histolytica. The authors also found that the MAb 20/7D reacted with a similar epitope 
in E. dispar under denaturing conditions, which confirms the results found during the 
immunoblot analysis. 
4.3.6 Titration of E. histolytica and E. dispar Lysates and Proteins Using Rabbit 
Immunoaffinity Purified IgG 
After purification, the rabbit anti-E. histolytica specific IgG was assayed against E. 
histolytica and E. dispar lysates (Figure 4.9) and these ELISA titrations were compared to 
those obtained using the purified proteins (Figure 4.10). This rabbit serum reacted with 
both E. histolytica and E. dispar lysate but its apparent avidity (as indirectly measured by 
the slope in the graph of the ELISA titrations) for the purified proteins was slightly higher 
against the E. dispar protein than against the homologous E. histolytica protein. This 
implied that this serum would, therefore, capture these proteins from both E. histolytica and 
E. dispar during the screening of faecal samples. 
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FIGURE 4.9 RABBIT SPECIFIC IgG VS 
E. h istol yti ca AND E. dispar 
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4.3.7 FAC-ELISA Using Affinity Purified MAb 20/7D Against E. histolytica and E. 
dispar Lysates 
Absorbance values were reduced when faecal samples were added to E. histolytica 
and E. dispar lysates (Table 4.4). This effect was also reported in the original FAC-ELISA 
when the limit of detection of the test was determined using spiked negative faeces and it 
was attributed to nonspecific background in the stools used, although degradation of the 
antibody protein by potent proteases contained in the faecal samples (Viscidi et al., 1984) 
was also considered (Gonzalez-Ruiz et al., 1994b). This may be despite the use of FCS in 
the sample diluent to overcome protein degradation. The addition of a mixture of protease 
inhibitors to the sample diluent may help to reduce epitope degradation. 
4.3.8 FAC-ELISA Using Immunoaffinity Purified MAb 20/7D to Detect E. histolytica 
and E. dispar Immunoaffinity Purified Proteins 
The capture in this assay was also tested using immunoaffinity purified E. 
histolytica and E. dispar proteins. MAb 20/7D recognised both E. histolytica and E. dispar 
proteins, but higher optical densities were obtained against the same concentration 
(10µg/ml) of E. dispar immunoaffmity purified protein than from the homologous E. 
histolytica protein (Table 4.4). These results, therefore, confirm the stronger reaction of 
MAb 20/7D against the E. dispar immunoaffinity purified protein (Figure 4.8, page 134). 
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TABLE 4.4 COMPARISON OF ABSORBANCES IN ANTIGEN CAPTURE ELISA USING LYSATES AND 
PURIFIED PROTEIN OF E. histolytica and E. dispar IN THE ABSENCE OR PRESENCE OF FAECES 
ANTIGEN PROTEIN ABSORBANCE ABSORBANCE 
pg/ml WITHOUT FAECES** WITH FAECES** 
OD SD OD SD 
E. histolytica Lysate* 12.0 0.643 ± 0.034 0.538 ± 0.014 
E. histolytica Lysate* 2.4 0.537 ± 0.027 0.485 ± 0.012 
E. dispar Lysate* 12.0 0.485 ± 0.032 0.439 ± 0.020 
E. dis par Lysate* 2.4 0.421 ± 0.028 0.422 ± 0.007 
E. histolytica Proteins 10.0 0.516 ± 0.028 NT 
E. dis par Proteins 10.0 0.886 ± 0.026 NT 
Blanko (No Antigen) 0.0 0.320 ± 0.014 0.308 ± 0.011 
Cut Off Value (X Blank OD+3SD) --- 0.362 0.341 
**: PBS/T/FCS used as diluent 
*: Average OD of four Observations. 
Protein equivalences: lx 10° Trophozoites=approx. 12 gg/m1 and 2x 10' Trophozoites= approx. 2.4 µg/ml of protein 
': Average OD of 16 Observations, 
b: Average OD of 8 Observations 
4.4 DISCUSSION 
Subcloning of MAbs has been routinely used to eliminate non-producing 
hybridoma cells which eventually outnumber the MAb secreting cells (Tijssen, 1985). This 
strategy was successfully used to produce stable cell-lines of MAb 20/7D which, therefore, 
had higher titres. While the subclones also showed a greater specificity for E. histolytica 
rather than E. dispar in the IFAT as described previously (Gonzalez-Ruiz et al., 1992a), 
they all reacted with a protein present in both parasites in immunoblot assay. 
Purification of the components to be used in the antigen capture ELISA was 
performed in an attempt to improve the sensitivity of the original test (Gonzalez-Ruiz et al., 
1994b). The substitution of the impure MAb 20/7D (ascites) and of the rabbit anti-E. 
histolytica antisera by affinity purified MAb and IgG for the capture step did not affect the 
capture of antigen, but the assay could not discriminate between E. histolytica and E. 
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dispar and MAb 20/7D was therefore not E. histolytica specific. While this may have 
resulted from the different concentration of the antigens in E. histolytica and E. dispar 
lysates, this was confirmed by the comparison of the reaction of the same quantity (10 
µg/ml) of the purified proteins attached to the wells in ELISA, where the purified rabbit 
IgG and the MAb both reacted better with E. dispar. Similar results were found for the 
antigen capture ELISA, when the purified rabbit IgG was attached to the wells to capture 
the purified proteins and the MAb was used for detection (Table 4.4). This is not surprising, 
since it has been established that E. histolytica and E. dispar have homologous antigens 
(e. g. superoxide dismutase, hexokinase, phosphoglucomutase, cysteine proteinases, and 
pore-forming peptides) with only slight differences in either their protein concentration or 
epitopes in these proteins (Tannich et al, 1991; Ortner et al., 1997; Horstmann et al., 1992; 
Petri et al., 1990b; Leippe, 1992). 
The successful use of MAb 20/7D for detection of this antigen in faecal lysates from 
cases of amoebic dysentery may be the result of the higher output of the protein per cell and 
of the overall larger number of trophozoites present in infections by E. histolytica. Thus, 
differences between detection of the two proteins in E. histolytica and E. dispar may relate 
to the differences in concentration of both proteins in the lysates, as it is the case for the 
galactose-specific adherence lectin, which is present in both E. histolytica and E. dispar but 
in significantly different concentration (Petri et al., 1990a). 
The presence of potent bacterial proteases in polyxenic cultures could have been 
responsible for differences in the protein mobility noted, in particular for the double band 
of the protein in E. dispar. A possible alternative explanation for the stronger reaction 
observed using MAb 20/7D against the purified E. dispar protein could have been 
mechanically or chemically-induced degradation of the E. histolytica protein during the 
process of purification, which was reflected in lower ODs when the MAb 20/7D reacted 
with the E. histolytica purified protein in ordinary ELISAs (Figure 4.8, page 134) and in the 
antigen capture assay (Table 4.4, page 138). This could also explain the fact that the rabbit 
antibody reacted slightly better with the pure protein from E. dispar. Indeed, MAb 20/7D 
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detected further bands in both lysates by western blot (Figure 4.6), which could be truncated 
products. Immunofluorescence assays gave evidence that the epitope detected by the MAb 
20/7D is located internally, mainly in the cytoplasm (Gonzalez-Ruiz et al., 1992a) and by 
ELISA titration it has been indirectly revealed that there is approximately a three to ten fold 
difference in concentration of the protein between E. histolytica and E. dispar lysates. This 
difference in antigen concentration is likely to be responsible for its detection in E. 
histolytica but not in E. dispar isolates by IFAT, as it was shown for MAb 4G6 (Tachibana 
et al., 1990), which was reported to react specifically with E. histolytica but not with E. 
dispar by IFAT. However, this MAb also recognised a homologous antigen in lysates of 
E. dispar trophozites by western blot analysis (Tachibana et al., 1990). Another more 
recent example is the report by Walderich et al., (1998) of the production of three MAbs 
that reacted with cysts of E. histolytica in faecal smears. One of these, MAb 1.11 D 10, 
strongly reacted with a protein of 80 kDa in cysts and trophozoites of E. histolytica, but also 
reacted (although faintly) with trophozites of E. dispar by IFAT. Further investigations 
could clarify the dynamics of expression and function of both proteins recognised by MAb 
20/7D in E. histolytica and E. dispar, and the first step was taken when the monoclonal 
antibody was used to isolate a cDNA clone from a expression library from E. histolytica 
(Rehman, 1992). The recombinant protein exhibited promising results for its use in 
serological test as a substitute for culture-derived antigen (Gonzalez-Ruiz et al., 1992d). 
Although MAb 20/7D represents an advance in the detection of invasive E. histolytica 
infections in dysenteric faecal samples, and the use of MAb 20/7D will be pursued for 
IFAT from cultured isolates (see Table 5.9, page 178), the modifications to the original 
FAC-ELISA format were abandoned for the purpose of fulfilling the aims proposed in this 
thesis and a change in strategy was decided in order to produce a test that would be able to 
specifically detect E. histolytica, to differentiate it from E. dispar and vice-versa. For this, 
taking advantage of the fact that gene sequences in E. histolytica and E. dispar differ to a 
greater or lesser extent (Tannich et al, 1991; Ortner et al., 1997; Que and Reed, 1997; Petri 
et al., 1990b; Leippe, 1992; Spice and Ackers, 1992; Clark and Diamond, 1993), the 
design, standardisation and evaluation of a new differential test based on known genomic 
sequences was adopted and is discussed in the following chapter. 
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CHAPTER 5 
THE POLYMERASE CHAIN REACTION-SOLUTION HYBRIDIZATION 
ENZYME-LINKED IMMUNO-ASSAY (PCR-SHELA) FOR THE 
DIFFERENTIAL DIAGNOSIS OF ENTAMOEBA HISTOLYTICA AND 
ENTAMOEBA DISPAR 
5.1 INTRODUCTION 
Until recently, duality in amoebiasis was a matter of discussion (Sargeaunt, 1987, 
Mirelman, 1987). The question whether E. histolytica sensu lato was able to establish a 
commensal relationship with its host without causing any harm, unless certain 
environmental unknown conditions turned it into an invasive pathogen, or whether two 
morphologically identical species with different pathogenic potential existed. Vigorous 
research on this area by several groups demonstrated numerous differences at the nucleic 
acid level and among them, the sequences of genes encoding for ribosomal RNA 
(Bhattacharya et al., 1988, Bhattacharya et al., 1989; Huber et al., 1989), which were found 
to diverge by 2.2% and it was concluded that sequences for ribosomal DNA were divergent 
enough to separate E. histolytica sensu lato into two species, namely E. histolytica sensu 
stricto for the invasive forms and E. dispar for the non-invasive forms (Clark and Diamond, 
1991; Diamond and Clark, 1993). 
Because one of the priorities for research is to produce tools able to identify 
potentially invasive populations of what by microscopy has been identified as E. histolytica 
sensu lato (WHO/PAHO, 1992), the exploration of E. histolytica and E. dispar genomic 
libraries in search of clones with inserts able to differentiate between invasive and non- 
invasive forms resulted in the production of the first DNA probes by two different teams, 
Garfinkel and colleagues and Samuelson et al in 1989. Both groups reported probes derived 
from the specific and abundant repetitive sequences found in the 24.5 kb episome of the 
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organism, such as the PvuI 140 bp and the BamHI 133 bp fragments in E. histolytica and 
E. dispar respectively (Figure 5.1). 
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FIGURE 5.1 Circular map of the 24.5 kb episomal molecule containing two copies of rDNA genes 
in E. histolytica HMI-IMSS according to Huber et al., 1989 and showing the 15 PvuI 140 bp repeats 
located between positions 22000 and 24000. Another 4 kb fragment containing Dral repeats is located 
downstream of the two rDNA genes around the position 14000. 
This extra chromosomal circular molecule also contains one or two copies of the 
rDNA in invasive and non-invasive forms (Figure 5.2, Huber et al., 1989; Bhattacharya et 
al., 1989). Located downstream of those sequences, a ScaI repeat with 90-95% sequence 
homology to the Pvul repeat was also found in E. histolytica (Mittal et al., 1992a, Mittal 
et al., 1992b) 
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FIGURE 5.2 Detail on the organisation of one of the rRNA transcription units of E. histolyt[ca 
between two Hindlll sites (5'-18S-5.8S-28S-3'). The size of each transcription unit is given, and the 
percentage of G+C content is enclosed in the parentheses. Ramachandran et aA, 1993, Bhattacharya 
et al., 1998. 
The successful application of the sequences described above as probes for 
differential diagnosis on culture isolates (Bracha et al., 1990, Mittal et al., 1992b) and 
faecal samples (Samuelson et al., 1989, Romero et al., 1992, Acuna-Soto et al., 1993) has 
opened a new path for their adaptation as routine laboratory methods for specific diagnosis 
of E. histolytica and E. dispar infections. Also, their use in a user-friendly format will 
permit to clarify the epidemiology and distribution of E. histolytica and E. dispar infections 
in endemic and non-endemic areas with particular emphasis for their application in the 
developing world (WHO/PAHO/UNESCO, 1997). 
The main aim of the work described in this chapter was to produce a diagnostic tool 
with improved sensitivity, and specificity based on gene sequence information already 
available. With the use of such a tool, the specific objectives were to reduce the time 
required to produce a confirmatory result for species distinction and to allow for a high 
number of samples to be processed at once, which is necessary for future epidemiological 
studies. 
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5.2 MATERIALS AND METHODS 
Polymerase Chain Reaction-Solution Hybridization Enzyme-Linked I umunosorbent 
Assay (PCR-SHELA) was first described by Wilson et al., in 1993 for diagnosis of M. 
tuberculosis and it was later successfully used for detection of Leishmania donovani by 
Qiao et al., (1995). Here the system was adapted for the detection of E. histolytica and E. 
dispar in cultures, stools and body fluids. PCR-SHELA involves the use of a digoxigenin 
labelled primer in each specific pair, which once incorporated into a PCR product, is able 
to hybridise to a biotin labelled specific probe. ELISA is then used for detection of the 
hybrids which bear biotin and digoxigenin ends. Briefly, the double marked products are 
captured in an avidin coated plate and detected by an anti-digoxigenin antibody conjugated 
to alkaline phosphatase (AP). The reaction is developed by addition of the specific 
substrate (p-Nitrophenyl phosphate, pNPP) using MgCl, as the cofactor for the enzymatic 
reaction (Appendix 1, Figure 5.3 A and B). 
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FIGURE 5.3 A. PCR-SHELA FORMAT. AV: Avidin. Bio: Biotin labelled probe. Dig: Digoxigenin 
labelled PCR product. AP-Conj: Alkaline phosphatase-anti-digoxigenin labelled antibody. pNPP: p- 
Nitrophenyl phosphate, the substrate. B. ELISA, Eli: Products of amplification with 
E. hisiolviica specific 
primers and probe. Ed: Products of amplification with E. dispar specific primers and probe. 
Samples in 
duplicate wells, side by side. 
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PCR-SHELA for E. histolytica and E. dispar is based on the amplification of a 125 
bp PvuI tandemly repeated region on the episomal DNA of E. histolytica and a 133 bp 
BamHI region in E. dispar episomal DNA with specific primers. The sequences are located 
between the two copies of the rDNA. It has been calculated that there are approximately 
200 episomes per trophozoite, each containing about 14-15 copies in tandem repeats 
(Bhattacharya et al., 1988), which are equivalent to 50-100 fg of target DNA per 
trophozoite of E. histolytica sensu stricto (Samuelson et al., 1989). 
Among the advantages of using this PCR with hybridisation is the fact that the 
aboundance of the region to be amplified provides a high probability for amplification in 
samples with low numbers of parasites, and the specificity of the system is guaranteed by 
the hybridisation step with the probe located within the sequence amplified in each species. 
Horse-radish peroxidase labelled probes to the 145 bp and 133 bp sequences on the 
episome of E. histolytica and E. dispar were successfully used to hybridise PCR products 
in dot-blot assays. The non-radioactive probes identified and differentiated intestinal 
infections in children with dysentery in Mexico (Romero et al., 1992). However, the high 
percentage of mixed infections (93%) found could be the result of cross contamination 
during the protocol application. Nevertheless, the probe and the immunoenzymatic 
detection step for the hybridised PCR products give an appreciable potential increase in 
sensitivity when compared to electrophoresis and detection by ethidium bromide in agarose 
gels. The same probes, labelled with biotin were incorporated in the PCR-SHELA system, 
where hybridisation was carried out after PCR before transferring the hybridised products 
to ELISA plates. The advantage of the ELISA format is that numerous samples can be 
processed at the same time and absorbances can be registered automatically. Alternatively, 
colorimetric qualitative reading of results by eye is possible. 
5.2.1 DNA Extraction from Axenic and Polyxenic Cultures 
DNA from axenic cultures was extracted after confluent monolayers were observed 
in the culture flasks. Trophozoites were made to detach from the flasks walls by immersion 
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in an ice water bath for 20 minutes. The culture medium containing the trophozoites was 
then transferred to sterile 50 ml conical tubes (Sterilin, UK) and pelleted at 700 g for 10 
minutes. The pellets were pooled and resuspended in 1 ml of PBS pH 7.2 and counted in 
a haemocytometer. Lysis buffer (Appendix 1) containing 1004g/ml of proteinase K was 
added in a 1: 1 ratio (v/v) and after an overnight incubation at 37°C, the DNA was extracted 
using standard phenol-chloroform method with ethanol precipitation (Romero et al., 1992). 
For extraction of polyxenic Robinson's cultures, the content of 1 to 5 bijou bottles 
was pooled together, and the trophozoites were pelleted by spinning at 700 g for 5-10 
minutes. The supernatant was discarded and the pellet was transferred to a 1.5 ml screw 
capped centrifuge tube and lysed and extracted as described above. 
5.2.2 DNA Extraction from Faecal Samples and Other Clinical Specimens 
The protocol used for DNA extraction was successfully used for processing faecal 
samples from Mexican patients during the evaluation of the 145bp probe (Samuelson et al., 
1989). For our study, approximately 1g of each faecal sample was resuspended in 3 ml of 
PBS, passed through gauze to eliminate particles and frozen/thawed three times in a 
mixture of dry ice-ethanol and thawed in a water bath. The suspension was then micro- 
centrifuged for one minute at 6500 rpm and supernatants were diluted 1: 1 in lysis buffer 
(Appendix 1), containing 100 ug/ml of proteinase K, incubated overnight at 37'C and 
extracted the next morning using the phenol-chloroform method followed by ethanol 
precipitation as before. The phenol-chloroform purification was introduced in order to 
reduce the amount of possible PCR inhibitors from the faeces and the lysis buffer, such as 
bilirubin-derived pigments and EDTA. The DNA was diluted in 50 µl of sterile distilled 
water and if the resulting solution was coloured, it was diluted 1/100 prior to PCR. DNA 
was also extracted from pus after liver puncture, for which 500 gl of lysis buffer were 
added to 500 gl of pus, containing 100µg/ml of proteinase K. After incubating overnight, 
the suspension was treated as described above. 
146 
Chapter 5 PCR-SHELA 
5.2.3 Estimation of DNA Concentrations 
Once the DNA was resuspended in 50 µl of sterile distilled water, 10 µl were run 
in a 0.8% agarose mini-gel for 1 hour at 75 V in order to check integrity. Concentration 
and purity were assayed by absorbance measurement at 260 and 280 nm using a 1/100 
dilution of each DNA. For calculation of the DNA concentration of each sample, it was 
assumed that an absorbance of 1 at A260 was equivalent to 50 µg/ml of double stranded 
DNA. A 260/280 ratio of 1.8 is indication of high purity. Ratios of less than 1.8 indicate 
contamination by proteins or phenol. 
5.2.4 E. histolytica and E. dispar Target Sequences 
DNA from reference strains E. histolytica BM-IMSS and E. dispar SAW 1734 
was amplified with two different pairs of primers for each species (5.2.4). The E. 
histolytica "P145" target sequence was cloned from the axenic strain HM-1: IMSS c16, 
GeneBank accession number A01325 (Samuelson et al., 1989; Garfinkel et al., 1989): 
+10 +20 +30 +40 +50 
GATCGATTTT CCCAGTTAGA AATTATTGTA CTTTGTACTT TGTATTTAGT 
1 ------------------------------------------------------ 
CTAGCTAAAA GGGTCAATCT TTAATAACAT GAAACATGAA ACATAAATCA 
+10 +20 +30 +40 +50 
ACTTTTCATT AAAAATGGTG AGGTTCTTAG GAAATCCGAA AATCAACGGT 
51 ------------------------------------------------------ 
TGAAAAGTAA TTTTTACCAC TCCAAGAATC CTTTAGGCTT TTAGTTGCCA 
+10 +20 +30 +40 +50 
GTAAATTGGT CAAAAAATAT TTTGCCTAGA CGACGACCAT TTTGAATAAT 
101 ------------------------------------------------------ 
CATTTAACCA GTTTTTTATA AAACGGATCT GCTGCTGGTA AAACTTATTA 
TCGATC 
151 ------ 
AGCTAG 
The E. histolytica PCR System incorporates the following pair of primers derived 
from the sequence described above: 
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Forward Primer (positions 13-37 of P145): 
5'... CAG TTA GAA ATT ATT GTA CTT TGT A... 3' 
Tm= 62'C 
Reverse Primer (positions 145-124 of P145): 
5'... DIG-TCA AAA TGG TCG TCG TCT AGG C... 3' 
Tm= 66'C 
The E. dispar "B133" target sequence was cloned from polyxenic strain SAW 
1734R cIAR, Genebank accession number A01326 (Garfinkel et al., 1989): 
+10 +20 +30 +40 +50 
GGATCCTCCA AAAAATAAAG TTTTATCAGA AATGGTGAGG TTGTAGCAGA 
1 ------------------------------------------------------ 
CCTAGGAGGT TTTTTATTTC AAAATAGTCT TTACCACTCC AACATCGTCT 
+10 +20 +30 +40 +50 
GATATTAATT CAACAATTTT ATTGAAAAAA GGTGCACTTT TTTGATTTTA 
51 ------------------------------------------------------ 
CTATAATTAA GTTGTTAAAA TAACTTTTTT CCACGTGAAA AAACTAAAAT 
+10 +20 +30 
ATATAAAGTA CTAGGTATCC AATATCGTTC TGTGGATCC 
101 ------------------------------------------ 
TATATTTCAT GATCCATAGG TTATAGCAAG ACACCTAGG 
Forward Primer (positions 1-23 of B133): 
5'... GGA TCC TCC AAA AAA TAA AGT TT 3' 
Tm= 60'C 
Reverse Primer (Positions 133-109): 
5'... DIG-ACA GAA CGA TAT TGG ATA CCT AGT A... 3' 
Tm=6 8°C 
The primers were prepared by automated oligonucleotide synthesis (British Bio- 
technology Products Ltd, UK) on a scale of 0.2 µmol, with one of each pair digoxigenin- 
labelled at the 5' end. For the calculation of molar primer concentrations the following 
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formulas were used: 
Molecular Weight (MW) of Primer: Average MW of a base (=333) x No. of bases 
Concentration of the primer (µg/ml): A260 x 33 
Molar concentration of the primer: Concentration of Primer in g/l divided by the MW of 
the Primer 
Where, 
A260: Absorbance at 260 nm in a1 cm path length cell. 
5.2.5 Optimisation of PCR Reactions 
Standard reaction mixtures were prepared in Promega Taq buffer A (M-1861) 
containing 500 mM KCI, 100 mM Tris-HCI, 1% Triton X-100,4mM MgC12, and 0.2 mm 
of each deoxynucleoside triphosphate per 100 pl of mixture. Two concentrations of 
Promega Taq polymerase (5U and 2.5U per l00µ1 of reaction mixture) were tested in 4Oµ1 
PCR reactions containing DNA of E. histolytica HMI-IMMS and E. dispar SAW 1734. 
The "hot start" PCR protocol (Wilson et al., 1993) was adopted to avoid the contact of the 
primers with the Taq before denaturation begins. The hot start requires a physical barrier 
provided by a pellet of wax with melting temperature between 57'C and 58'C, thus 
avoiding extension of any primer dimers formed at room temperature. For this purpose, the 
50 pmol of primers in each PCR reaction were contained in a fixed volume of 18 µl to 
which two wax pellets were added, melted at 58 °C and allowed to solidify. Over this layer, 
20 gl of reaction mix were added and finally, 2 µl of DNA template were added last. When 
the PCR cycle was initiated at 94'C the two layers mixed for the first time. 
For standardisation purposes, the amplification conditions were set as described by 
Acura-Soto et al. (1989): a cycle of denaturation at 94'C for 2 minutes was followed by 
30 cycles of: 
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Denaturation 
Annealing 
Polymerisation 
94'C 1 minute 
55 °C 2 minutes 
72'C 2 minutes 
and one final cycle of extension at 72'C for 7 minutes. 
5.2.6 Titration of E. histolytica and E. dispar DNA 
DNA obtained from axenic cultures of E. histolytica HM 1-IMS S and polyxenic 
Robinson's cultures of E. dispar SAW 1734 as described in 5.2.1 was diluted and titrated 
after quantitation according to the method in 5.2.3. The quantities tested ranged from 10 
pg to 10 ng for E. histolytica DNA and from 10 pg to 100 ng for E. dispar DNA. The 
concentrations in the stocks were adjusted by diluting the DNA with distilled water to a 
suitable volume. 
5.2.7 Polymerase Chain Reaction (PCR) on E. histolytica and E. dispar Cultures 
PCR amplification of 2 to 4 t1 of undiluted DNA extracted from axenic (TYI-S-33, 
Appendix 1) and polyxenic (Robinson's medium, Appendix 1) cultures was done using the 
conditions described in 5.3. For clinical diagnosis DNA obtained from cultures derived 
from microscopy positive samples was tested with both sets of primers. Controls 
containing water as sample replacement and positive reactions containing reference DNA 
from E. histolytica and E. dispar were included for each batch of amplifications. PCR 
products were initially detected by electrophoresis in 2% agarose gels using ethidium 
bromide. A product of 125 bp was expected for E. histolytica positive controls and a band 
of 133 bp was expected for E. dispar positive controls. Band migration was compared 
against a 123bp DNA marker ladder (Gibco BRL, Life Technologies, UK). 
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5.2.8 Southern Blot Analysis of E. histolytica and E. dispar PCR Products 
Due to a sequence homology of 43.6% between the E. histolytica and E. dispar 
targets (Garfinkel et al., 1989) and because of reports by both Samuelson et al. (1989) and 
Mirelman et al. (1990) on cross reactivity of the E. histolytica-derived P145 sequence with 
E. dispar, the products of amplification of reference strains of both species were purified 
from agarose gels according to the Magic PCR preps"' DNA Purification System protocol 
(Promega, UK) and further isotope-labelled and used as probes against each other. After 
PCR, electrophoretic separation of the PCR products was carried out in a 2% agarose gel 
for lh at 75 V. After staining with ethidium bromide, the gel was photographed followed 
by immediate denaturation of the double-stranded DNA in the gel with 250 ml of 
denaturing solution (Appendix 1). A change to 250 ml of fresh denaturing solution was 
made after 15 minutes, with incubation for further 30 minutes. The gel was then transferred 
to neutral pH first by rinsing with distilled water for 5 minutes and then by addition of 500 
ml of neutralising solution (Appendix 1) for 45 minutes. 
Meanwhile, 3 sheets of Whatman 3MM paper were cut to the exact size of the gel, 
with a further sheet cut to the width of the gel but longer to allow contact between the gel 
and the buffer (20X SSC) in the plastic tray. A piece of nylon membrane (Hybond-N, 
Amersham) was cut to the size of the gel and soaked with 2X SSC. The gel was then 
transferred facing down onto the 3 MM paper wick in contact with the buffer in the tray 
taking care to remove trapped bubbles by rolling a plastic pipette over the surface. The 
nylon membrane cut to the size of the gel was then placed on the top of the gel, again 
removing air bubbles and also marking the orientation of the gel (well positions and sample 
positions). Then, three sheets of soaked Whatman 3 MM paper (removing air bubbles) and 
a stack of adsorbent paper towels were placed on the top of the membrane. Finally, a glass 
plate and a heavy weight were applied and the transference was carried out overnight. Next 
day, the weight, the glass and the paper towels were removed and the membrane was 
soaked in 2X SSC for 5 minutes and then dried facing up on a dry sheet of 3MM paper. 
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After covering with cling film, the DNA was covalently bound to the membrane by 
exposure to UV light on an automatic illuminator, Stratalinker (Stratagene, UK). 
5.2.9 Cross Hybridisation Assay With E. histolytica and E. dispar PCR Products as 
Probes in Southern Blot Analysis 
A prehybridisation step was carried out overnight at 42'C in a solution containing 
50% formamide, 5X SSC(1X SSC= 0.15 M NaCI-0.015 M sodium citrate), 5X Denhardt's 
solution and 100 . tg/ml denatured salmon sperm DNA to block non-specific binding sites. 
Membranes were hybridised overnight in the same solution with addition of 0.1 % sodium 
dodecyl sulphate (SDS) and the corresponding labelled-oligo DNA PCR product (125 bp 
or 133 bp respectively). Probes were labelled with a32P-dCTP (Amersham. UK) using a 
random primer DNA labelling kit (rediPrime, Amersham, UK) according to the protocol 
provided by the manufacturer. The membrane was washed for 15 min in 2x SSC-0.1% 
SDS at room temperature and twice for 15 min in 0.2x SSC-0.1% SDS at 60°C. The 
membrane was exposed to X-ray film (Kodak XAR-5 film) at -70'C. 
5.2.10 Optimisation of Hybridisation of Amplicons With Specific Digoxigenin 
Labelled Probes and Detection of Hybrids by ELISA (SHELA) 
After successful amplification of DNA from cultured reference strains and isolates 
from clinical samples, the next step was to establish the optimal conditions for 
hybridisation of PCR products and their detection by ELISA. The use of probes was 
introduced to increase the specificity of the test. The sequence of each biotinylated probe 
is complementary to the corresponding strand primed by the digoxigenin labelled primer 
and this facilitates detection after the capture of the hybrids on avidin coated ELISA plates. 
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Reactions containing primers for E. histolytica DNA were hybridised with the 
corresponding probe, and similarly, the homologous probe was used for reactions 
containing primers for E. dispar DNA. Although the probes had been used at 45 °C in 
previous hybridisation assays by Romero et al. (1992), for our assays, the temperature of 
hybridisation was set to 55 °C taking into account the Tm of each probe. The sequence of 
the biotinylated probe for hybridisation of E. histolytica DNA is the following: 
+70 +92 
5'... BIO-GAGGTTCTTAGGAAATCGAAAA... 3' 
Tm= 60'C 
And the sequence of the biotinylated Probe for hybridisation of E. dispar DNA is: 
+34 +56 
5'... BIO-GGTGAGGTTGTAGCAGAGATATT... 3' 
Tm= 66'C 
Post-PCR hybridisation was carried out by addition of 5pmol of 5'-biotin-conjugated 
probes specific for E. histolytica or E. dispar to 20 iii of PCR product prior to 
denaturation at 99'C for 10 minutes, which separates complementary strands and 
annealing of the probes at 55 °C for 90 minutes. Immediately after hybridisation, the 
products were diluted with 200 il of TBS-0.05 % Tween 20. 
The ELISA was based on the assay proposed by Wilson et al for detection of 
Mycobacterium tuberculosis PCR products (Wilson et al., 1993), microwell strips (Greiner, 
Germany) were coated with 100 µl of carbonate buffer (coating buffer, Appendix 1) 
containing 1 gg of avidin (Sigma, UK) per well. After incubation of 1 hour at 37°C or 
overnight at 4°C, the strips were washed three times with Tris-Buffered saline containing 
0.05% Tween-20 (TBS-T), blocked for 1 hour with 0.2 ng/well of salmon sperm DNA in 
100 µl of TBS at room temperature and after washing with TBS-T as described before, 100 
gl of the hybridised PCR products were added to duplicate wells and incubated for 60 
minutes at room temperature. A 60 minutes incubation of 100 µl/well of anti-digoxigenin 
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alkaline phosphatase-labelled (Fab fragment, Boehringer Mannheim, Germany) antibody 
diluted 1/5000 was followed by three washings with TBS-T and a final wash with TBS. 
The ELISA was developed by addition of 100 µl/well of carbonate buffer (coating 
buffer) containing 1 mg/ml of p-nitrophenyl phosphate (pNPP) and 1 mM of MgC12. After 
1 hour incubation at room temperature, absorbance was read at 405 nm. 
5.2.11 Detection Limit of E. histolytica and E. dispar Isolates from Polyxenic Cultures 
by PCR-SHELA 
Diagnosis of amoebiasis based on polyxenic cultures or faeces implies that the 
sample used for PCR contains DNA from several species, mainly from bacterial flora. In 
order to establish the limit of detection of PCR-SHELA in polyxenic cultures, trophozoites 
of E. histolytica strain 882 and of E. dispar 533 strain were used for the test. Both strains 
had been isolated from faecal samples and were maintained in Robinson's culture at the 
Hospital Clinic i Provincial in Barcelona and were brought to the LSHTM where 
hexokinase characterisation and PCR were carried out. 
For the assay, the trophozites were washed in PBS pH 7.2, counted in a Neubauer 
chamber and diluted to a starting stock of 1x106 trophozoites per ml with PBS (see 5.2.1, 
page 145). From this stock, dilutions were made to final concentrations of 1x105 
trophozoites, 1x104 trophozoites, lx 102 trophozoites and 1 trophozoite in a volume of 0.5 
ml and to each of them 0.5 ml of lysis buffer were added for DNA extraction. The final 
volume extracted was 1 ml and after extraction, the DNA was diluted in 50µ1 of sterile 
distilled water. Two microlitres were used for PCR reactions, equivalent to 4000 
trophozoites per ml, 400 trophozoites per ml, 4 trophozoites per ml and less than 1 
trophozoite per ml. 
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5.2.12 Evaluation of PCR-SHELA With E. histolytica and E. dispar Polyxenic Clinical 
Isolates from Endemic Areas 
A collection of frozen pellets of 60 strains cultured in Robinson's medium from 
Bangladesh and Colombia were tested by PCR-SHELA. Pellets of trophozoites from 28 
strains isolated at the International Centre for the Control of Diarrhoeal Diseases (ICCDR), 
in Dhaka, Bangladesh were transported frozen to the LSHTM. Similarly, 32 pellets 
obtained from cultures at the Centro de Investigaciones en Microbiologia y Parasitologia 
Tropical, in Bogota, Colombia were also brought to the LSHTM. DNA was extracted as 
described in 5.2.1 and 2 µl of each DNA were used for the PCR reactions. 
5.2.13 PCR Amplification of the Small Ribosomal Subunit (rSSIJ) DNA from E. 
histolytica and E. dispar 
Amplification of the SSU rDNA in cultures of E. histolytica and E. dispar with 
species specific primers was used by Clark and Diamond to test the two species hypothesis 
between E. histolytica and E. dispar (Clark and Diamond, 1991). The advantage of using 
ribosomal DNA is the abundance of those genes, which are also very conserved within the 
same species but different between closely related but different species. 
Because of the background amplification found on the cultures from Bangladesh 
and Colombia by PCR-SHELA, the rSSU PCR was used as a complementary tool for 
confirmation of results since it does amplify E. histolytica DNA even in the presence of 
very small amounts of homologous E. dispar DNA and viceversa (Clark, 1997). 
The amplification of the diagnostic fragment of 876 bp is based on the 1932 bp E. 
histolytica-specific sequence of rSSU submitted by Que and Reed in1991, GeneBank 
accession number X61116, from which bases 1-1091 are shown: 
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1 CCACCGTCCG CAGTATTATA TGCTGATGTT AAAGATTAAG CCATGCATGA 
-------------------------------------------------- 
GGTGGCAGGC GTCATAATAT ACGACTACAA TTTCTAATTC GGTACGTACT 
51 GTAAGTATAA AGACCAAGTA GGATGAAACT GCGGACGGCT CATTATAACA 
--------------------------------------------------- 
CATTCATATT TCTGGTTCAT CCTACTTTGA CGCCTGCCGA GTAATATTGT 
101 GTAATAGTTT CTTTGGTTAG TAAAATACAA GGATAGCTTT GTGAATGATA 
---------------------------------------------------- 
CATTATCAAA GAAACCAATC AATCATGTTT CCTATCGAAA CACTTACTAT 
151 AAGATAATAC TTGAGACGAT CCAGTTTGTA TTAGTACAAA ATGGCCAATT 
----------------------------------------------------- 
TTCTATTATG AACTCTGCTA GGTCAAACAT AATCATGTTT TACCGGTTAA 
201 CATTCAATGA ATTGAGAAAT GACATTCTAA GTGAGTTAGG ATGCCACGAC 
----------------------------------------------------- 
GTAAGTTACT TAACTCTTTA CTGTAAGATT CACTCAATCC TACGGTGCTG 
251 AATGTAGACA ACACAGTGTT TAACAAGTAA CCATGAGAAT TTCTGATCTA 
------------------------------------------------------ 
TTACATCTGT TGTGTCACAA ATTGTTCATT GGTACTCTTA AAGACTAGAT 
301 TCAATCAGTT GGTAGTATCG AGGACTACCA AGTTATAACG GATAACGAGG 
----------------------------------------------------- 
AGTTAGTCAA CCATCATAGC TCCTGATGGT TCAATATTGC CTATTGCTCC 
351 AATTGGCGTT CGACATCGGA GAGGGAGCTT TACAGATCGG ATTACCACTT 
----------------------------------------------------- 
TTAACCGCAA GCTGTAGCCT CTCCCTCGAA ATGTCTAGCC TAATGGTGAA 
401 CTAAGGAAGG CAGCAGGCGC GTAAATTACC CACTTTCGAA TTGAAGAGGT 
GATTCCTTCC GTCGTCCGCG CATTTAATGG GTGAAAGCTT AACTTCTCCA 
451 AGTGACGACA CATAACTCTA GAGTTGAGTA AAATCAATTC TTGAAGGAAT 
TCACTGCTGT GTATTGAGAT CTCAACTCAT TTTAGTTAAG AACTTCCTTA 
501 GAGTAGGAGG TAAATTCTCC TACGAAATCA ATTGGAGGGC AAGTCTGGTG 
CTCATCCTCC ATTTAAGAGG ATGCTTTAGT TAACCACCCG TTCAGACCAC 
551 CCAGCAGCCG CGGTAATTCC AGCTCCAATA GTGTATATTA AAGTTGCTGT 
GGTCGTCGGC GCCATTAAGG TCGAGGTTAT CACATATAAT TTCAACGACA 
601 GATTAAAACG CTCGTAGTTG AATTAAAATG TGGTTTTATA CATTTTGAAG 
CTAATTTTGC GAGCATCAAC TTAATTTTAC ACCAAAATAT GTAAAACTTC 
651 ACTTTATGTA AGTAAAGTTT CTAGAAATGT TAAATTAAAA TCAAAGAAGG 
TGAAATACAT TCATTTCAAA GATCTTTACA ATTTAATTTT AGTTTCTTCC 
701 AAACAATTCA AGTAATTGAG TTGTTATTAC TTTGAATAAA ATAAGGTGTT 
TTTGTTAAGT TCATTAACTC AACAATAATG AAACTTATTT TATTCCACAA 
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751 TAAAGCAAAA CATTATGTTA ATGAATATTC AAGCATGGGA CAATGCTGAG 
ATTTCGTTTT GTAATACAAT TACTTATAAG TTCGTACCCT GTTACGACTC 
801 GGGATGTCAA TAAGACATTT CGAGAGAAGG ATTAAAAGGA ACAATTGGGG 
CCCTACAGTT ATTCTGTAAA GCTCTCTTCC TAATTTTCCT TGTTAACCCC 
851 TGATTCAGAA AATAACGGGA GAGGTGAAAA TCCATGATCG CTATAAGATG 
ACTAAGTCTT TTATTGCCCT CTCCACTTTT AGGTACTAGC GATATTCTAC 
901 CAGCGAGAGC GAAAGCAGAT TTCACTCAAC TGTGTCCATT AATCAAGAAC 
GTCGCTCTCG CTTTCGTCTA AAGTGAGTTG ACACAGGTAA TTAGTTCTTG 
951 GAAAGTTAGG GGATCGAAGA CGATCAGATA CCGTCGTAGT CCTAACTATA 
CTTTCAATCC CCTAGCTTCT GCTAGTCTAT GGCAGCATCA GGATTGATAT 
1001 AACGATGTCA ACCAAGGATT GGATGAAATT CAGATGTACA AAGATAGAGA 
TTGCTACAGT TGGTTCCTAA CCTACTTTAA GTCTACATGT TTCTATCTCT 
1051 AGCATTGTTT CATGATCTGA GTATATCAAT ATTACCTTGT TCAGAACTTA 
TCGTAACAAA GTACTAGACT CATATAGTTA TAATGGAACA AGTCTTGAAT 
The sequences of the primers (highlighted in bold from the sequence above) used 
for E. histolytica rDNA amplification are: 
Forward Primer (Positions 193 to 216) 
Psp5: 5'... GGC CAA TTC ATT CAA TGA ATT GAG... 3' 
Tm= 66'C 
Reverse Primer (Positions 1071-1047) 
Psp3: 5'... CTC AGA TCT AGA AAC AAT GCT TCT C... 3' 
Tm= 70'C 
The sequence of the rSSU in E. dispar has a 2.2% divergence from the sequence 
described above, represented by 17 different point mutations (Clark and Diamond, 1991) 
in the positions shown below marked as E. dispar: 
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5'... 3'... 
101 GTAATAGTTT CTTTGGTTAG TAAAATACAA E. histolytica 
G E. dispar 
170 CCAGTTTGTA E. histolytica 
A E. dispar 
191 ATGGCCAATT CATTCAATGA A TTGAGAAAT E. histolytica 
GT GT GT A E. dispar 
931 TGTGTCCATT E. histolytica 
G E. dispar 
1041 AAGATAGAGA E. histolytica 
GA E. dispar 
1051 AGCATTGTTT CATGATCTGA E. histolytica 
AA CA E. dispar 
1081 ATTACCTTGT E. histolytica 
C E. dispar 
The sequences of the specific primers used for E. dispar rDNA amplification are: 
Forward primer: 
Npsp5: 5'... GGC CAA TTT ATG TAA GTA ATT TGA G... 3' 
Tm= 66 
Reverse Primer: 
Npsp3: 5'... CTT GGA TTT AGA AAC AAT GTT TCT TC... 3' 
Tm= 68 
The conditions for 35 cycles of amplification were set as follows: 
Denaturation 94'C 1 minute 
Annealing 55'C 1.5 minutes 
Elongation 72'C 2 minutes 
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The two pairs of primers used for specific amplification differ in 5 and 6 bases 
respectively between E. histolytica and E. dispar, and the expected result is the presence 
of a band of 876 bp (Clark and Diamond 1992). DNA from reference axenic and polyxenic 
strains of E. histolytica and E. dispar respectively was amplified during standardisation, 
and later these DNA stocks were used as controls (Table 5.1). 
TABLE 5.1 REFERENCE STRAINS USED AS CONTROLS FOR DNA TESTS 
STRAIN ZYMODEME ORIGIN ISOLATED BY 
E. histolytica HM1-IMSS II Amoebic Dysentery B. Sepulveda, M. de la Tone 
E. histolytica NIH: 200 II Amoebic Dysentery J. E. Tobie 
E. histolytica NIH: H-303 H Amoebic LDLsente L. S. Diamond 
E. histolytica SD157 NA NA G. Clark 
E. histol tics SD184 NA NA G. Clark 
E. histolytica ST 138 II Amoebic Dysentery and 
Amoeboma 
J. Osisanya 
E. histolytica ST 140 II Amoebic Colitis J. Osisan a 
E. dis par SAW 1734 III Cyst Carrier P. G. Saz eaunt and J. Williams 
E. dis par SAW 760 NA NA P. G. Saz eaunt and J. Williams 
NA: Data Not Available 
5.2.14 Detection of E. histolytica and E. dispar in Faecal Samples and Other Body 
Fluids by PCR-SHELA 
PCR-SHELA was first successfully used for direct clinical diagnosis in 7 faecal 
samples (Table 5.2) from an endemic area for intestinal parasites at La Mesa, 
Cundinamarca (Colombia). The samples were provided by individuals with intestinal 
complaints suggestive of amoebiasis attending the outpatients clinic at the Hospital Pedro 
Leon Alvarez. The samples were examined by microscopy at the parasitology section in 
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the clinical laboratory at the hospital and immediately frozen and transported to the 
LSHTM where DNA was extracted following the methodology described in 5.2.2. 
TABLE 5.2 MICROSCOPY ON FAECES FROM LA MESA 
SAMPLE 
ID 
PATIENT ID MICROSCOPY 
Fl LAC E. histolytica Haemato h ous trophozites 
F2 JA Entamoeba s p. trophozoites 
F3 RM Entamoeba s p. trophozoites, Bl. hominis 
F4 MS E. coli cysts 
F5 FC E. histolytica haemato ha ous trophozoites 
F6 DG E. histol tica/E. dis arcysts 
F7 PC Hookworm eggs 
Also, as part of initial evaluation of PCR-SHELA with clinical samples, a small 
series of faecal samples and pus drained from liver abscesses from patients attending the 
Hospital for Tropical Diseases (HTD) in London were processed according to the 
methodology described in 5.2.2, although the overnight incubation with lysis buffer at 37 °C 
was substituted by a two hours incubation at 55 °C and screened by PCR-SHELA (Table 
5.3). 
TABLE 5.3 HTD CLINICAL SPECIMENS FOR DIAGNOSIS BY PCR-SHELA 
SAMPLE ID SPECIMEN CLINICAL DIAGNOSIS MICROSCOPY 
001472 Faeces Ulcerative Colitis Negative 
AW Faeces Dysentery Haemato ha ous Trophozoites 
65004534 Faeces Amoebic Liver Abscess Negative 
65004534 Pus Amoebic Liver Abscess Negative 
1079 Pus Amoebic Liver Abscess Negative 
65004534 Blood Amoebic Liver Abscess NT 
65004534 Urine Amoebic Liver Abscess NT 
65004534 Serum Amoebic Liver Abscess NT 
HTD: HOSPITAL FOR TROPICAL DISEASES 
NT: Not Tested 
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For PCR, each 100 gl of reaction mixture contained 4 MM MgC12,5 Units of Taq 
polymerase in Promega Taq Buffer system (M-1861) and 0.2 mM of each deoxynucleoside 
triphosphate. 40 µl PCR reactions were set to contain 25 pmol of each primer separated 
from the other reaction components by a wax layer, 0.5-1 ng of sample DNA and between 
0.5 and 10 ng of reference E. histolytica and E. dispar DNA for control reactions. Also, 
negative controls including Escherichia coli DNA grown in R medium (Robinson's 
polyxenic culture medium, Appendix 1), DNA from parasite-free faeces and water as a 
sample replacement were used. 
Modifications to the amplification conditions initially standardised for DNA from 
cultured material were introduced when testing multiple faecal samples: The first cycle of 
denaturation was reduced from 2 to 1 minute at 94'C and was followed by an increment 
in the number of cycles to 35. A reduction in the time for primer annealing and omission 
of the final 7 minutes of elongation were other modifications introduced according to the 
protocols published by Acufia-Soto et al., in 1993. 
The final modified protocol for the 35 cycles of the PCR was then set as follows: 
Denaturation at 94'C for 30 seconds 
Annealing at 55'C for 1 minute and, 
Elongation at 72'C for 2 minutes, 
Modifications were also introduced for the hybridisation step, which was reduced 
from 90 to 15 minutes. The methodology for the ELISA step was followed as described 
in 5.2.9. 
161 
Chapter 5 PCR-SHELA 
5.2.15 Application of PCR-SHELA for the Diagnosis of Amoebiasis in a Dutch Family 
Faecal samples from 7 members of a Dutch household and their derived polyxenic 
cultures (Table 5.4) were tested by PCR-SHELA following the methodology described 
above. The index case was a5 year old female (Child I) who was diagnosed as suffering 
from amoebic dysentery although she had never been abroad (Visser et al., 1998). 
However, the mother had an amoebic liver abscess five year before on return from a trip 
to India. Because of the risk and the epidemiological implications of leaving asymptomatic 
cyst carriers untreated, it was decided to screen all the individuals in the household. Faecal 
samples were referred to the Laboratory of Parasitology of the Faculty of Medicine at the 
University of Leiden for microscopy, and from there the samples were sent by post to 
LSHTM where an aliquot was cultured in Robinson's medium by Mr J. Williams at the 
Malaria Reference Laboratory and a second aliquot was used for DNA extraction. The 
DNA was then diluted 1/ 10 and 1/ 100 and 2 µl of the corresponding dilution were used for 
the PCR reactions. 
Hybridisation and ELISA were performed according to the modifications described 
in 5.2.12. 
TABLE 5.4 MICROSCOPY OF FAECAL SAMPLES FROM HOLLAND 
SAMPLE ID PATIENT ID MICROSCOPY RESULT 
1H(1204 Nanny D. a ills, Bl. hominis 
2H(1206) Nanny's Husband Bl. hominis 
3H(1203) Mother D. a ills, E. histol tica/dis ar cysts, E. coli cysts, Bl. hominis 
4H(1 187 Child I E. histol tica haemato ha ous troph., E. histol ticaldis ar cysts, E. coli cysts 
5H(1205) Father E. histol tica/dis ar cysts, E. coli cysts 
6H(1095) Child 11 E. histolyticaldispar cysts 
7H( 1096 Child III E. histol tica/dis ar cysts 
Number in parentheses: Corresponding Culture ID number 
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Serology data were obtained from the Laboratory of Parasitology at the Faculty of 
Medicine in Leiden after testing all the samples and cultures blindly by PCR-SHELA. 
5.2.16 Evaluation of PCR-SHELA for Detection of E. histolytica and E. dispar 
Intestinal Infections in Holland and Colombia 
The development of PCR-SHELA as a diagnostic aid for differentiation of amoebic 
intestinal infections with E. histolytica and E. dispar required a wider evaluation in two 
fronts: at the reference laboratory level in non endemic areas such as developed countries 
where the main affected group are travellers and their close contacts and in tropical 
endemic areas, where a high percentage of carriers are present. 
The results obtained with PCR-SHELA at the time encouraged our collaborators to 
initiate a further evaluation of both systems. For that purpose, funding was obtained 
through the EC INCO-DC program for a multicentric collaborative project between the 
London School of Hygiene and Tropical Medicine, the Laboratory of Parasitology attached 
to the Faculty of Medicine at the University of Leiden (The Netherlands), the Centro de 
Investigaciones en Parasitologia and Medicina Tropical (CIMPAT) at Los Andes 
University, Bogota (Colombia), the Laboratorio de Microbiologia and the Department of 
Tropical Medicine at the Hospital Clinic i Provincial of Barcelona (Spain). Training on 
culture and isoenzyme electrophoresis when required, DNA extraction using the phenol 
chloroform method with ethanol precipitation and PCR-ELISA was provided to the 
research teams before the start of the pilot studies for PCR-SHELA evaluation. 
The pilot study was carried out in Leiden by Teig et al., (1997), where 31 E. 
histolytica/E. dispar microscopy positive and culture positive stool samples were tested by 
PCR-SHELA and compared to two other PCR systems, the amplification of the 30 kDa 
antigen gene (Tachibana et al., 1991) and of the rSSU DNA (Clark and Diamond, 1992). 
163 
Chapter 5 PCR-SHELA 
Although PCR-SHELA was successful for the distinction of amoebic intestinal 
infections and results were produced the day following receipt of the samples, it was 
evident that modifications to the whole protocol were necessary in order to produce results 
within one working day. As part of the modifications, the QIAamp Tissue DNA Extraction 
Kit, from QIAGEN® (Figure 5.4) was introduced for the evaluation of a total of 369 faecal 
samples arriving from different laboratories in the Netherlands to the reference laboratory 
at the Department of Parasitology of the University of Leiden (Polderman and Verweij, 
1997; Verweij et al., 1998). All the faecal samples were referred to the reference laboratory 
because of microscopical or clinical suspicion of E. histolytica/dispar infection and were 
concentrated on arrival and processed by the formol-ether method (Allen and Ridley, 1970). 
A second evaluation of PCR-SHELA was carried out with samples from Quibdo, 
the capital of the department of Choco, on the pacific coast of Colombia. The Department 
of Choco has a population of 406,199 inhabitants surrounded by a tropical lowland forest. 
The geographical characteristics of the region have kept it isolated from the rest of the 
country, which influences its very poor economy and sanitary conditions. For the pilot 
study, faecal samples were collected from an heterogeneous population of volunteers 
belonging to all age groups (0-70 years), involving personnel from the police force and 
from the slums around Quibdo. A total of 427 single stool samples were examined by 
microscopy with micrometric measurement by Sandra Molina and Patricia Fuya from the 
CIMPAT (Universidad de los Andes, Bogota). The samples that were positive for E. 
histolytica/E. dispar or E. hartmanni by microscopy were transported frozen to Bogota for 
DNA extraction. 
DNA from samples harbouring E. histolytica/dispar cysts and E. hartmanni cysts 
was extracted using the QIAGEN' Tissue kit (QIAGEN® Cat. No. 29304, Figure 5.4). The 
DNAs were tested by PCR-SHELA and the results were compared to the results obtained 
with the amplification of the small ribosomal subunit (rSSU) DNA (5.2.13). Unfortunately, 
no cultured material was obtained for comparison of the PCR results with zymodeme 
analysis. 
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FIGURE 5.4 QIAamp DNA EXTRACTION METHOD WITH THE QIAGEN'o TISSUE KIT 
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5.2.17 Characterisation of Intestinal Amoebic Infections in Travellers Returning 
From the Tropics to Barcelona (Spain) 
Diagnosis of amoebiasis in travellers is one of the most important issues for the 
control of the dispersion of E. histolytica. The laboratory of Parasitology at the 
Microbiology Department Hospital Clinic i Provincial in Barcelona screens the faecal 
samples from patients with gastrointestinal complaints referred by the hospital's travellers 
clinic. The microscopy of 57 samples (Table 5.5) and the primary polyxenic cultures were 
carried out in Barcelona and results were stored in a database in Access for windows. An 
aliquot of each unpreserved sample was frozen at -70'C until transported to the LSHTM, 
where DNA extraction and PCR-SHELA were carried out. 
The microscopy of the samples collected at Barcelona consisted of 29 E. 
histolytica/dispar single infections and 28 faeces containing E. histolytica/dispar and other 
parasites, from which 19 harboured other amoebas (4 containing cysts of E. hartmanni) and 
9 contained other parasites as well as E. histolytica/dispar, but no other amoebas. The 
country visited was recorded in most cases, and this collection represents infections 
acquired from around the world (Table 5.5). 
TABLE 5.5 SAMPLES FROM TRAVELLERS RETURNING TO BARCELONA FROM THE TROPICS 
SAMPLE ID COUNTRY VISITED MICROSCOPY-MICROBIOLOGY 
2675 MEXICO E. histol tica/dis ar, E. hartmanni cysts 
2436 PERU E. histol tica/dis ar cysts 
219 CUBA E. histol tica/dis ar cysts, Bl. hominis 
622 ECUADOR E. histol tica/dis ar cysts; Negative coproculture 
819 20/3 NA E. histol tica/dis ar, E. coli cysts 
2394 MADAGASCAR E. histol tica/dis ar, E. coli cysts, G. intestinalis 
423 SENEGAL E. histol tica/dis ar, E. coli cysts 
505 MEXICO E. histol tica/dis ar, E. coli cysts 
1614 NICARAGUA E. histol tica/dis ar, E. nana cysts, T. trichiura Eggs, Bl. hominis 
L695 GUATEMALA E. histol tica/dis ar E. coli cysts 
166 
Chapter 5 PCR-SHELA 
SAMPLE ID COUNTRY VISITED MICROSCOPY-MICROBIOLOGY 
696 GUATEMALA E. histol tica/dis ar, E. coli cysts 
2635 TOGO E. histol tica/dis ar, E. hartmanni, E. coli, E. nana cysts, 
2877 ZAIRE E. histol tica/dis ar, E. coli cysts 
3210 INDONESIA E. histol tica/dis ar trophozoites; Escherichia coli NET, NEP 
3187 NA E. histol tica/dis ar trophozoites 
280 NA E. histolyticaldispar cysts 
910 INDONESIA E. histolyticaldispar cysts 
1060 NA E. histol tica/dis ar, E. nana cysts 
2529 MALI, BURKINA FASO E. histol tica/dis ar, E. hartmanni, E. nana cysts 
2103 SALVADOR E. histol tica/dis ar cysts, Bl. hominis 
88 BENIN E. histolyticaldispar cysts 
112 COLOMBIA E. histol tica/dis ar, E. coli cysts; Negative coproculture 
764 NA E. histolyticaldispar cysts 
1628 INDIA E. histol tica/dis ar cysts, T. hominis 
2333 SALVADOR E. histol tica/dis ar, E. coli cysts 
264 GUINEA EQUATORIAL E. histol tica/dis ar, E. coli, I butschlii cysts, T. trichiura Eggs 
2512 UGANDA, KENYA E. histol tica/dis ar cysts; Escherichia coli 
287 NA E. histolyticaldispar cysts 
2407 SENEGAL E. histolyticaldispar cysts 
323 ZAMBIA, TANZANIA E. histol tica/dis ar cysts, Klebsiella pneumonie 
2597 UGANDA, KENYA E. histolyticaldispar cysts 
2015 NA E. histolyticaldispar cysts 
2564 INDIA E. histol tica/dis ar, E. nana cysts; Negative coproculture 
3201 MOROCCO E. histol tica/dis ar, E. coli cysts 
746 BURKINA FASO E. histol tica/dis ar, E. coli, E. nana cysts 
963 NA E. histolyticaldispar cysts 
107 MALI E. histolyticaldispar cysts 
617 INDONESIA E. histolyticaldispar cysts 
2552 ETIOPIA E. histol tica/dis ar trophozoites; Escherichia coli 
971 MEXICO E. histol tica/dis ar, E. coli, E. nana cysts, Bl. hominis; Escherichia coli 
2828 NA E. histol tica/dis ar, E. nana Cysts 
1127 ECUADOR E. histol tica/dis ar cysts 
277 SALVADOR E. histol tica/dis ar I. butschlii cysts 
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SAMPLE ID COUNTRY VISITED MICROSCOPY-MICROBIOLOGY 
1198 INDIA E. histolyticaldispar cysts 
2399 VIETNAM E. histol tica/dis ar, E. coli cysts, Cam lobacter jejunii 
2891 BURKINA FASO E. histol tica/dis ar cysts; Cam lobacter je'unii 
822 VIETNAM E. histolyticaldispar cysts 
563 BURKINA FASO E. histolyticaldispar cysts 
533 BURKINA FASO E. histolyticaldispar cysts 
472 NA E. histolyticaldispar cysts 
466 MOROCCO E. histolyticaldispar cysts 
2024 INDIA E. histolyticaldispar cysts 
675 GUINEA ECUATORIAL E. histol tica/dis ar cysts; Salmonella s pp. 
315 IVORY COAST E. histol tica/dis ar cysts, G. intestinal is; Negative coproculture 
1136 SPAIN E. histol tica/dis ar, E. coli, E. nana cysts 
2409 TCHAD E. histolytica/dispar, E. hartmanni, I butschlii cysts, S. mansoni; 
Escherichia coli NEP, NET 
428 IVORY COAST E. histol tica/dis ar cysts 
NA: Data not available 
NET: Not Enterotoxigenic E. coli 
NEP: Not Enteropathogenic E. coli 
5.2.18 Sensitivity and Specificity of PCR-SHELA 
The sensitivity and specificity of PCR-SHELA were calculated according to the 
following formulas (Altman, 1991): 
Sensitivity= [TP / (TP + FN)] x 100%, defined as the proportion of gold-standard positives 
correctly identified by the test. 
Specificity= [TN / (TN + FP)] x 100%, defined as the proportion of negatives that are 
correctly identified by the test. 
Positive Predictive Value= [TP / (TP + FP)] x 100%, defined as the proportion of patients 
with positive test results who are correctly diagnosed. 
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Negative Predictive Value= [TN / (TN + FN)] x 100%, defined as the proportion of 
patients with negative test results who are correctly diagnosed. 
Accuracy= [(TP+TN)/(TP+FN+TN+FP)]x 100%, defined as the proportion of gold 
standard positives and negatives correctly identified by the test. 
Where, 
TP: True Positives are the individuals identified as positive by the gold standard test and 
the test under trial. 
TN: True Negatives are the individuals identified as negative by the gold standard test and 
the test under trial. 
FP: False Positives, are the individuals with a negative result in the gold standard but 
positive with the test being evaluated. 
FN: False Negatives are the individuals identified as positive by the gold standard but 
which were negative with the test being evaluated. 
5.3 RESULTS 
5.3.1 PCR System for Amplification of E. histolytica and E. dispar Reference DNA 
PCR amplification was achieved in reactions containing 2.5U of Taq polymerase, 
however, 5 Units of enzyme gave optimal results, producing a band corresponding to 125 
bp for E. histolytica and to 133 bp for E. dispar. Specificity of the products was tested by 
southern blot hybridisation. Each product was used as a probe and made to react under the 
same conditions of stringency with its homologous product and the product 
from the other 
species (Figure 5.5). 
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A 
125 bp 
B 
FIGURE 5.5 Southern Blot Analysis of E. histolytica (125 bp) and E. dispar (133 bp) PCR Products. 
PCR products in a 2% agarose gel (centre), lanes 1 and 4: E. histolytica, lanes 2 and 5: E. dispar, lane 3: 123 
bp Molecular Weight Marker Ladder. Each homologous radioactive PCR Product was used as the probe. 
E. dispar probe (A), E. histolytica probe (B). 
No cross reactivity was observed, indicating that the PCR products are species 
specific. Also, because the sequence amplified is present in multiple copies in both 
organisms, multiple sites for primer annealing are present and products of amplification of 
multiple molecular weights are also expected. The presence of bands on a "ladder" pattern 
depend on the number of repeats amplified so that bands of 125 bp, 250bp, and 375bp 
correspond to one, two, or three copies of the E. histolytica repeat. Similarly, bands of 
133bp, 266bp, and 399bp are one to three copies of the corresponding repeat respectively. 
5.3.2 Assessment of PCR Sensitivity by DNA Titration 
DNA concentrations ranging from 10 pg/2µ1 to 10 ng/2µ1 for E. histolytica and from 
10 pg/2µ1 to 100 ng/2µ1 for E. dispar produced specific bands of the expected molecular 
weights with their respective PCR systems (Figure 5.6 A and B). The multiple banding 
pattern of amplification observed correlates with the variation in the concentration of DNA. 
No amplification was observed in the controls in which water replaced the sample. 
170 
to 0 
Chapter 5 PCR-SHELA 
125 b p- 
FIGURE 5.6 A Titration of E. histolytica HM1-IMSS DNA by PCR. Lane 1: 10 pg of DNA. Lane 2: 
50 pg of DNA. Lane 3: 100 pg of DNA. Lane 4: 500 pg of DNA. Lane 5: 1 ng of DNA. Lane 6: 5 ng of 
DNA. Lane 7 10 ng of DNA. Lane 8: Water control (No DNA). 
133 BP 
FIGURE 5.6 B Titration of E. dispar SAW 1734 DNA by PCR. Lane 1: 10 pg of DNA. Lane 2: 50 pg 
of DNA. Lane 3: 100 pg of DNA. Lane 4: 500 pg of DNA. Lane 5: 1 ng of DNA. Lane 6: 5 ng of DNA. 
Lane 7 10 ng of DNA. Lane 8: 50 ng. Lane 9: 100 ng and Lane 10: Water control (No DNA). 
5.3.3 PCR Amplification of DNA From Colombian Isolates in Polyxenic Cultures 
In order to test the PCR systems using isolates from the field, DNA from 32 E. 
dispar isolates derived from microscopically positive samples was extracted at the Centro 
de Investigaciones en Microbiologia y Parasitologia Tropical, at Los Andes University in 
Bogota. The DNAs were transported frozen to the LSHTM and the PCR was carried out 
in London with both sets of primers and the products of amplification were first detected 
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by agarose gel electrophoresis. The products of each reaction with primers for E. 
histolytica and primers for E. dispar were placed side by side in the gel so that 
amplification is expected in only one of both lanes. 
All strains isolated in Colombia were correctly amplified as E. dispar, however, 
some cultures also produced a single band of approximately 375 bp with E. histolytica 
specific primers (Figure 5.7). 
123 bpº -4123 bp 
FIGURE 5.7.2% Agarose Gel Electrophoresis of PCR Products of Cultured Material from Colombia. 
Lanes 2,4,6,8,10 and 12 correspond of products of amplification with E. histolytica primers. Lanes 3,5, 
7,9,11 and 13 correspond to products of amplification with E. dispar primers. Lanes 1 and 14: 123 bp 
Molecular Weight Ladder Marker. Lanes 2 and 3: Jennifer. Lanes 4 and 5: Luisa. Lanes 6 and 7: 217. Lanes 
8 and 9: Mauricio. Lanes 10 and 11: Pol 10. Lanes 12 and 13: 86. 
Those cultures were retested with similar results. Contamination of the components 
of the PCR reaction was ruled out when no amplification was present in the water controls. 
Because no cloning procedure was followed prior to the collection of the trophozoites all 
those cultures were classified as possibly mixed cultures. However, cross contamination 
with minimal amounts of DNA can occur on cultured material while subculturing great 
numbers of isolates or during extraction of DNA. 
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In order to avoid possible contaminations during the manipulation of cultured 
material, modifications to the protocol for collection of the culture for DNA extraction from 
Colombia, an improvement in the drying process of the glassware by increasing the 
temperature over 170'C was introduced, and also the collection of cultured material in 
disposable tubes only. In addition, the use of aerosol protected tips and the use of screw 
capped tubes during extraction and further manipulations of DNA, were adopted. The 
frequent change of gloves during DNA extractions and for the preparation of the PCR 
reactions was consistently encouraged until it became part of the routine process. 
5.3.4 Titration of E. histolytica fTVH-IMSS and E. dispar SAW 1734 by PCR-Solution 
Hybridisation Enzyme-Linked Immuno Assay (SHELA) 
The process of standardisation of PCR-SHELA for detection of E. histolytica and 
E. dispar DNA involved the titration of different concentrations of trophozoite DNA from 
reference strains HM1-IMSS and SAW 1734 with their corresponding specific primers and 
probes. After extraction, the DNA was diluted in 50µl of sterile distilled water and its 
concentration measured as described in 5.2.3 (page 147). For titration, dilutions were 
prepared to reach concentrations of 10 pg/2 tl, 50 pg/2µ1,0.1 ng/2µ1,0.5 ng/2µ1,1 ng/2 tl, 
5 ng/2µ1,10 ng/2µ1,50 ng/2 tl and 100 ng/2µ1, and added to the PCR reactions. 
Hybridisation with the corresponding probes followed PCR, and detection of the hybrids 
was carried out by ELISA (5.2.10, page 152). ODs are registered in Table 5.6. 
For the E. histolytica system, positive reactions were observed from the first 
concentration of HM 1-IMS S DNA tested (10 pg/2 µl) and it was observed that the ODs 
increased as the concentration of DNA was increased up to 10 ng/2µ1. For the E. dispar 
system, a yellow positive reaction was also readable by eye in all the concentrations tested, 
however the increase in the DNA concentration was not directly proportional to the optical 
densities developed. 
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Because many factors may affect DNA amplification in polyxenic samples, the 
variation in the behaviour of the optical density trend in regard to concentration may be 
explained by the variable bacterial content of the polyxenic Robinson's medium, which 
would account for much of the total DNA estimated after extraction. Also, during the 
amplification, the number of repeats amplified varies and depends on the accessibility of 
the multiple annealing points on the target sequences, which also affects the annealing of 
the probe during the hybridisation step. 
TABLE 5.6 E. histolytica HMI-IMSS AND E. dispar SAW 1734 DNA TITRATION BY PCR-SHELA 
DNA CONCENTRATION PER 
21 OF SAMPLE 
E. histolytica 
11M1-IMSS OD 
E. dispar 
SAW 1734 OD 
0 (Water Control) 0.037 0.029 
10 0.096 0.252 
50 0.099 0.262 
0.1 n 0.181 0.152 
0.5n 0.227 0.114 
1 ng 0.309 0.518 
5n 0.315 0.513 
10 n 0.406 0.174 
50 n NT 0.130 
100 n NT 0.240____Jl 
OD: Optical Density at 410 nm. 
Eh Break Point x+2SD*= 0.0194+2(0.022)= 0.0639 
Ed BP*= 0.0188+2(0.021)= 0.0630 
*BP calculated with duplicate OD readings of water controls in 15 independent assays. 
Also, the isolation of new strains from faeces can only be done in polyxenic culture 
medium, which contains Escherichia coli strain B and some of the original bacterial flora 
from the faecal sample. DNA from E. coli grown in Robinson's medium was amplified 
with both sets of primers and compared to the same amount (2ng) of E. histolytica and E. 
dispar DNA in order to test the possibility of cross reactions (Figure 5.8). No PCR 
products were obtained with E. coli DNA when amplified with the two specific set of 
primers used in the test and it produced minimal non-specific background in the ELISA. 
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Figure 5.8 PCR-SHELA AMPLIFICATION OF 
CONTROL DNA (2 ng) 
OD 405 nm 
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5.3.5 Detection Limit of PCR-SHELA With E. histolytica and E. dispar Trophozoites 
From Polyxenic Cultures 
The DNA extracted from dilutions of trophozoites derived from polyxenic 
Robinson's cultures were tested by PCR-SHELA to determine the limit of detection of the 
tests for material isolated in culture (see 5.2.1, page 146). Numbers were adjusted to 1x105, 
1x104, lx 102 and 1 trophozoites, in a volume of 0.5 ml of PBS and completed to 1 ml with 
lysis buffer before extraction with phenol-chloroform and ethanol precipitation (see 2.9, 
page 70). PCR-SHELA results on E. histolytica culture 822 and on E. dispar culture 533 
are found in table 5.7. 
TABLE 5.7 PCR-SHELA TITRATION OF POLYXENIC E. histolytica and E. dispar TROPHOZOITES 
ESTIMATED No. OF 
TROPHOZOITES PER 
PCR REACTION 
E. histolytica 822 
PCR-SHELA 
OD ± SD 
E. dispar 533 
PCR-SHELA 
OD ± SD 
4x103 0.071 ± 0.090 0.037 ± 0.001 
4x102 0.114±0.014 0.133±0.005 
4 0.230 ± 0.021 0.078 ± 0.007 
<1 0.281 ± 0.026 0.005 f 0.0007 
OD: Optical Density at 410 nm. SD: Standard Deviation. 
Eh Break Point x+2SD*= 0.0194+2(0.022)= 0.0639 
Ed BP*= 0.0188+2(0.021)= 0.0630 
*BP calculated with duplicate OD readings of water controls in 15 independent assays. 
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Positive reactions were observed using two microlitres from a final 50µl stock of 
each DNA extracted, equivalent to 4x103,400,4 and less than 1 trophozoite of E. 
histolytica per reaction respectively, indicating that the sensitivity of the system is high and 
the intensity of the colour developed permits the reactions to be read by eye. Also, the 
increment in the optical density in direct relation to the dilution of the sample may indicate 
that at high concentrations of DNA, inhibition occurs during PCR amplification, (probably 
due to components of the extract that are not completely eliminated during the process of 
DNA extraction), and optimal primer annealing conditions are reached after dilution of the 
DNA stocks. 
The results of PCR-SHELA for DNA extracted from trophozoites of E. dispar 
grown in polyxenic cultures indicated that this system could probably be less sensitive than 
the assay for detection of DNA of E. histolytica trophozites grown in the same culture 
medium. 
5.3.6 Detection of E. histolytica and E. dispar Polyxenic Clinical Isolates by PCR- 
SHELA 
Pellets of trophozoites from field isolates made at the ICCDR in Dhaka 
(Bangladesh) and at CIMPAT in Bogota (Colombia) were tested by PCR-SHELA (Table 
5.8). The polyxenic cultures from Bangladesh had been classified according to zymodeme 
analysis as 23 E. histolytica strains, 13 belonging to zymodeme II and 10 to zymodeme 
XIV. An additional culture (798) had not been characterised by zymodeme analysis. 
Further 4 isolates were classified as E. dispar, zymodeme I, for a total of 28 isolates to be 
tested by PCR-SHELA. The E. histolytica system correctly identified 23 cultures, 15 of 
which were pure cultures, 6 belonging to zymodeme II and 9 to zymodeme XIV. However, 
mixture with E. dispar was detected in material from 6 cultures with zymodeme H and in 
one with zymodeme XIV. Culture 798 was identified as E. histolytica by PCR-SHELA. 
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The absorbances obtained with the PCR-SHELA system from the 4 E. dispar 
cultures according to zymodeme analysis at the ICCDR evidenced surprising results: two 
cultures (1351400 and 616) were positive with the E. histolytica system only, the material 
from one culture (6191) was confirmed as E. dispar but also contained some background 
DNA from E. histolytica, and the remaining culture with zymodeme 1 (1383875) was 
negative with both systems. Conclusions on the specificity of the test were difficult to 
reach until a greater number of E. dispar cultures from Colombia were tested (Table 5.9). 
TABLE 5.8 PCR-SHELA RESULTS OF CULTURES FROM BANGLADESH 
SAMPLE ID ZYMODEME Eh OD ± SD Ed OD ±SD PCR-SHELA 
RESULT 
1363050 II 0.525 ±0.027 0.003 ±0.0007 E. histolytica 
2701 II 0.231 ±0.004 0.006 ±0.0007 E. histolytica 
1351400 I 0.520 ±0.018 0.009 ±0.006 E. histolytica 
48286 II 0.378 ±0.011 0.013 ±0.0007 E. histolytica 
44298 XIV 0.386 ±0.001 0.009 ±0.0007 E. histolytica 
3771 II 0.630 ±0.021 0.140 ±0.002 Mixed Infection 
8691 XIV 0.595 ±0.002 0.044 ±0.002 E. histolytica 
4530 XIV 0.465 ±0.002 0.005 ±0.002 E. histolytica 
46385 XIV 0.571 ±0.002 0.004 ±0.001 E. histolytica 
6942 XIV 0.348 ±0.002 0.005 ±0.0007 E. histolytica 
798 ND 0.631 ±0.003 0.001 ±0.002 E. histolytica 
144536 XIV 0.496 ±0.002 0.009 ±0.000 E. histolytica 
1381150 XIV 0.519 ±0.001 0.190 ±0.002 Mixed Infection 
1353600 XIV 0.491 ±0.003 0.002 ±0.0014 E. histolytica 
1375975 II 1.052 ±0.066 0.060 ±0.019 E. histolytica 
1374300 II 0.416 ±0.0007 0.169 ±0.007 Mixed Infection 
1339525 II 0.565 ±0.012 0.000 ±0.004 E. histolytica 
58996 XIV 0.569 ±0.004 0.007 ±0.000 E. histolytica 
1320300 II 0.668 ±0.007 0.031 ±0.004 E. histolytica 
1383875 I 0.009 ±0.002 0.017 ±0.009 Negative 
6191 1 0.128 ±0.002 0.458 ±0.014 Mixed Infection 
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SAMPLE ID ZYMODEME Eh OD ± SD Ed OD ±SD PCR-SHELA 
RESULT 
1378275 II 0.578 ±0.048 0.007 ±0.0007 E. histolytica 
7098 XIV 0.631 ±0.007 0.007 ±0.000 E. histolytica 
506 II 0.665 ±0.094 0.608 ±0.113 Mixed Infection 
616 I 0.699 ±0.008 0.004 ±0.001 E. histolytica 
372 II 0.819 ±0.012 0.581 ±0.019 Mixed Infection 
379 II 0.745 ±0.024 0.288 ±0.0007 Mixed Infection 
478 II 0.677 ±0.008 0.397 ±0.0007 Mixed Infection 
Eh OR Optical density with E. histolytica PCR-SHELA. Eh SD: Standard deviation of two readings in the E. 
histolytica system. Ed OD: Optical density with E. dispar PCR-SHELA. Ed SD: Standard deviation of two readings 
in the E. dispar system. Eh Break Point 57<+2SD*= 0.0194+2(0.022)= 0.0639. Ed BP*= 0.0188+2(0.021)= 0.0630 
*BP calculated with duplicate OD readings of water controls in 15 independent assays. 
The analysis of PCR-SHELA results on 32 additional colombian isolates (Table 
5.9), revealed amplification on DNA of 26 E. dispar cultures, however, 8 of those cultures 
also contained background E. histolytica DNA and were classified as mixed infections. The 
six remaining cultures were negative when tested by both PCR-SHELA systems. 
TABLE 5.9 PCR-SHELA RESULTS ON CULTURES FROM COLOMBIA 
SAMPLE ID IFAT MAb 
20/7D 
HK E. histolytica 
OD ± SD 
E. dispar 
OD ± SD 
PCR-SHELA 
RESULT 
11 HOSP FUT Negative SLOW 0.056 ±0.070 0.191 ±0.013 E. dispar 
11 HOSP COL NT NT 0.013 ±0.001 0.171 ±0.005 E. dis par 
10 COL Negative SLOW 0.031 ±0.004 0.085 ±0.004 E. dispar 
16 COL Negative SLOW 0.008 ±0.003 0.165 ±0.012 E. dispar 
34 COL Negative SLOW 0.037 ±0.004 0.102 ±0.009 E. dis par 
33 COL NT NT 0.010 ±0.002 0.042 ±0.002 Negative 
41 COL Negative SLOW 0.023 ±0.012 0.177 ±0.007 E. dispar 
11 FUT Negative SLOW 0.186 ±0.001 0.089 ±0.007 Mixed Infection 
12 FUT NT NT 0.039 ±0.0007 0.120 ±0.003 E. dispar 
43 HOSP FUT NT NT 0.007 ±0.002 0.148 ±0.008 E. dispar 
7 FUT Negative SLOW 0.108 ±0.0056 0.122 ±0.000 Mixed Infection 
5 FUT Negative SLOW 0.014 ±0.0007 0.0007 ±0.002 
T 
Negative 
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SAMPLE ID IFAT MAb 
20/7D 
HK E. histolytica 
OD ± SD 
E. dispar 
OD ± SD 
PCR-SHELA 
RESULT 
19 FUT NT NT 0.130 ±0.002 0.183 ±0.003 Mixed Infection 
83 LMP Negative SLOW 0.016 ±0.002 0.132 ±0.001 E. dis par 
86 NT NT 0.000 ±0.001 0.126 ±0.004 E. dis par 
66 Negative SLOW 0.111 ±0.0004 0.199 ±0.028 Mixed Infection 
217 NT NT 0.001 ±0.000 0.176 ±0.004 E. dispar 
MAURICIO NT NT 0.005 ±0.004 0.048 ±0.002 Negative 
POL 9 NT NT 0.352 ±0.028 0.064 ±0.0007 Mixed Infection 
POL 10 NT NT 0.009 ±0.001 0.035 ±0.004 Negative 
JULIA Negative SLOW 0.108 ±0.001 0.106 ±0.024 Mixed Infection 
JENNIFER NT NT 0.016 ±0.0007 0.136 ±0.006 E. dispar 
RENE NT NT 0.001 ±0.004 0.008 ±0.003 Negative 
9 LMP Negative SLOW 0.092 ±0.016 0.164 ±0.019 Mixed Infection 
MIIZEYA NT SLOW 0.006 ±0.004 0.036 ±0.004 Negative 
LUISA NT NT 0.004 ±0.002 0.127 ±0.006 E. dispar 
MARCOS NT NT 0.046 ±0.006 0.131 ±0.0007 E. dispar 
64 LMP NT NT 0.091 ±0.021 0.121 ±0.003 Mixed Infection 
DG LMP NT NT 0.020 ±0.005 0.079 ±0.0007 E. dispar 
LIZ LMP Negative SLOW 0.010 ±0.002 0.195 ±0.004 E. dispar 
LAB LW Negative SLOW 0.007 ±0.004 0.066 ±0.003 E. dispar 
MB LMP P NT NT 0.004 ±0.007 0.097 ±0.005 E. dispar 
IFAT MAb 20/7D: IlVIMUNOFLUORESCENCE WITH MONOCLONAL ANTIBODY 20/7D. NT: Not Tested 
HK: Hexokinase Migration. Slow: Characteristic migration for E. histolytica. Fast: Characteristic for E. dispar. 
OD: Optical Density reading at 410 nm. 
Eh Break Point(BP)*: X+2SD= 0.0194+2(0.022)= 0.0639 
Ed BP*= 0.0188+2(0.021)= 0.0630 
*BP calculated with duplicate OD readings of water controls in 15 independent assays. 
The comparison of PCR-SHELA for diagnosis of amoebic infection in pellets from 
cultures evidenced that the system for detection of E. histolytica DNA produced better OD 
readings than the system for detection of E. dispar DNA. It also evidenced that although 
no amplification was detected in the internal water controls included with each batch of 
PCR reactions, background contamination was present in the DNA obtained from the 
pellets of cultured material, the possible origin of which will be disscussed later. 
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5.3.7 PCR Amplification of the SSUr DNA on Polyxenic Cultures 
In order to evaluate the performance of PCR-SHELA when compared to a well 
known standard PCR system, 55 of the 60 DNAs tested in 5.3.6 were used used to amplify 
a region of the small subunit of ribosomal DNA in E. histolytica and E. dispar with the 
corresponding specific primers according to the protocol described in 5.2.13, page 155. 
This amplification also intended to clarify (when possible) the results on the mixed 
infections detected by PCR-SHELA and on the apparently false positive E. histolytica 
isolates reported as zymodeme I in the collection obtained from Bangladesh. 
The DNA from 25/28 of the cultures from Bangladesh was amplified using specific 
primers for the SSU rDNA and the results are found in the table below: 
TABLE 5.10 COMPARISON OF PCR-SHELA AND SSU rDNA AMPLIFICATION ON 
CULTURES FROM BANGLADESH 
SAMPLE ID ZYMODEME PCR-SHELA rSSU PCR 
1363050 II E. histolytica E. histolytica 
2701 II E. histolytica E. histolytica 
1351400 I E. histolytica E. histolytica 
48286 II E. histolytica E. histolytica 
44298 XIV E. histolytica E. histolytica 
3771 II Mixed Infection E. histolytica 
8691 XIV E. histolytica E. histolytica 
4530 XIV E. histolytica E. histolytica 
46385 XIV E. histolytica E. histolytica 
6942 XIV E. histolytica E. histolytica 
798 ND E. histolytica E. histolytica 
144536 XIV E. histolytica E. histolytica 
1381150 XIV Mixed Infection E. histolytica 
1353600 XIV E. histol tica E. histolytica 
1375975 II E. histolytica E. histolytica 
1374300 II Mixed Infection E. histolytica 
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SAMPLE ID ZYMODEME PCR-SHELA rSSU PCR 
1339525 II E. histolytica E. histolytica 
58996 XIV E. histolytica E. histol tica 
1320300 II E. histolytica E. histolytica 
1383875 I Negative E. dis par 
6191 I Mixed Infection Mixed Infection 
1378275 II E. histolytica E. histolytica 
7098 XIV E. histolytica E. histolytica 
616 I E. histolytica E. histol tica 
478 II Mixed Infection E. histol tics 
SSU rDNA amplification was achieved and agreed with the results obtained with 
PCR-SHELA in the DNA of 19 E. histolytica cultures and confirmed one (6191) mixed 
infection by amplification with both sets of primers in the material from Bangladesh. It 
also clarified further 4 mixed infections (3771,1381150,1374300 and 478) by 
amplification with the E. histolytica pair of primers only. Among the cultures with 
zymodeme I, as shown before, culture 6191 was confirmed as containing DNA from both 
species and cultures 1351400 and 616 amplified as E. histolytica, in agreement with the 
PCR-SHELA results. Culture 1383875 which did not amplify by PCR-SHELA was 
confirmed as E. dispar. 
Overall, results on the amplifications of the DNA with PCR-SHELA and SSU 
rDNA specific sets of primers agreed in 24/25 cultures from Bangladesh, although results 
on 3 samples classified as mixed infections by PCR-SHELA were confirmed as containing 
DNA of E. histolytica only by amplification of the SSU rDNA. 
In a similar fashion, it was possible to test 30 of the 32 colombian E. dispar isolates 
using specific primers for amplification of the SSU rDNA of E. histolytica and E. dispar. 
Amplification was achieved in DNA of 28 cultures and the results are listed in the table 
below: 
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TABLE 5.11 COMPARISON OFPCR-SHELA AND SSU rDNA AMPLIFICATION ON CULTURES 
FROM COLOMBIA 
SAMPLE ID HK PCR-SHELA rSSU PCR 
11 HOSP FUT SLOW E. dis par E. dis par 
11 HOSP COL NT E. dis par E. dis par 
10 COL SLOW E. dis par E. dis par 
16 COL SLOW E. dis par E. dis par 
34 COL SLOW E. dis par E. dis par 
33 COL NT Ne ative Negative 
41 COL SLOW E. dis par E. dis par 
11 FUT SLOW Mixed Infection E. dis par 
12 FUT NT E. dis par E. dis par 
43 HOSP FUT NT E. dis par E. dis par 
7 FUT SLOW Mixed Infection E. dis par 
5 FUT SLOW Negative E. dis par 
19 FUT NT Mixed Infection E. dis par 
83 LMP SLOW E. dis par E. dis par 
217 NT E. dis par E. dis par 
MAURICIO NT Negative E. dis par 
POL 9 NT Mixed Infection Negative 
POL 10 NT Negative E. dis par 
JULIA SLOW Mixed Infection E. dis par 
JENNIFER NT E. dis par E. dis par 
RENE NT Negative E. dis par 
9 LMP SLOW Mixed Infection E. dis par 
MIREYA SLOW Negative E. dis par 
LUISA NT E. dis par E. dis par 
MARCOS NT E. dis par E. dis par 
64 LU P NT Mixed Infection E. dis par 
DG LMP NT E. dis par E. dis par 
LIZ LUIP SLOW E. dis par E. dis par 
LAB LMT SLOW E. dis par E. dis par 
MB LMP NT E. dis par E. dis par 
NT: NOT TESTED 
HK: Hexokinase Migration 
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The rSSU PCR amplified 23 cultures as E. dispar, in agreement with the results 
obtained by PCR-SHELA. However, 6 mixed infections detected by PCR-SHELA were 
found to contain E. dispar DNA only by amplification of the SSU rDNA. One culture (33 
col) remained negative with in both PCRs and one sample which amplified as a mixed 
infection detected by PCR-SHELA did not amplify with the rSSU PCR. Amplification 
with the primers for E. dispar rSSU was achieved in 5 of the cultures that were negative 
by PCR-SHELA. Overall, the E. dispar PCR-SHELA system amplified 25/30 samples, 
meanwhile the PCR for amplification of the E. dispar SSU rDNA amplified 29/30 samples 
tested (Table 5.11). 
Bangladesh: 25 E. histolytica Cultures 
Colombia: 30 E. dispar Cultures 
E. histolytica 
SSU rDNA 
E. dispar 
SSU rDNA 
+- Total 
E. histolytica + 24 0 24 
PCR-SHELA -1 30 31 
Total 25 30 55 
PCR-SHELA Sensitivity: [24/(24+1)]x 100%= 96% 
PCR-SHELA Specificity: [30/(30+0)]x 100%= 100% 
Positive Predictive Value: [24/(24+0)]x 100%= 100% 
Negative Predictive Value: [30/(30+1)]x 100% 96.8% 
+- Total 
E. dispar + 24 1 25 
PCR-SHELA -4 26 30 
Total 28 27 55 
PCR-SHELA Sensitivity: [24/(24+4)]x 100%= 85.7% 
PCR-SHELA Specificity: [26/(26+1)]x 100%= 96.3% 
Positive Predictive Value: [24/(24+1)]x 100%= 96% 
Negative Predictive Value: [26/(26+4)]x 100%= 86.7% 
From the above evaluation several aspects have to be discussed, firstly, it appears 
that the PCR-SHELA system for detection of E. histolytica is more sensitive than the 
system for detection of E. dispar in cultured material when both are compared to the rSSU 
PCR. Also, although mixed infections are likely to exist in nature, and mixed populations 
of trophozoites may be present in early cultures, their detection in long term cultured 
material is not likely, especially in the case of E. histolytica isolates, where its higher rate 
of multiplication should led to elimination of non-invasive populations present during long 
term subculture, however, it is still possible that a residual non-pathogenic population is 
passed on. PCR-SHELA detected 16 (26.6%) mixed infections in a sample of 60 cultures 
from endemic areas. Consequently, the presence of background DNA of either species in 
cultures can be explained by mechanical contamination through different sources: the first 
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and more likely source is the process of subculture, when cross contamination between 
samples is possible if DNA residues from previous culturing are left in the glassware after 
washing, in particular in the reused glass bijou bottles used for polyxenic Robinson's 
culture. The second source could be the production of aerosol droplets when adding the 
secondary Robinson's medium, in which case a few trophozoites would be enough to 
contaminate the original culture. This would be translated as different degrees of 
contamination in PCR reactions, ranging from slight amounts of background DNA to a total 
change in the species cultured. A third source could be the process of extraction of DNA 
itself, in which case, the multiple steps of the process (in particular the phenol-chloroform 
method) favoured cross contamination due to manipulation. An alternative explanation for 
the presence of background DNA after PCR from cultures is the possible non-specific 
priming. If this is the reason, a similar percentage of samples presenting background DNA 
would be expected after PCR-SHELA directly on uncultured stool samples from endemic 
areas and this will be examined later. 
The analysis of the results presented in this section emphasises that diagnosis of 
amoebiasis ideally should not be based only on cultured material ()WHO/PAHO/UNESCO, 
1997) and that it is also necessary to detect intestinal amoebic infections directly in faecal 
samples, where diagnosis can be carried out promptly without the possibility of selection 
of parasite populations or contamination after successive subcultures. 
5.3.8 Detection of E. histolytica and E. dispar by PCR-SHELA in Faecal Samples, Pus 
From Liver Abscess and Other Body Fluids 
PCR-SHELA from 7 faecal samples collected at La Mesa, in Cundinamarca 
(Colombia) resulted in the detection of two E. histolytica and three E. dispar infections 
(Figure 5.9 A and B). No amplification was observed in samples harbouring Entamoeba 
coli or hookworm infections, nor in the controls containing water as sample replacement 
or parasite negative faeces (Aguirre et al., 1995). 
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SAMPLES 
Fl 
F2 
F3 
F4 
F5 
F6 
F7 
NF 
cl 
C2 
C3 
NPPC 
NNPPC 
Eh: Enlamoeba hlstolyllca 
Ed. - Enfamoeba dispar 
'Cut o11 Value: 0.063 
FIGURE 5.9 A PCR-SHELA results from faeces (F), Robinson's cultures (C) and Primer Controls. 
NF: Negative faeces, NPPC: negative pathogenic primer control, NNPPC: negative non-pathogenic primer 
control. Microscopy results: F1: E. histolytica, hematophagous troph., F2: Entamoeba sp, trophozoites, 
F3: Entamoeba sp, troph. and Blastocystis hominis, F4: E. coli, cysts, F5: E. histolytica, hematophagous 
trophozoites, F6: E. histolytica, cysts, F7: Hookworm, Eggs. Cl: E. histolytica, cysts, C2: Entamoeba 
histolytica, cysts, E. coli, cysts, 1. buetschlii, cysts and E. nana, cysts; C3: E. histolytica, cysts, E. coli, cysts 
and I. buetschlii, cysts. 
SAMPLE 
HM1-IMSS 
SAW 1734 
PAA 
NPPC 
NNPPC 
0 0.5 1 1.5 2 
ABSORBANCE (405 nm) 
L Eh PRIMERS Ed PRIMERS 
Eh: Entamoeba hlstolytica 
Ed: Entamoeba dispar 
'Cut Off Value: 0.063 
FIGURE 5.9 B PCR-SHELA Results from Reference Strains, Amoebic Abscess and Primer Controls. 
HM1-IMSS: Reference E. histolytica strain, SAW 1734: Reference E. dispar strain. PAA: Pus Amoebic 
Abscess, NPPC: negative pathogenic primers control, NNPPC: negative non-pathogenic primers control. 
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The samples collected at HTD in London were processed blindly and PCR-SHELA 
results are found in Table 5.12. Included among the samples for evaluation, faeces from 
cases of invasive amoebiasis (intestinal and extra-intestinal) and from a case of ulcerative 
colitis in which differential diagnosis was necessary were included. PCR-SHELA detected 
three amoebic liver infections demonstrating the feasibility of amplification when DNA 
from pus is the source. Although further testing with pus derived from pyogenic liver 
abscesses is necessary, PCR-SHELA can be used as an aid to serology for diagnosis of 
invasive amoebiasis of the liver in cases where drainage of the abscess is indicated. 
Although in one of the cases where a liver abscess was diagnosed it was also possible to 
identify DNA of E. histolytica in the faeces, microscopy on faecal samples from patients 
with amoebic liver involvement is often negative. 
TABLE 5.12 PCR-SHELA RESULTS ON HTD SPECIMENS 
SAMPLE ID SPECIMEN PCR-SHELA 
E. histolytica 
OD 
PCR-SHELA 
E. dispar 
OD 
001472 Faeces 0.033 0.032 
AW Faeces 0.309 0.036 
65004534 Faeces 0.783 -0.011 
65004534 Pus from Liver Abscess 0.101 -0.001 
018090 Pus from Liver Abscess 1.602 0.030 
1079 Pus from Liver Abscess 0.744 0.004 
65004534 Blood 0.009 0.010 
65004534 Urine 0.063 -0.014 
65004534 Serum 0.011 -0.008 
NT: Not Tested. OD: Optical Density at 410 nm. 
Eh Break Point x+2SD*= 0.0194+2(0.022)= 0.0639. Ed BP*= 0.0188+2(0.021)= 0.0630 
*BP calculated with duplicate OD readings of water controls in 15 independent assays. 
In order to test the possibility of using other sources of DNA, red blood cells, serum, 
and urine in a case of amoebic liver abscess were screened for the presence of amoebic 
DNA. No amplification was achieved with any of those samples and further amplifications 
were not attempted. 
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5.3.9 Diagnosis of Intestinal Amoebiasis by PCR-SHELA in a Dutch Family 
PCR-SHELA gave positive results with the E. histolytica specific system in four 
from the five microscopy positive samples (Table 5.4, page 162) and it was also positive 
in all four derived cultures. The results of further PCR amplifications on the false negative 
sample remained negative, evidencing again the need for an improvement in the 
methodology for extraction of DNA, which would bring sensitivity to the same level 
achieved by means of the use of the concentration methods (Table 5.13). 
TABLE 5.13 PCR-SHELA RESULTS FROM FAECES AND CULTURES COMPARED TO 
ZYMODEME ANALYSIS AND SEROLOGY 
SAMPLE 
ID 
FAECES 
Eh PCR-SHELA 
OD 
FAECES 
Ed PCR-SHELA 
OD 
CULTURE 
Eh PCR-SHELA 
OD 
CULTURE 
Ed PCR-SHELA 
OD 
ZYMODEME ELISA 
SEROLOGY 
1H 0.031 0.027 NT NT NT <1/40 
2H 0.033 0.034 NT NT NT NT 
3H 0.143 0.035 0.340 0.036 Ha- 1/320 
4H 0.323 0.036 NT NT NT 1/80 
5H 0.266 0.035 0.591 0.041 Ha- <1/40 
6H 0.048 0.045 0.183 0.010 Ha- 1/320 
7H 0.177 0.049 0.134 -0.003 Ha- 1/40 
Eh: Entamoeba histolytica. Ed: Entamoeba dispar 
OR Optical Density at 410 nm. 
Eh Break Point 57<+2SD*= 0.0194+2(0.022)= 0.0639. Ed BP*= 0.0188+2(0.021)= 0.0630. 
*BP calculated with duplicate OD readings of water controls in 15 independent assays. 
NT: Not Tested 
It is interesting to note that although the nanny (sample III and her husband 
(sample 2H) were in close contact with the family, only the family members were infected, 
and from them, the mother (sample 3H), and the children (samples 4H, 6H and 7H), 
presented a positive serology. Only the index case (4H) presented haematophagous 
trophozoites. This family cluster highlights the importance of the concomitant use of 
several diagnostic techniques to achieve high sensitivity and specificity of diagnosis, which 
in this case involved microscopy, culture, serology and PCR-SHELA. 
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5.3.10 Detection of E. histolytica and E. dispar Intestinal Infections in Holland and 
Colombia 
The results described in this section were obtained through collaborative work for 
the evaluation of PCR-SHELA with two types of samples: the material arriving to a 
reference laboratory setting at the University of Leiden, the Netherlands for confirmation 
of microscopy results (study in which I did not have a direct involvement other than 
training to the staff carrying out the study), and the material obtained after a screening of 
a sample of the general population in an "endemic" area in Colombia (in which access to 
the study material and results was kindly provided by Prof. Felipe Guhl and colleagues 
from Universidad de los Andes). 
During the pilot evaluation at Leiden (Netherlands), PCR-SHELA on DNA from 
the stools detected 9 E. histolytica and 22 E. dispar cyst passers as confirmed by identical 
results obtained with the two PCR methods used as gold standard. In this case, specificity 
and sensitivity of PCR-SHELA were both 100% for the E. histolytica and E. dispar 
systems. The PCR-SHELA results of 30 of the corresponding cultures were in complete 
agreement with the hexokinase results. One culture harbouring E. dispar remained negative 
by PCR-SHELA. This negative culture was later amplified after dilution of the DNA when 
the test was repeated at the LSHTM. The sensitivity of the E. dispar system for cultures 
was 95%, with a specificity of 100% and positive and negative predictive values of 100% 
and 90% respectively. 
After the pilot study described above, 369 faecal samples received for confirmation 
of diagnosis of amoebiasis by the reference laboratory of Parasitology at the University of 
Leiden were divided in two aliquots, one concentrated and the other was tested by PCR- 
SHELA. The samples belonged to patients with clinical suspicion of invasive amoebiasis, 
or with a strong positive antibody reaction in serological tests, and/or the presence of 
trophozoites of E. histolytica/dispar in the stools was observed when direct examination 
was carried out before referral to the reference laboratory. 
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For the analysis of results in PCR-SHELA, the samples were divided into two 
groups according to the results of the concentration method, which was used as the gold 
standard method: 246 samples(67%) were positive for E. histolytica/dispar cysts by 
concentration, and 123 samples (33%) were negative for cysts of E. histolytica/dispar by 
concentration. This group included samples where cysts of other amoebas were identified 
or no cysts at all were detected by the reference laboratory after concentration (Table 5.14). 
TABLE 5.14 PCR-SHEILA EVALUATION ON CLINICAL SAMPLES AT LEIDEN, NETHERLANDS 
PCR-SHELA 
CLASSIFICATION 
E. histolytica/dispar 
(Concentration) 
NEGATIVES 
(Concentration) 
TOTAL No. OF 
SAMPLES 
E. dis par 221 (90%) 10 (8%) 231(63%) 
E. histolytica 23 (9%) 7 (6%) 30(8%) 
Negative 2(0.8%) 106(86%) 108 (29%) 
TOTAL 246 123 369 
PCR-SHELA detected 221 E. dispar and 23 E. histolytica infections in the group 
of samples in which cysts of E. histolytica/dispar had been identified after concentration, 
for a total of 244/246 positives (99%), with only two microscopy positive but PCR negative 
samples. From the samples on the former group, 90%(221/246) were E. dispar passers and 
more importantly 9%(23/246) of the cyst positives were due to E. histolytica. These results 
are in proportion with previous estimations on the epidemiology and distribution of 
invasive amoebiasis, in which approximately 10% of individuals identified as E. 
histolytica/dispar positive were, in fact, infected with E. histolytica sensu stricto (Walsh, 
1986). 
For the second group of 123 samples that were found negative for E. 
histolytica/dispar cysts after concentration, E. histolytica DNA was amplified in 7 and E. 
dispar DNA was amplified in 10, revealing that 14%(17/123) of the samples reported as 
not containing E. histolytica/dispar cysts after concentration were found positive for either 
E. histolytica or E. dispar DNA after PCR-SHELA. 
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According to the results described above, the following evaluation of PCR-SHELA 
is based in the formulas described in 5.2.17 (page 168): 
NUCROSCOPY 
PCR + 244 17 261 
SHELA -2 106 108 
246 123 369 
PCR-SHELA Sensitivity: [244/(244+2)]x100%= 99.2% 
PCR-SHELA Specificity: [(106/(106+17)]x 100%= 86.2% 
Positive Predictive Value: [244/(244+17)]x100%= 93.5% 
Negative Predictive Value: [ 106/(106+2)]x 100%= 98.1 % 
Accuracy: [(244+106)/(244+2+106+17)]x 100%= 94.8% 
If we assume that false positives are likely to be true infections, and analyse the 
results with PCR-SHELA as the gold standard, the sensitivity of PCR-SHELA remains as 
99.2%, due to the two samples that were positive by concentration but negative by PCR- 
SHELA. However, the specificity of the test increased to 100%, hence the positive 
predictive value of 100%, and the same negative predictive value of 98.1%. Since the 
accuracy depends on the sensitivity and specificity of the test, it increases to 99.4%. 
No mixed infections were found in 261 positives, which is remarkable when these 
results are compared to those in previous studies on samples from endemic areas using 
PCR. Another important conclusion after the analysis of these results is the fact that in 
86%(106/123) of the samples in which there was clinical suspicion of amoebiasis but no 
E. histolytica/dispar cysts were found, other etiologies should be investigated and this is 
one of the justifications for the screening of those samples with very sensitive methods such 
as PCR, where a fast negative result makes way for a different diagnostic approach. 
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The overall consideration of PCR-SHELA results in Leiden, indicate that 
71%(261/369) of the samples received by the reference laboratory with possible diagnosis 
of E. histolytica/dispar infection were correctly diagnosed and from them, 8%(30/369) 
contained Entamoeba histolytica sensu stricto. Remarkably, the 7 E. histolytica positive 
samples detected by PCR-SHELA in the group of negatives by concentration (Table 5.14) 
accounted for 23% (7/30) of the total of E. histolytica infections detected, which suggests 
that examination of stool samples using only a concentration method for confirmation of 
amoebic infection at the reference laboratory level involves the risk of missing potentially 
invasive infections. 
The PCR-SHELA pilot study in an endemic area was carried out at Quibdo in 
Choco, Colombia (Molina et al., 1998), and the results of that screening indicated that of 
427 faecal samples analysed by microscopy 330 (77%) harboured at least one parasite 
species, indicating a high exposure to faecal contamination in the population. Among the 
most prevalent parasitic infections, Giardia intestinalis was present in 11.6% of the 
samples, Bl. hominis in 45%, A. lumbricoides in 22%, T trichiura in 17%, S. stercoralis 
in 6% and Hookworm in 4%. Among the amoeba species, E. histolytica/dispar infections 
were detected in 40 (9.6%) of the samples, E. hartmanni in 2.8%, E. coli was present in 
18% and E. nana in 39%. 
A total of 52 samples including 40 microscopically cyst positive samples identified 
as E. histolytica/dispar carriers (6 mixed with E. hartmanni) and 12 samples identified as 
containing E. hartmanni but no E. histolytica/dispar were tested by rSSU DNA 
amplification and PCR-SHELA using the methodology described in 5.2.11 and 5.2.12 
respectively. 
PCR-SHELA tests on the 40 E. histolytica/dispar microscopy positive samples 
identified 3 as E. histolytica (confirmed when the samples were amplified with the PCR for 
the rSSU). In contrast, E. dispar was identified in 21/40 samples by PCR-SHELA 
(confirmed in 18 by the rSSU DNA PCR). Among the 12 "E. hartmanni " from Quibdo, 
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2 were identified as E. histolytica and other 2 as E. dispar by PCR-SHELA (and confirmed 
with the rSSU DNA PCR), bringing the prevalence for E. histolytica infections to 9.6% 
(5/52 samples) and for E. dispar infections to 44% (23/52 samples) among the group of 
positives. Thus, from the 12 E. hartmanni suspected samples, 8 did not amplify, and 
therefore could be E. hartmanni. DNA from 16 out of the 40 E. histolytica/dispar 
microscopy positives did not amplify despite extracting those samples twice and using the 
DNA extract undiluted, and diluted 1/10 and 1/100 in water for further PCRs. Because no 
amplification was achieved after dilution, it was assumed that those samples were 
misdiagnosed by microscopy and those could represent possibly E. hartmanni infections. 
However, for further screenings it was decided to increase the amount of faecal lysate to 
be extracted from 200 µl (as adviced by the QIAGEN kit) to 1 ml to enhance detection and 
when dilution of the DNA was necessary, 5 µl of the extracted DNA (instead of 2µl) were 
used for each PCR reaction. 
It is important to point out that one mixed infection was found and confirmed by 
both PCRs, which is interesting because Acura-Soto and colleagues (1993) reported a 
prevalence of 12% E. histolytica/dispar infections in an indigenous population from 
Chiapas (Mexico) when faecal samples were screened by microscopy. From them, 36% 
were infected with E. histolytica and 56% were found to harbour mixed infections when 
tested by PCR (Acura-Soto et al., 1993). Whether those results reflect a particular case in 
which transmission of E. histolytica and E. dispar is being maintained in a closed 
population or it is the result of cross contamination of samples, is not clear. However, in 
a more recent study, Newton et al., (1997) found mixed infections in 78% of the 
microscopically-positive faeces of 48 non-dysenteric Mexican children. Because the same 
methodology involving a cyst concentration technique before extraction of DNA was used 
in both Mexican studies, further studies using a different method involving less 
manipulation of the samples should be applied. 
The results above discussed would indicate that in a sample of 427 subjects from 
the general population at Quibdo (Choco, Colombia), 1.2%(5/427) E. histolytica infections 
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were detected and these subjects were at risk of developing invasive disease and 
accordingly were treated. In contrast, 5.3% (23/427) had E. dispar infections without any 
risk of developing disease. Also, 8/427 (1.9%) infections could be suspected to be E. 
hartmanni. This will be confirmed only after the standardisation of a PCR system for 
amplification of the E. hartmanni rSSU with specific primers (sequence kindly provided 
by Dr G. Clark), which also will be used to test all the E. histolytica/dispar microscopy 
positive samples which did not amplify by E. histolytica or E. dispar PCR. 
The feasibility of screening faecal samples by PCR in endemic areas was tested in 
Colombia and it was successful. However, because only one sample from each subject was 
collected and only microscopy positive samples were tested in PCR-SHELA during the 
pilot study at Quibdo, a new screening project in which DNA of a pool of three consecutive 
samples will be extracted (regardless of the microscopy result) will be carried out for a 
complete evaluation of PCR-SHELA in the field. 
5.3.11 Assay Modifications 
The need for a reduction in the length of the whole process to fit within a working 
day was the starting point for reductions in the times of PCR cycles, the hybridisation step 
and of the ELISA incubations. Also, a change in the method for extraction of DNA was 
critical, especially for the reduction of cross contamination during the simultaneous 
processing of several samples. The incorporation of a kit for purification of DNA from 
clinical samples made it possible to reduce the extraction to 20 minutes. The procedure 
which provided the best results was that advised for large volume samples by the 
manufacturers, but the starting temperature and lysis protocol used previously (described 
on page 148, section 5.2.2) were kept for the extraction of faecal samples: 
1. Approximately 1 gram of faeces was diluted in 3 ml of sterile PBS pH 7.2, followed by 
three cycles of freezing in a mixture of dry ice-ethanol and thawing in water bath at room 
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temperature. This step was kept unaltered because it is a physical method efficient in 
breaking cyst walls and liberating their content. 
2. From this step forward, the QlAamp Tissue kit for DNA extraction (QIAGEN® Cat. 
No. 29304) was incorporated. 1 ml of the suspension (c 1 /3 g faeces) containing the lysate 
(measured using tips with wide end) was transferred into a 1.5 ml screw capped eppendorff 
tube, given a short spin in the microfuge (a manual pulse) at 6500-8000 rpm and the 
supernatant was put into a new screw capped eppendorff avoiding any disturbance of the 
pellet. Addition of 25 microlitres of proteinase K (20mg/ml stock) per 200 microlitres of 
supernatant was followed by an equal volume of Buffer AL (QIAamp kit). The mixture 
was vortexed and incubated in a 70'C water bath for 10 minutes. 
3. Then, 210µ1 of 96-100% Ethanol per 200 microlitres of sample were added and vortexed 
immediately. A QlAamp spin column (from the kit) was placed in a2 ml collection tube 
(provided in the kit) and 635µl of the lysate were applied. The lid was carefully closed and 
then the column was centrifuged at 8000 rpm for 1 minute. A new collection tube was 
prepared for the column and after adding further 63 5µl or what was left of the remaining 
lysate, the column was centrifuged again and transferred to a clean collection tube. The 
filtrates from the centrifugations were all discarded. 
4. The column was then washed with 500 microlitres of Buffer AW (QlAamp kit) followed 
by a spin at 8000 rpm for 1 minute. Again the filtrate was discarded and the column was 
transferred to a new collection tube. Further 500 microlitres of buffer AW (provided in the 
kit) were added and centrifuged at 14000 rpm or full speed. 
5. Before discarding the filtrate, the column was placed in a2 ml screw capped eppendorf 
(not provided in the kit) or in any screw capped centrifuge tube that fitted the column in 
order to elute the DNA with 200 microlitres of buffer AE (QIAamp kit) preheated at 70°C. 
An incubation of 5 minutes was followed by a spin at 8000 rpm for 1 minute. This step 
was repeated twice, for a final volume of 400 microlitres of DNA suspension. Thus, from 
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starting the DNA extraction with c 1/3 g of faeces (step 2 of the protocol), the final quantity 
of faeces in each PCR reaction was [1/3 g (2[tU400µ1)]= 0.0016 g (1.6 mg) when 2 gl of 
the extracted DNA are tested. When 5 µl of a 1/10 dilution of the DNA are used, the 
equivalent amount of faeces used is 0.4 mg. 
Protocol for Cultures: 
The content of 1 to 5 culture bijou bottles was collected, avoiding disturbance of the 
starch layer, and pelleted spinning at 700 g for 5-10 minutes. The supernatant was 
discarded and the pellet was taken into a 1.5 ml screw capped centrifuge tube. 25 
microlitres of proteinase K (from a 25 mg/ml stock) per 200 microlitres of pellet were 
added, followed by 200 microlitres of buffer AL per 200 microlitres of pellet, vortexed and 
incubated in a 70 'C water bath for 10 minutes. The same extraction protocol as for faeces 
was then followed from step 3. 
Protocol for Pus: 
200 microlitres of pus were mixed with 25 microlitres of proteinase K (25 mg/ml) 
and 200 microlitres of buffer AL. After vortexing, the mixture was incubated in a 70°C 
water bath for 10 minutes. Then, the faeces extraction protocol was followed from step 3. 
Further modifications were introduced for the SHELA protocol by omitting the 
blocking step with salmon sperm DNA. In addition, the washing buffer was changed from 
TBS-T to PBS-T which is readily available in reference laboratories in the tropics and 
incubations of the ELISA steps at 37°C were introduced to accelerate the kinetics of the 
reactions. The final protocol for the ELISA follows: 
Avidin coated (according to the protocol described in page 156, section 5.2.10) 
ELISA strips (Greiner, Germany) were washed with PBS-T, before addition of 100 pi of 
each diluted PCR product. Each sample was tested in duplicate wells and after washing, 
100 µl of anti-digoxigenin alkaline phosphatase labelled antibody (Cat. No. 1093 274 
Boehringer Mannheim, GmbH, Germany) diluted 1/5000 in PBST/were added to each well, 
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followed by four washings (PBS-T) and (xl, PBS only). The ELISA was developed by 
adding 100 µl of p-nitro-phenyl-phosphate in carbonate buffer supplemented with 1 mM 
MgC12. After stopping the reaction with 50 microliters 3M NaOH, absorbances were read 
at 405 nm. 
5.3.12 Diagnosis of Intestinal Amoebiasis by PCR-SHELA in Travellers Returning 
From the Tropics to Barcelona, Spain 
Screening of 57 samples collected between 1994 and 1997 by the laboratory of 
Parasitology from the Hospital Clinic i Provincial, Barcelona was carried out at the London 
School of Hygiene and Tropical Medicine (table 5.15). Although a first batch of 10 of the 
samples was extracted using the phenol-chloroform DNA purification method (5.2.2), a 
second batch of 47 was extracted using the QIAamp Kit for Tissue DNA from QIAGEN®. 
The result of the introduction of the kit was a reduction in the time for extraction and 
manipulation of samples. It is now possible to process batches of 10 samples in as little as 
90 minutes (approximately 20 minutes for one sample only) with very low risk of cross 
contamination between them. 
TABLE 5.15 PCR-SHELA ON FAECAL SAMPLES FROM TRAVELLERS RETURNING TO BARCELONA 
SAMPLE ID HK E. histolytica 
PCR-SHELA 
OD 
E. dispar 
PCR-SHELA 
OD 
RESULT 
2675 NT NEGATIVE NEGATIVE NEGATIVE 
2436 NT 0.001 0.146 E. dis par 
219 S 0.011 0.174 E. dis par 
622 S 0.010 0.262 E. dis par 
819 20/3 S 0.004 0.128 E. dis par 
2394 S 0.007 0.173 E. dis par 
423 NT 0.004 0.125 E. dis par 
505 S 0.003 0.145 E. dis par 
1614 NT 0.009 0.317 E. dis par 
695 NT 0.0015 0.184 E. dis par 
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SAMPLE ID HK E. histolytica 
PCR-SHELA 
OD 
E. dispar 
PCR-SHELA 
OD 
RESULT 
696 NT -0.010 0.165 E. dis par 
2635 S 0.004 0.255 E. dis par 
2877 S 0.008 0.132 E. dis par 
3210 F 1.041 -0.014 E. histolytica 
3187 NT -0.057 0.283 E. dis par 
280 NT 0.007 0.911 E. dis par 
910 NT -0.052 0.774 E. dis par 
1069 S 0.029 0.135 E. dis par 
2529 NT 0.005 0.191 E. dis par 
2103 NT 0.006 0.257 E. dis par 
88 S -0.0005 0.191 E. dis par 
112 F 0.116 0.050 E. histolytica 
764 S -0.052 0.131 E. dis par 
1628 NT 0.019 0.501 E. dis par 
2333 NT 0.004 0.428 E. dis par 
264 NT 0.027 0.354 E. dis par 
2512 NT -0.014 0.127 E. dis par 
287 NT 0.087 0.383 E. dis par 
2407 NT -0.014 0.199 E. dis par 
323 S -0.001 0.135 E. dis par 
2597 NT 0.091 0.031 E. histolytica 
2015 S 0.003 0.269 E. dis par 
2564 NT 0.054 0.281 E. dis par 
3201 NT 0.054 0.138 E. dis par 
746 NT 0.116 0.037 E. histolytica 
963 NT 0.018 0.527 E. dis par 
107 S 0.003 0.302 E. dis par 
617 NT 0.016 0.527 E. dis par 
2552 F 0.562 0.005 E. histolytica 
971 NT 0.104 0.042 E. histolytica 
2828 S -0.007 0.141 E. dis par 
1127 NT 0.038 0.334 E. dis par 
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SAMPLE ID HK E. histolytica 
PCR-SHELA 
OD 
E. dispar 
PCR-SHELA 
OD 
RESULT 
277 NT 0.049 0.129 E. dis par 
1198 NT 0.000 0.102 E. dis par 
2399 S 0.051 0.596 E. dis par 
2891 NT 0.030 0.973 E. dis par 
822 F 0.434 0.017 E. histolytica 
563 S 0.006 0.179 E. dis par 
533 S 0.009 0.128 E. dis par 
472 S 0.000 0.156 E. dis par 
466 S 0.057 1.068 E. dis par 
2024 F 0.335 0.018 E. histolytica 
675 S 0.015 1.334 E. dis par 
315 NT 0.011 0.133 E. dis par 
1136 NT 0.011 0.934 E. dis par 
2409 NT 0.008 0.350 E. dis par 
428 NT 0.005 0.238 E. dis par 
OD: Optical Density at 410 nm. Eh Break Point x+2SD*= 0.0194+2(0.022)= 0.0639 
Ed BP*= 0.0188+2(0.021)= 0.0630 
*BP calculated with duplicate OD readings of water controls in 15 independent assays. 
HK: Hexokinase characterisation. F: Fast. S: Slow 
NT: Not Tested 
PCR-SHELA successfully classified 56 of the 57 faecal samples tested, from which 
8 (14%) were identified as Entamoeba histolytica and 48 (84%) as Entamoeba dispar 
infections. The technique was evaluated after the last modification to the protocol for DNA 
extraction at the LSHTM with faecal samples from those travellers. All patients had a 
presumptive diagnosis of amoebiasis after positive microscopy. Hexokinase 
characterisation on 25 derived cultures (Figures 5.9 and 5.10) was in total agreement with 
the PCR-SHELA results. The sensitivity of the tests for faecal samples was 98% and the 
specificity was 100%. With one possible exception (sample 287), no mixed infections were 
detected. Only one sample did not amplify with either PCR-SHELA system and after 
retrospective analysis of the microscopy result of this specimen, an infection with E. 
hartmanni was detected. 
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FIGURE 5.10A Hexokinase Characterisation of Strains from Barcelona and Controls. Lane 1: E. 
histolytica, Fast. Lane 2: E. dispar, Slow. Lane 3: 19, Slow. Lane 4: 822, Fast. Lane 5: 563, Slow. Lane 6: 
25, Fast. Lane 7: 472, Slow. Lane 8: 533, Slow. 
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FIGURE 5.10B Hexokinase Characterisation of Strains from Barcelona and Controls. Lanes 1 and 7: 
E. histolytica, Fast. Lanes 2 and 8: E. dispar, Slow. Lane 3: 466, Slow. Lane 4: 159, Slow. Lane 5: 2024, 
Fast. Lane 6: 25, Negative. 
The E. histolytica PCR system correctly identified the DNA of all five E. histolytica 
hexokinase positive samples, while the E. dispar PCR system gave negative reactions. 
Similarly, the E. dispar specific PCR system detected all 20 cyst-passers samples with E. 
dispar identified by hexokinase. The sensitivity and specificity on those samples was 
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100%, in agreement with the results found by Teig and colleagues at Leiden (Teig et al., 
1997). A further evaluation with the modified protocol for DNA isolation using fresh 
samples at Quibdo, (Choco, Colombia) is currently being carried out at the CIlVPAT in 
Bogota. 
5.4 DISCUSSION 
The main aim of this work was to produce a very specific tool for differential 
diagnosis in cases where microscopy and/or clinical manifestations are indicative of 
invasive amoebiasis, and for analysis of asymptomatic carriers of amoebae. Thus, PCR- 
SHELA was standardised and evaluated as a new tool for differentiation between E. 
histolytica and E. dispar infections from diverse geographical origin. This tool was 
demonstrated to be useful for the differential diagnosis of intestinal and extraintestinal 
amoebic infection. 
PCR-SHELA incorporates the use of a PCR technique for increased sensitivity 
together with a probe which provides total specificity by detecting specific internal regions 
on the sequences amplified. The introduction of this format enables non-radioactive 
detection of hybridized amplicons in a user and environmentally-friendly test in which 
electrophoresis in agarose gels and staining with ethidium bromide are replaced by ELISA, 
which is widely used in reference laboratories for the diagnosis of other infectious diseases 
such as tuberculosis and hepatitis. 
The use of methodology involving the amplification of nucleic acids has been 
introduced for routine diagnosis of a number of clinical conditions and as such, costs of 
materials and equipment are slowly becoming affordable at laboratories in both developed 
and developing countries. Thus, several methods able to distinguish E. histolytica from E. 
dispar by PCR have been evolving in recent years in order to improve diagnosis in cultures, 
abscess-derived material and faeces. For instance, Tachibana et al., (1992) developed a 
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PCR method based on specific sequences for the 30 kDa peroxidoxin from E. histolytica 
and from E. dispar. DNA from cultures was amplified and PCR products of 100 bp for E. 
histolytica and of 101 bp for E. dispar were detected by agarose gel electrophoresis. Also, 
the amplification of ribosomal genes of E. histolytica and E. dispar became the gold 
standard for PCR amplification after the sequences for both organisms were described as 
divergent (Bhattacharya et al., 1988; Battacharya et al., 1989; Huber et al., 1989; Diamond 
and Clark, 1993). Furthermore, amplification of diverse regions of the small subunit of 
ribosomal RNA gene have been proposed for diagnostic purposes (Katzwinkel et al., 1994, 
Troll et al., 1997) and validation of antigen detection systems in ELISA format as 
compared to amplification of the SSU of rDNA have recently been published for cultures 
and faeces (Mirelman et al., 1997 and Haque et al., 1998). 
After the evaluation of DNA derived from reference axenic and polyxenic cultures 
of E. histolytica and E. dispar, the E. histolytica kit from TechLab, USA (which detects the 
adherence lectin of the parasite), was 100 times less sensitive than PCR, with a detection 
limit of 1,000 E. histolytica trophozoites/well (Mirelman et al., 1977). When specific 
nested PCR with restriction digestion of a 0.9 kb region of rSSU DNA (Katzwinkel et al., 
1994) was compared to culture of clinical specimens with isoenzyme analysis (Haque et al., 
1998), the sensitivity found was 96% (51 of 53 E. histolytica cultures), and when the 
corresponding fresh faecal samples were amplified using the same method, the sensitivity 
found was 87% (46 of 53 stools). The sensitivity of the E. histolytica Techlab kit after 
testing the same stool samples was similar, detecting 45 out of 53 samples as positive 
(85%). A further comparison of the Techlab kits with PCR-SHELA in stool samples from 
the reference laboratory at the University of Leiden reported that the Entamoeba kit from 
TechLab, which does not discriminate between E. histolytica and E. dispar, was positive 
in 100% of the E. histolytica infections and in 73% of the E. dispar infections detected by 
PCR-SHELA. However, the E. histolytica kit detected only 30% of the infections 
confirmed as E. histolytica by PCR-SHELA (Verweij et al., 1998). The possible 
explanation for the poor sensitivity found in this case could be the effect of storage of 
samples for long periods of time at -20°C upon the antigen concerned. Interestingly, a 
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second generation E. histolytica specific ELISA by TechLab using the same format as the 
original test, but with an improved capture antibody, reported an improved sensitivity of 
97% (compared with zymodeme analysis) when tested with 62 stool samples from 
Bangladesh (Eubanks et al., 1998). TechLab's antigen detection tests are user friendly and 
rapid to perform however, when compared to PCR detection, the latter is more sensitive, 
detecting infections missed by other methods. It is also capable of specifically 
demonstrating the presence of E. dispar DNA and it can detect mixed infections. 
The results of the first epidemiological study for differential diagnosis of E. 
histolytica/E. dispar in stool samples in endemic areas using PCR were published by 
Acura-Soto et al., (1993) working in a rural area in Mexico. Because the amplification of 
a target from faecal samples sometimes produced smears in agarose gels, this study 
incorporated filter-hybridisation of the PCR products with specific radioactive probes, in 
which positive reactions were revealed as dots. In this case, the specificity provided by the 
probes was added to the sensitivity of the PCR technique. However, the use of radioactive 
probes introduces an additional degree of complexity to the test, which linked to the 
difficulty for radioactive disposal made this methodology unsuitable in countries such as 
Colombia. The alternative was to use non-radioactive probes in solution hybridisation 
instead, with the added advantage that the reaction is more rapid (Wolcott, 1992). It was 
then possible to standardise the detection using immunoenzymatic assay (PCR-SHELA, 
Aguirre et al., 1995). 
The process of DNA extraction originally used in PCR-SHELA was time 
consuming and in consequence, it was successfully substituted by a commercially available 
kit for extraction of DNA. Batches of 10 samples can be extracted in a short time, limiting 
the risk of cross contamination during manipulation. An early modification to the method 
for DNA extraction was introduced by Britten et al., (1997) and it was applied in an 
epidemiological study of E. histolytica in Turkey (Jetter et al., 1997). Only E. dispar was 
detected by PCR-SHELA in 15 (20%) out of 79 faecal samples, including 5 samples that 
were negative by microscopy. Also, ten samples with positive microscopy did not amplify 
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by PCR. The samples were not cultured and it is not clear if differential diagnosis with E. 
hartmanni was carried out, and because no other PCR method was applied, it is difficult 
to evaluate if the false negatives according to microscopy are due to lack of sensitivity 
introduced by the modifications to the original methodology or are samples in which 
artifacts were mistaken for parasites. 
Although the application of PCR for routine diagnosis remains controversial, 
contamination problems are minimal when adequate controls, and training with adequate 
materials for sample handling are provided to the relevant staff. This has been 
demonstrated by the elimination of cross contamination problems at Leiden, London, 
Barcelona and Bogota during this study. As a result, it was possible to evaluate PCR- 
SHELA in clinical environments at the reference laboratory level in Leiden and at the 
LSHTM with samples from travellers. This evaluation evidenced that as a clinical test, 
with samples that had been selected by their result in microscopy, PCR-SHELA is over 
90% sensitive and specific. In contrast, in the pilot study for the evaluation of PCR- 
SHELA as an epidemiological tool which was carried out in an endemic area in Colombia, 
the test presented a high number of false negative samples which had been classified as 
positive according to microscopy. Although some of these results were probably due to 
incorrect diagnosis by microscopy, changes in the methodology in order to increase 
sensitivity were needed, for which an increment in the amount of sample lysate has now 
been introduced in the protocol for DNA extraction. Additionally, an increment in the 
amount of sample added to the PCR reactions was also suggested. These modifications are 
being tested in the field at the moment and their effect on the sensitivity of the test will be 
known in the near future. 
In future studies, because of the low prevalence of E. histolytica in populations of 
healthy carriers and because of the subjectivity of microscopy for discrimination of 
morphological characteristics in samples with cysts and trophozoites of amoebas, negative 
results with PCR-SHELA will be confirmed by a different PCR system to eliminate the 
possibility of misdiagnosis by microscopy. Additionally, a new PCR system for the specific 
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amplification of the rSSU of E. hartmanni will be standardised in order to test all samples. 
This will explain some cases of false negative results for E. histolytica/E. dispar and also 
establish the true prevalence of the organism. 
On the policy front, frequent updates on the morphological identification of parasitic 
infections by microscopy given to the relevant staff in diagnostic laboratories should be 
established as a measure for the improvement of the quality control in developing countries 
(Guhl et al., 1996). This is necessary because microscopy is the most widely available tool 
for screening during diagnosis of intestinal parasitic infections, and because of its utility 
it should not be discarded (Gonzalez-Ruiz and Bendall, 1995). 
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CHAPTER 6 
GENERAL DISCUSSION AND PERSPECTIVES 
Entamoeba histolytica and Entamoeba dispar although closely related and with 
identical morphology under light microscopy, have been separated in two different species 
(Clark and Diamond, 1991; Diamond and Clark, 1993). This separation has multiple 
implications, on one hand the study of the biology of E. dispar as an independent organism 
and its comparison to the homologous processes known in E. histolytica may provide a 
better understanding on the processes involved in the different levels of virulence 
associated to isolates of the latter organism. On the other hand, it is necessary to establish 
routine differential diagnostic methodologies for use in non-endemic and in endemic areas, 
where a differential test that permits the processing of a great number of samples in a short 
space of time will, in turn, contribute to the collection of new accurate data for 
epidemiological purposes. 
The identification of index cases (symptomatic individuals) and their close 
contacts, particularly in travellers returning from tropical areas is important for the 
prevention of outbreaks of invasive disease in developed countries. Differentiation is also 
necessary for diagnosis by exclusion of, for example, liver or bowel carcinomas, or when 
considering immunosuppressive treatment for Crohn's disease or irritable bowel syndrome. 
However, for differentiation it is critical to provide clinicians with reliable tests to not only 
identify patients harbouring E. histolytica infections but also for those carrying E. dispar, 
which will avoid unnecessary treatment. Accordingly, WHO/PAHO (1997) has 
recommended that treatment should be provided only in cases where E. histolytica infection 
is proven or strongly suspected after exclusion of other entities with similar 
symptomatology (WHO/PAHO, 1997). These recommendations were drawn after it was 
shown that the risk of developing invasive disease for E. dispar carriers is very low (Ruiz- 
Palacios et al., 1992; Garduno-Espinosa et al., 1997). This fact, linked to the undesirable 
side effects of the treatment, and to the possibility that resistance may develop due to drug 
pressure, are convincing arguments in favour of this policy. However, widespread 
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automedication with metronidazole is common in endemic areas such as Colombia and 
although metronidazole is effective against symptoms and tissue forms, luminal amoebae 
are less affected, generating transient healthy carriers of invasive strains, which are 
responsible for infection of new cases including small outbreaks of invasive disease 
mentioned above (Visser et al., 1998). 
The need for a test able to distinguish between Entamoeba histolytica and 
Entamoeba dispar infections in stool samples of symptomatic and asymptomatic 
individuals in Colombia originated the work described in this thesis. The starting point 
however, was the data on the prevalence of E. histolytica/dispar available then, which were 
based on the microscopy of stool samples, in which for example, very few studies had 
detected E. hartmanni. Wide variation in prevalence of intestinal E. histolytica/dispar 
infection was reported, and no reliable data were available for reference purposes. 
Nevertheless, the presence of high background antibody titres to E. histolytica in the 
population, and the occurrence of amoebic abscesses indicated that invasive strains were 
circulating in the population throughout the country. Thus, evaluating and later adapting 
systems to identify not only symptomatic individuals but also the carriers of E. histolytica, 
became one of the priorities for research in the field in Colombia. Culture of stool samples 
and serology (in volunteers) were added to the routine diagnosis by microscopy at the 
reference laboratory, and as standard methodology for field collection. 
Chapter three refers to the results after the analysis of a small section of the 
population at Ibague and La Mesa using microscopy and culture. The endemicity of 
intestinal parasites and amoebal infections in particular was confirmed. The prevalence of 
E. histolytica/E. dispar was found to be 26% at Ibague and 17.4% at La Mesa. After 
culture, only the presence of E. dispar strains was proven, despite previous evidence of 
invasive episodes in the population at Ibague. The low rate of survival (10%) of the cultures 
from the field work at Ibague was linked to the possibility that most of these cultures 
contained E. dispar or other amoeba species, although the loss of these cultures could have 
been also due to their suceptibility to changes in the environment, specially the temperature 
fluctuations during their transportation to the reference laboratory in Bogota. The efficiency 
206 
Chapter 6 General Discussion and Perspectives 
of the culture technique was improved at La Mesa (58%), although no invasive strains were 
isolated either, as confirmed by isoenzyme analysis and immunofluorescence with MAb 
20/7D. The possibility for the evaluation of the potential invasiveness of cultured isolates 
with MAb 20/7D was a considerable step forward for strain characterisation, thanks to its 
extremely high sensitivity and specificity when used in IFAT (Gonzalez-Ruiz et al., 1992). 
However, there were no amoebic dysentery cases among the individuals tested during the 
field work, although the serological data indicated that a small percentage of the population 
tested at Ibague had been or were currently infected with E. histolytica. Detection of E. 
histolytica directly in the faecal specimens was needed. 
The MAb 20/7D had been adapted into a capture ELISA format (FAC-ELISA) and 
it produced encouraging results when testing cases of amoebic dysentery and colitis 
(Gonzalez et al., 1994). However, as discussed in Chapter 4, the low titre of the MAb 
20/7D produced made it necessary to reclone the original hybridoma. A clone with high 
titre was obtained, although the antibody product of this clone, as did the original, also 
reacted with an homologous protein in E. dispar by western blot under non-reducing 
conditions. Similar reactions were observed in several studies using other MAbs (Petri et 
al., 1990; Walderich et al., 1998). Also, although E. histolytica and E. dispar are different 
enough to be classified as separate species (Clark, 1998), there are considerable antigenic 
similarities between them. This could explain the reaction of MAb 20/7D with proteins in 
lysates of both parasites. Further study of the interaction of the MAb 20/7D with lysates 
of E. histolytica and E. dispar revealed an affinity of approximately one order of magnitude 
greater toward E. histolytica. It was concluded that this small difference would limit the 
use of the FAC-ELISA in endemic areas due to the presence of variable concentrations of 
soluble antigen of either species in the faecal samples, which could lead to identification 
of heavy E. dispar infection as E. histolytica. 
Whereas it was decided to continue to use MAb 20/7D to characterise cultured 
isolates by IFAT and to keep the original format of the FAC-ELISA test for detection of 
amoebic dysentery and colitis, its adaptation as a routine tool for soluble antigen detection 
in asymptomatic individuals was abandoned. Chapter 5 refers to the alternative approach 
207 
Chapter 6 General Discussion and Perspectives 
followed: Differentiation at the nucleic acid level, where clearly distinct sequences of E. 
histolytica and E. dispar had been recognised. Successful PCR amplification of the 145bp 
and 133 bp specific repeats located between the ribosomal DNA sequences of E. histolytica 
and E. dispar respectively was achieved using DNA obtained from faecal samples, cultures 
and body fluids (Aguirre et al., 1997). Samples can be sent unpreserved by post (Verweij 
et al., submitted) or kept frozen for long periods of time to be transported to the reference 
laboratory. Alternatively, DNA can be extracted in the field on collection of the sample, 
since this process has been facilitated by the introduction of a commercially available kit, 
which also reduces the possibility of cross contamination between samples. After PCR, the 
ELISA format of PCR-SHELA allows the analysis of results according to clear-cut 
colorimetric differentiation, and with high sensitivity and specificity. 
The presence of "false positive or negative" results when evaluating PCR-SHELA 
against microscopy highlights the unreliability of the diagnosis based on the morphology 
of the organisms found. Cysts of other species of amoebas with similar features, cells and 
debris can be misidentified as E. histolytica/dispar even by experienced microscopists. 
Also, the lability of the morphological characteristics of trophozoites contributes to the 
high amount of false negative results by microscopy in samples examined at the reference 
laboratory level. However, false negative results on samples from the field could also be 
the consequence of sequence variation in the intergenic spacers of E. histolytica and E. 
dispar amplified for PCR-SHELA. This possibility has to be considered in view of the 
restriction length polymorphisms found in the Dral and Hinft repeats of the episomal DNA 
of E. histolytica (Bhattacharya and Bhattacharya, 1998). For these cases, amplification of 
a different target such as the DNA sequences for the small subunit of the ribosomes (SSU) 
might help to clarify results. The further analysis on the variability of these sequences will 
be useful for the interpretation of epidemiological data and genetic characterisation of E. 
histolytica and could be important in determining prognosis in cases of invasive disease 
(Tang et al., 1997, Whelen and Persing, 1996). For instance, the parallel application of 
two or more PCR techniques for intestinal E. histolytica infections could be used as 
confirmatory tests in areas where high prevalence of mixed infections has been reported 
such as Mexico and Bangladesh (Acura-Soto et al., 1993; Newton et al., 1997; Haque et 
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al., 1998). These observations contrast with the results obtained using PCR for 
amplification of SSU rDNA and PCR-SHELA in samples from an endemic area in 
Colombia and in samples from travellers returning to Barcelona and Leiden. 
The prevalence of E. histolytica infections detected by PCR-SHELA in the samples 
collected at Quibdo in Choco (Colombia) was 1.2% or 5 positives from 40 E. 
histolytica/dispar microscopy positives in 427 samples. According to the latest estimates 
from the World Bank, the population of the country for mid-1997 was 38.1 million, 24% 
of them (approx. 9.1 million people) did not have access to safe water. Assuming a base- 
line prevalence of 1.2%, approximately 457,200 people in the country could be at risk of 
developing invasive disease. Surveys aiming for the specific identification and treatment 
of these individuals will probably have a major impact on the control of the transmission 
of E. histolytica in Colombia. 
The objective of this thesis was the evaluation and adaptation of tools for the 
identification and differentiation of E. histolytica and E. dispar in faecal samples from 
symptomatic and asymptomatic individuals. PCR-SHELA has been validated as such a 
tool and differentiation is used as an addition to microscopy at Leiden, Barcelona and 
Bogota at the reference laboratory level. The problem of costs and complexity of PCR and 
ELISA as limiting factors for their application in developing countries is being slowly 
overcome. The local production of reagents has improved the availability of primers and 
Taq polymerase in Colombia, and adequate laboratory facilities for procedures involving 
molecular techniques are being established in endemic regions, as it 
is the case at the 
Universidad del Tolima in Ibague. Hence, the application of PCR-SHELA for diagnostic 
and epidemiologic purposes at Ibague and surrounding areas will 
be carried out locally, 
providing an accessible reference laboratory for confirmation 
in cases of suspected amoebic 
infection or when cysts and/or trophozoites are detected by microscopy. 
Clarification of the distribution of E. histolytica and E. dispar infections in the 
world is on its way, meanwhile, many questions remain to 
be answered in amoebiasis: 
Which are the transmission dynamics of E. histolytica and E. dispar?, Are mixed infections 
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a common feature in some endemic areas only?, Does E. dispar carnage protect against E. 
histolytica infection?, Does the degree of virulence or type of pathogenesis vary between 
strains of E. histolytica? What is the relationship between parasite density and disease?, 
Does prior exposure to E. histolytica infection favour the "asymptomatic cyst passer" state? 
Is there acquired immunity to infection or to type of pathology?, Does drug pressure by 
generalised use of commonly available remedies in endemic areas favour resistance to 
treatment in E. histolytica?. 
It is possible that the creation of DNA banks from well characterised sources and 
from wide geographic origins and the setting up of multicentre studies using standardised 
methodologies will help to find answers to some of the above questions. The continuation 
of the collaborative work described in this thesis involves the further characterisation of E. 
histolytica and E. dispar DNAs. Riboprinting (Clark and Diamond, 1992) of isolates from 
Colombia, The Netherlands, Spain and England will be pursued, in addition to the detection 
of strain polymorphisms by amplification of the serine-rich antigen gene (SREHP) (Stanley 
et al., 1990) and of the strain specific gene (SSG) (Burch et al., 1991) in order to 
incorporate species-specific and strain-specific molecular markers into the study (Figure 
6.1, page 211). Also, a database on travellers returning from the tropics to the centres 
participating in the study has been initiated, aiming to collect data with epidemiologic 
purposes. 
The analyses of results gathered using traditional and novel diagnostic tools are 
expected to help provide guidelines for the effective treatment and control of invasive 
amoebiasis in places where the lack of proper sanitation and limited access to clean water 
make control much more difficult than in developed areas. 
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APPENDIX 1 
REAGENTS, CULTURES AND BUFFERS 
A. SOLUTIONS FOR COPROLOGY 
Iodine Stock Solution 
Iodine 4g 
Potassium iodide 8g 
Distilled water 200m1 
The iodine was added to the potassium iodide solution. Stored at room temperature in a 
brown bottle. 
Iodine working solution 
25% v/v Acetic acid 10m1 
Lugol's Iodine lOml 
Isotonic Saline (0.85% w/v) 
NaCl 0.85g 
Distilled Water 100ml 
Store at room temperature. 
Zinc Sulphate Solution (33% w/v) 
Zinc Sulphate 165g 
Distilled water 500m1 
Dissolved in a hot water bath, mixing until completely dissolved. Density was measured 
with a hydrometer until correct density of 1.180 was reached. Stored at room temperature. 
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Stock Schaudinn's Fixative 
Mercuric chloride 
Ethanol (95% w/v) 
Distilled water 
35g 
250m1 
500m1 
Mercuric chloride was dissolved in water using a hot water bath, then the solution was 
cooled and decanted and measured. Ethanol was added in a proportion of 1 part to two 
parts or mercuric chloride solution. 
Working Solution 
Stock Schaudinn's solution 95m1 
Glacial acetic acid 5m1 
Trichrome Stain 
Chromotrope 2R 0.6g 
Light Green SF 0.15g 
Fast Green 0.15g 
Phosphotungstic acid 0.7g 
Glacial acetic acid I ml 
Distilled water 100ml 
The staining components were mixed with the acetic acid before adding the water. Stored 
at room temperature. 
B. ISOLATION OF ENTAMOEBA SPP IN POLYXENIC CULTURE MEDIA 
ROBINSON'S CULTURE MEDIUM (Robinson, 1968) 
Saline Agar Slopes 
Agar base 1.5g 
NaCl 0"7g 
dH2O l 00m1 
the agar and the NaCl were dissolved in the water and dispensed in 2.5 ml aliquots in 
bijoux bottles. Autoclaved at 121 °C and 15 lb of pressure for 15 minutes. Sloped and 
stored at room temperature. 
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Erythromycin Solution 
2g of Erythromycin base (Sigma E-5389) were suspended in 10 ml of ETOH (20% w/v) in 
a sterile bottle, after 2 hours the stock was diluted 40X to 0.5% with sterile distilled water 
(adding ETOH to water dropwise). Stored at 4'C. 
Bactopeptone 20% Stock Solution 
20g Bactopeptone dissolved in 100 ml of water. Distributed in aliquots and autoclaved. 
Stored at 4'C. 
Phthalate 0.5M Stock Solution 
204g Potassium phthalate (Phthalic acid Sigma P-6758) were dissolved in 100 ml of 40% 
NaOH. Made up to 2 litres and pH was adjusted to 6.3. Dispensed in universal bottles (20 
ml aliquots) and autoclaved. Stored at room temperature. A 1/10 dilution with sterile 
distilled water was used as working dilution. 
R Stock Medium 
NaCl 
Citric Acid 
KH2PO4 
Ammonium sulphate 
Magnesium sulphate. 7H20 
Lactic acid(90%) 
Made up to 2.51 with distilled water. 
125 g 
50 g 
12.5g 
25 g 
1.25 g 
100 ml 
For the working solution, 100 ml of stock were diluted with 7.5 ml of 40% NaOH and 
2.5ml of a 0.04% bromothymol blue solution and made up to 1 litre with distilled water. 
Adjusted to pH 7.5, and autoclaved. 
BR Culture Medium 
Escherichia coli strain B was grown in 0.5% bactopeptone and added to 11 of R, incubated 
at 37°C for 48 hours or overnight. Stored at room temperature up to 
2 months. BR was 
used to set primary cultures up. 
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BRS Medium 
Equal volumes of bovine serum Sigma B-2771 (heat inactivated at 56'C for 30 minutes) 
were added to the bottles of BR and incubated at 37'C for 4 hours. Stored at 4'C. 
BRS-Phthalate Medium 
Equal volumes of phthalate working solution and BRS were mixed and kept at 4'C ready 
to use in secondary cultures and further subcultures. 
B. METHODS 
Primary Culture 
A bijoux bottle containing the agar slope and BR to about 2/3 of the bottle was inoculated 
with a small piece of faeces, 4 drops of erythromycin solution and approximately 10 mg of 
rice starch (BDH Chemicals Ltd. No. 30263). Incubated at 37°C for 24 hours. 
Secondary Culture 
After 24 hours, the supernatant of the culture was discarded (without disturbing the starch- 
faecal layer) and replaced by BRS-phthalate to 2/3 of the bottle, two drops of 20% 
bactopeptone, two drops of 0.5% erythromycin and more starch. Incubated for further 24 
hours at 37°C. 
Reading of Cultures 
A wet preparation of the starch-faecal layer and Lugol's Iodine was examined for the 
presence of trophozoites after 48 hours of inoculation of the sample. Further readings were 
made every 48 hours during one week for negative cultures before discarding them. 
Subcultures 
Subcultures from positive Robinson's were made every 48 hours to a fresh bijou slope using 
secondary culture medium. Amplification of cultures for further assays such as DNA 
extraction and isoenzyme lysates were carried out in 25 cm3 plastic flasks in liquid 
secondary Robinson's medium. 
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Liquid Robinson's Medium 
BRS 
K-phthalate 0.5M Stock 
Erythromycine 0.5% 
Bactopeptone 20% 
100 ml 
3 ml 
7.5ml 
7.5 ml 
The volume was made up to 400 ml with steril destilled water. Distributed in 25cm3 falcon 
flasks or 12 ml flat-bottomed tubes and starch layers from positive bijoux bottles were 
added. Incubated at 37'C for 48 hours and examined under the inverted microscope. 
C. CULTURE MEDIUM FOR AXENIC CULTURE OF REFERENCE STRAINS 
TYI-S-33 Axenic Culture Medium 
TYI Broth 
The following ingredients were dissolved in 500 ml of distiled water and brought to 870 
ml: 
Trypticase (BBL) 
Yeast Extract(BBL/Difco) 
Glucose 
NaCl 
K2HPO4 
KH2PO4 
L-Cysteine HC1(Sigma C-1276) 
L-Ascorbic acid 
Ferric Ammonium Citrate(Sigma F-5879) 
20g 
log 
log 
2g 
lg 
0.6g 
lg 
0.2g 
2.28mg 
pH was adjusted to 6.8 with IN NaOH, clarified by filtering by Whatman No. I filter paper 
and autoclaved for 15 min. at 121'C and 15 lb. Cool at room temperature and store up to 
3 months in the freezer. 
Vitamin Mixture Stocks 
Solution A: Vitamin mixture NCTC 107 
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1. Water soluble B vitamins 
A: 
Niacin Sigma (N-4126) 62.5mg 
PABA Sigma (A-3659) 125mg 
Dissolved in boiling water and brought to a final volume of 150 ml. 
B: 
Niacinamide Sigma (N-0636) 62.5mg 
Pyridoxine HCl Sigma (P-6280) 62.5mg 
Pyridoxal HCl Sigma (P-6155) 62.5mg 
Thiamine HCL Sigma (T-1270) 25 mg 
Ca Pantothenate Sigma (P-5155) 25mg 
i-Inositol Sigma (1-7508) 125mg 
Choline Chloride Sigma (C-7527) 1.25g 
Dissolve in distilled water and brought to a final volume of 150 ml. 
C: 
Riboflavin Sigma (R-9504) 25mg 
Added to 75 ml of distilled water and dissolved with drops of 0.1N NaOH (until solution 
became transparent). Brought to a final volume of 100 ml. 
Combined A, B and C were brought to a final volume of 500 ml with distilled water. 
2. d-Biotin Sigma B-4501 30mg 
Dissolved in 200 ml distilled water with the aid of 0.1N NaOH 
3. Folic Acid Sigma F-7876 
Dissolved in 300 ml of distilled water. 
4. ADK Lipid Soluble Vitamins 
a. Calciferol Sigma E-5750 
Vitamin A alcohol (Retinol)Sigma R-7632 
30mg 
300mg 
300mg 
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Dissolved in 63 ml of 95% ETOH 
b. Menadione sodium bisulfite Sigma M-5750 60mg 
Dissolved in 300 ml of 5% aqueous Tween 80 
Combined a and b and brought to 3000ml with distilled water 
5. a-tocopherol acetate Sigma T-3001 25mg 
Dissolved in 250 ml distilled water. 
Vitamin Mixture 107 was made up as follows: 
B-vitamins 500m1. 
Biotin 250m1 
Folic acid 250m1 
ADK vitamins 2500m1 
Vitamin E 250m1 
Filter sterilised as a single volume of 3750 ml. Stored in the freezer wrapped in foil. 
Solution B 
Vitamin B12 Sigma(V-2876) 40mg 
Dissolved in 100 ml of distilled water 
Solution C 
DL-6,8 Thioctic acid Sigma (T-1395) 100mg 
Dissolved in absolute ETOH and brought to a final volume of 100 ml 
Solution D 
Tween 80 Sigma (P-1754) 50g 
Dissolved in ETOH and brought to a final volume of 100 ml with distilled water. 
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Working solution: 
500 ml of A 
6 mlofB 
2 mlofC 
2 ml of D 
were combined and after additon of 90 ml of distilled water, filter sterilised through 0.2 µm filters. Dispensed in 15 ml aliquots and stored at -20'C in the dark. 
Bovine Serum 
Inactivated at 56°C for 30 min. before use. Kept at -20°C. 
Antibiotic Mixture: 
Streptomycin Sigma (S-9137) 
Ampicillin Sigma (A-0166) 
Complete Medium 
500 ml of complete medium were prepared by addition of: 
Vitamin-Tween 80 mixture 
Bovine Serum 
TYI Broth 
Antibiotic mixture 
200mg/ml 
100mg/ml 
15m1 
50m1 
435m1 
1. Oml 
Stored in the fridge in the dark for up to ten days. 12 ml flat-sided plastic test tubes (Nunc 
Cat. No. 1-56758) and standard 25cm3 flat bottomed Falcon flasks were used for culture of 
trophozoites. 
Subcultures 
Once monolayers of trophozoites were observed under the inverted microscope, subculture 
was carried out by first releasing the growing amoebas from the donor tube by chilling on 
ice for about 20 minutes. Then, centrifugation at 700g for 10 minutes, keeping only 1 ml 
of the supernatant and the corresponding pellet. Fresh cultures in plastic tubes were 
inoculated with 0.1 to 0.2 ml of the suspension which contained at least 5000 organisms 
per ml. About 40 ml of fresh complete medium were used in flasks. Medium was added 
to the vessels to fill them completely. 
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MRC Ringer for Cryopreservation 
NaCl 9g 
KC1 0.2 g 
CaCl2 0.2 g 
H20 1000 ml 
D. BUFFERS FOR ISOENZYME ANALYSIS 
200 mM Stock Stabilising Buffer: Parasite extracts for isoenzymes 
Dithiothreitol (DTT) Sigma D-5545 74mg 
E-amino-n-caproic acid Sigma A-7824 26mg 
Na2-EDTA pH 7.0 31 mg 
Distilled water l ml 
The water was first added to the EDTA and then the other inhibitors. Stored at 4'C for up 
to two weeks. 
Working Solution 
The stock solution was diluted to 2 mM in distilled water immediatly before use. 
An equal volume was added to the volume of the pellet to be lysed. 
Tank buffer Tris Maleate 0.1M for PGM and HK 
Tris HC1 12.14g 
Maleic acid 11.61g 
MgC12.6H20 2.03g 
EDTA 3.73g 
NaOH 4.872g 
Brought to 11 with distilled water. pH was adjusted to 7.4. A 3: 20 dilution (0.015M) of the 
tank buffer was used for the corresponding gel buffers. 
Tank buffer Phosphate 0.2M for ME and GPI 
NaH2PO4.2H20 12.15g 
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Na2HPO4 anhydrus 17.4g 
Diluted to 11 with distilled water. pH adjusted to 7.0 and a 3: 40 dilution (0.015M) was 
used for the corresponding gels 
Isoenzyme Developer Solutions 
PGM 
NADP 10mg/ml (use 0.5m1) 
MTT 30mg/ml ETOH (use 1ml) 
PMS I Omg/ 1 Oml (use 1 ml) MgC12 0.1 M (use 2ml) 
G6PD 1 iu/gl (use 5µl) 
GIP 30.4mg/ml(use I ml) 
Agar 15mg/ml (use 10m1) 
Tris HC1 pH 8.0 0.3M (use 10ml) 
Prepared immediately before use in a foil covered container. 
IlK 
NADP 10mg/ml (use 2m1) 
Glucose 1 g/ l Oml (use 1 ml) 
MTT 30mg/ml ETOH (use 1 ml) 
PMS I Omg/ 1 Oml (use 1 ml) 
ATP 360mg/ml (use 1 ml) 
MgCl2 0.1M (use 2m1) 
G6PD 1 iu/µl (use 5µl) 
Agar 15mg/ml (use 10ml) 
Tris HC1 pH 7.4 0.3M (use 10ml) 
Prepared immediately before use in a foil covered container. 
ME 
NADP 10mg/ml (use 0.5m1) 
MTT 30mg/ml ETOH (use 1 ml) 
PMS l Omg/ I Oml (use 1 ml) 
Na Malate 22.3mg/ml (use 1 ml) 
MgC12 0.1M (use 2ml) 
Agar 15mg/ml (use 10ml) 
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Tris HC1 pH 7.4 0.3M (use IOml) 
Prepared immediately before use in a foil covered container. 
GPI 
NADP 10mg/ml (use 0.5m1) 
MTT 30mg/ml ETOH (use 1 ml) 
PMS I Omg/ I Oml (use 1 ml) 
MgC12 0.1 M (use 2m1) 
F6P 6mgml (use 0.5m1) 
G6PD 1 iu/µl (use 5µl) 
Agar 15mg/ml (use 10m1) 
Tris HC1 pH 8.0 0.3M (use 10m1) 
Prepared immediately before use in a foil covered container. 
E. BUFFERS AND SOLUTIONS FOR SDS-PAGE 
Stock Acrylamide (30%) Sigma A-4058 
Acrylamide (28.6%) 71.5g 
N, N'-Methylene-bis-acrylamide(1.4%) Sigma M-725 63.5g 
Distilled water to 250m1 
lOX Resolving Buffer pH 8.8 
1M HCL 48ml 
Tris Base 36.3g 
Distilled water to 100ml 
8X stacking Buffer pH 6.8 
IM Orthophosphoric Acid 26.6m1 
Tris Base 5"7g 
Distilled water to 100ml 
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Ammonium Persulphate (APS) Solution 
APS O. lg 
Distilled water to l ml 
Electrode Buffer pH 8.7-8.9 
Tris Base 8g 
Glycine 28.8g 
Sodium Dodecyl Sulphate Ig 
Distilled water to 1000ml 
5X Sample Buffer (without 2-Mercaptoethanol) 
Sodium Dodecyl Sulphate lg 
8X Stacking Buffer 6.25m1 
Distilled water to l Oml 
8% Resolving Gel 
30% Acrylamide Stock 3.2 ml 
l OX Resolving Gel Buffer 1.25 ml 
Distilled Water 7.15 
Amonium Persulfate Solution (APS, 10% w/v) 50 µl 
TEMED (N, N, N', N'-tetramethylethylenediamine) 5 µl 
Stacking Gel 
30% Acrylamide Stock 0.675 ml 
5X stacking Gel Buffer 0.75 ml 
Distilled water 4.58 
APS 15 µ1 
TEMED 15 gl 
Bromophenol Blue 
Bromophenol Blue 0.05g 
50% v/v Glycerol in water 20m1 
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Molecular Weight Markers (kDa) 
Myosin (Sigma C-3889) 200 
Phosphorylase B (Sigma P-4649) 97.4 
Bovine Albumin (Sigma A-7517) 66 
Albumin (A-7642) 45 
Carbonic Anhydrase (C-2273) 29 
Gel Fixative 
Methanol 200 ml 
Acetic Acid 70m1 
Distilled water 200m1 
Gel Staining Solution 
Coomassie Brilliant Blue R250 0.625g 
Gel Fixative 250ml 
Gel Destaining Solution 
Methanol 40m1 
Acetic Acid 60m1 
Distilled water 700m1 
F. BUFFERS AND SOLUTIONS FOR WESTERN BLOTTING 
10X Blotting Buffer pH 9.2 
Tris Base 0.48M 
Glycine 0.39M 
Distilled water to 1000ml 
1X Blotting Buffer (Working Solution) 
I OX Blotting buffer 20m1 
Methanol 40m1 
Distilled water 160ml 
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Blocking Solution 
Marvel fat-free milk (Cadburys, UK) 3g 
Sodium Azide 0.02g 
PBS to 100ml 
Antibody Diluent 
0.05% Tween 20/Blocking Solution 
Substrate Solution 
3,3' diaminobenzidine HCL (DAB)* 10mg 
4-Chloro-1-Naphthol (CN) 30mg 
30% Hydrogen Peroxide 10µ1 
PBS 40 ml 
*Dissolve the mixture DAB/CN in 5m1 methanol prior to PBS 
G. BUFFERS AND SOLUTIONS FOR ELISA 
10X Coating Buffer 
Sodium Carbonate (0.15M) 7.95g 
Sodium Bicarbonate(O. 35M) 14.65g 
Distilled water to 500m1 
20X Phosphate Buffered Saline (PBS) 
NaCI(2.74M) 800g 
KH2PO4(0.03M) 20g 
Na2HPO4(0.016M) 115g 
KC1(0.054M) 20g 
Distilled water to 5000m1 
pH was adjusted to 7.2. 
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Washing Solution (PBS/T) 
1X PBS pH 7.2-7.4 containing 0.05% Tween 20 
Blocking Solution 
1X PBS pH 7.2-7.4 containing 0.5% casein for serology 
1X PBS pH 7.2-7.4 containing 1% gelatin for monoclonal antibody ELISAS 
Antibody Diluting Solution 
PBS/T containing 0.25% w/v gelatin (PBS/T/G) for ELISA 
PBS/T/G/50%Foetal Calf Serum (PBS/T/G/FCS) for FAC-ELISA 
Stock Substrate Buffer 
Citric Acid 0.1M 
Na2HPO4 0.2M 
OPD Substrate Solution 
Stock Citric Acid Solution 25m1 
Stock Na2HPO4 Solution 25ml 
Distilled water 50m1 
o-Phenylene Diamine (OPD P-1526 Sigma, Uk) 40mg 
30% Hydrogen Peroxide (H-1009 Sigma, Uk) 40µl 
Stopping Solution 
HCL2.5M 50µ1/well 
H2SO4 2.5 M 50 µl/well 
H. MEDIA AND SOLUTIONS FOR MONOCLONAL ANTIBODIES 
RPMI (Rosewell Park Memorial Institute) medium (Gibco) was made to 1X containing 2g/1 
of sodium bicarbonate, adjusted to pH 7.3 and filter sterilized through a 
0.2µm membrane 
(Millipore, UK). 500 ml bottles were stored at 4°C. 
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100X PGAB Solution 
Pyruvic Acid (Sigma P-5280) 2.2g 
L-Glutamine (Sigma G-6392) 5.84g 
Penicillin G (Sigma P-3032) 4x106 iu 
Streptomycin Sulphate (Sigma S-9137) 4g 
Distilled water to 200 ml 
Filtered through a 0.2 µm membrane and dispensed in 5 ml aliquots stored at -20 0 C. 
Cell Growth Medium 
RPMI Medium l00ml 
PGAB lml 
Foetal Calf Serum (FCS) Sigma F-4135 20m1 
I. BUFFERS FOR IMMUNOAFFINITY PURIFICATION 
THE Buffer (Loading Buffer) 
Tris/HC1 pH 7.4 
NaCl 
EDTA 
20mM 
0.3M 
0.15M 
This buffer was used to dilute and load antibodies and proteins through affinity columns 
overnight. 
Coupling buffer 
NaHCO3 0.1 M 
NaCl 0.5M 
pH 8.5-9.0 
Blocking Buffer 
Na2HPO4 0.1m 
Glycine 0.2M 
pH 8.0 
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Washing Buffer (pH oscillation) 
Acetate Buffer 
0.5M NaCl 
pH 4.0 
Alternating with coupling buffer 
Elution Buffer 
Glycine/HC1 
pH 2.5 
Diethylamine (DEA) Buffer 
Diethylamine 
THE Buffer 
0.1M 
0.5M 
0.1m 
0.02M 
50 m1 
104 µl of a 9.58 M stock are added to 50 ml of TNE. Adjusted to pH 11.0 for elution of E. 
histolytica and E. dispar 20/7D proteins from columns. 
Protease Inhibitors 
Chymostatin (C-7268 Sigma, UK) 
Antipain (A-6191 Sigma, UK) 
Pepstatin A (P-4265 Sigma, UK) 
PMSF (P-7626 Sigma, UK) 
Bestatin (B-8385 Sigma, UK) 
TLCK (T-7254 Sigma, UK) 
EDTA 
E64 (E-8640 Sigma, UK) 
Added to 50 ml of THE Buffer. 
Stock: Use: 
5mg/ml DMSO lOµ1 
5mg/ml Water l0µ1 
5mg/ml Methanol lOµ1 
100 mM Ethanol 0.5 ml 
1mg/ml Methanol 10µl 
12.5mg/ml Water 4Oµ1 
10µg/ml Water l0µ1 
1 mM Water 20[d 
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J. BUFFERS AND SOLUTIONS FOR DNA 
Lysis Buffer for DNA Extraction (for phenol Chloroform method) 
Stocks (100 ml of each): 
NaC1 im 
EDTA 0.5M 
SDS log 
Tris/HC1 pH 8.0 im 
Working Solution (500 ml): 
Stock 
NaCl 50 mM 25 m1 
EDTA 50 mM 50 ml 
SDS 1% 50 ml 
Tris pH 8.0 50 mM 25 ml 
Distilled water 350 ml 
Samples were diluted 1: 1 v/v with lysis buffer. 
Proteinase K Buffer: 
0.01 M Tris pH 7.8 
0.005M EDTA 
0.5% SDS 
10 mg of Proteinase K are added per ml of buffer. 
Sodium Acetate Solution 
3M Sodium Acetate pH 5.2 
DNA Sample Buffer For Agarose Gel Electrophoresis 
6X stock: 
0.25% (v/v) bromophenol blue 
0.25% (v/v) xylene cyanol FF 
30% (v/v) glycerol 
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TAE Buffer: 
0.04 M Tris-acetate 
0.001 EDTA 
TBE Buffer (10X) Electrophoresis of DNA 
90mM Tris base 
90mM Boric acid 
2 mM EDTA 
pH 8.0 
TE Buffer to dissolve DNA 
10mM Tris HC1 pH 7.2 
1 mM EDTA 
Low TE Buffer for preparation of G-50 sephadex columns 
100 ml TE buffer pH 7.4 
900 ml Distilled water 
Denhardt's Solution for Blot prehybridization and hybridization 
100X stock: 
10 g Ficoll type 400 
10 g Polyvinylpyrrolidone 
10 g Bovine Serum Albumin (BSA) Fraction V 
Distilled water to 500 ml 
Filtered through a Nalgene filter, stored at -20'C 
20X SSC Buffer 
3M NaCl 
0.3M Sodium citrate 
pH 7.0 
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Prehybridisation Solution for Nylon membranes 
50% (V/V) formamide 
5X Denhardt's solution 
5X SSC 
0.5 mg/ml salmon sperm DNA (Sheared and denatured) 
Hybridisation Buffer for nucleic acids to membranes 
50% (v/v) formamide 
5X SSC 
1X Denhardt's Solution 
0.1 % (w/v) SDS 
l00µ g/ml Salmon Sperm DNA (Denatured and sheared) 
Denaturing Buffer (South 1) for DNA transfer to membranes 
1.5M NaCl 
0.5M NaOH 
pH 14.0 
Neutralising Buffer (South 2) DNA transfer to membranes 
IM Tris HCl pH 7.2 
1.5M NaCI 
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APPENDIX 2 
Aguirre et al., 1995. Polymerase Chain Reaction-Solution Hybridization Enzyme-Linked 
Immunoassay (PCR-SHELA) for the Differential Diagnosis of Pathogenic and Non-pathogenic 
Entamoeba histolytica. 
APPENDIX 3 
Aguirre et al., 1997. Diagnosis of Entamoeba histolytica and Entamoeba dispar in Clinical 
Specimens by PCR-SHELA. 
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Short Report 
Polymerase chain reaction-solution 
hybridization enzyme-linked 
immunoassay (PCR-SHELA) for the 
differential diagnosis of pathogenic 
and non-pathogenic Entamoeba 
histolytica 
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Keywords: Entamoeba histolytica, polymerase chain reaction, 
enzyme-linked immunosorbent assay, differential diagnosis 
This preliminary report describes the adaptation and 
simplification of recently described polymerase chain re- 
action (PCR) procedures (ROMERO et al., 1992; ACUtJA- 
SOTO et at., 1993) to enable the differential diagnosis of 
pathogenic and non-pathogenic Entamoeba histolytica. 
We have used the system described by WILSON et at. 
(1993) and QIAO et at. (in press), in which products are 
detected using a colorimetric method based on an 
enzyme-linked immunosorbent assay (ELISA). This en- 
ables the PCR results to be read either by spectrophoto- 
metry or, more importantly, directly by eye, and obvi- 
ates the need for electrophoresis, ultra-violet light or 
photographic equipment. 
Two reference strains of E. histolytica, HMI-IMSS (a 
pathogenic zymodeme) and SAW 1734 (a non-pa- 
thogenic zymodeme), 3 non-pathogenic isolates in Ro- 
binson's medium, and pus aspirated from a hepatic 
amoebic abscess were examined. Seven additional faecal 
samples (from the Hospital Pedro Leon Alvarez, La 
Mesa, Cundinamarca, Colombia), in which intestinal 
parasites had been detected by microscopy, were also 
examined. 
Approximately 1g of each faecal sample was sus- 
pended in phosphate-buffered saline, sieved (425 lam 
mesh) to eliminate large particles, and frozen/thawed 3 
times with dry ice-ethanol/water at room temperature. 
The mixture was then centrifuged (1 min, 2500 g) and 
the supernatants were diluted 1: 1 in lysis buffer (50 mm 
NaCl, 50 mm ethylenediaminetetraacetic acid, 1% so- 
dium dodecyl sulphate and 50 mm Tris-HC1, pH 8.0) 
containing 100 tg/mL of proteinase K. Overnight incu- 
bation at 37°C was followed by extraction using the 
standard phenol-chloroform method and ethanol pre- 
cipitation. 
Specific primer pairs (P1/P2 [5'... DIG-TCA AAA 
TGG TCG TCG TCT AGG C... 3'/5'... CAG TTA GAA 
ATT ATT GTA CTT TGT A... 3] and NP1/NP2 
[5'... DIG-GGA TCC TCC AAA AAA TAA AGT 
TT... 3' */5' ... 
ACA GAA CGA TAT TGG ATA CCT 
AGT A... 3']) were used to amplify a 125 base pair (bp) 
and a 133 bp repetitive region from extrachromosomal 
circular deoxyribonucleic acid (DNA) in pathogenic and 
non-pathogenic strains respectively. One primer of each 
pair was labelled with digoxigenin. 
Each 100 1uL of reaction mix contained 4mýM1 MgC12, 
Promega-ý (M-1861) Taq buffer (500 mm KC1,100 mm 
Tris-HC1,1% Triton X-100®'), 0.2 mm of each deoxynu- 
cleoside triphosphate, and 5 units of Promega R Taq 
polymerase. 0.5-1 ng of DNA was added to 40 uL of 
*Modified from ACL'NA-SOTO et al. (1993) to show the correct 
orientation of the sequence. 
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PCR reaction mix containing 25 pmol of each primer and 
1 pellet of wax. Between 0.5 and 10 ng of reference pa- 
thogenic and non-pathogenic strain DNA were used in 
control PCR reactions. Escherichia coli DNA, DNA ex- 
tracted from parasite-free faeces, and water as a sample 
replacement, were used as negative controls. Each DNA 
sample was tested with pathogenic (P) and non- 
pathogenic (NP) primer pairs. Amplification conditions 
were 1 min at 94°C, 30 s at 94°C (x 1), 1 min at 55°C, and 
2 min at 72°C (35 cycles). 
Specific internal sequences in the PCR products were 
detected by a solution hybridization procedure after PCR 
(the annealing temperature of the probes was the same as 
that used for the amplification primers). Five pmol of 5'- 
biotin-conjugated probes specific for pathogenic 
(5' ... GAG GTT CTT AGG AAA TCG AAA A... 3') and 
non-pathogenic (5' ... GGT GAG GTT GTA GCA GAG ATA TT... 3') E. histolytica (see ROMERO et al., 1992) 
were added to 20 uL of PCR product before denatura- 
tion (99°C, 10 min), annealing (55°C, 90 min), dilution 
with 200 µL of Tris-buffered saline (TBS) containing 
0 05% Tween 20® (TBS T); TBS is 0.02 M Tris and 0.15 
M NaCl, pH 7.2. 
Microwell strips (Greiner, Germany) coated for 1h at 
37°C with avidin (Sigma: 0.1 Fig/mL in 50 mm carbonate 
buffer, pH 9.6) were washed 3 times with TBS-T, 
blocked with 0.02 ng/mL of salmon sperm DNA for 60 
min, and rewashed 3 times with TBS-T. 100 uL of each 
diluted PCR product were added to duplicate wells and 
incubated (room temperature, 60 min). After washing 3 
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Figure. PCR-sm a., v results. A. Faeces (F), Robinson's cultures (C) and 
controls: NF, negative faeces; NPPC, negative pathogenic primer con- 
trol; NNPPC, negative non-pathogenic primer control. Fl, E. histolvtica 
haematophagous trophozoites; F2, Entamoeba sp. trophozoites; F3, Enta- 
inoeba sp. trophozoites and Blastocvstis hominis; F4, E. coli cysts; F5, E. 
histolvnca haematophagous trophozoites; F6, E. histohvtica cysts; F7, 
hookworm eggs; Cl, E. histohvtica cysts; C2, E. histolvtica cysts, E. coli 
cysts, lodamoeba buetschlü cysts and Endolimax nana cysts; C3, E. histoly- 
tica cysts, E. A! cysts and 1. huetschlü cysts. B. Reference strains, 
amoebic abscess and controls. HMI-INISS, reference pathogenic strain; 
SAW 1734, reference non-pathogenic strain; PAA. 'pus' from amoebic 
abscess; NPPC, negative pathogenic primers control; NNPPC, negative 
non-pathogenic primers control.  , Pathogenic primers; 1. non- 
pathogenic primers. 
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times with TBS-T, 100 uL of 1 5000 anti-digoxigenin al- 
kaline phosphatase-labelled antibody (Fab fragment: 
Boehringer Mannheim, Germany) were added to each 
well (room temperature, 60 min) followed by 4 washes (3 
with TBS-T, one with TBS). The ELISA was developed 
by adding 100 µL of p-nitrophenvl phosphate (1 mg/mL in 
50 mm carbonate buffer, pH 9.6, containing 1 mm 
MgC12). After 1h absorbance was read at 405 nm. No 
significant change in absorbance took place during the 
plate reading period of 1 min. The assay results are 
shown in the Figure. 
Whilst the PCR has been used successfully to differen- 
tiate between pathogenic and non-pathogenic E. histoly- 
tica by RoMERO et al. (1992) and ACUNA-SOTO et al. 
(1993), the simplification of the procedure described here 
is a significant step forward in the differential diagnosis 
of this parasite in central diagnostic laboratories. The 
assay can be used on DNA extracted directly from stool 
samples or on DNA obtained from trophozoites in short- 
term cultures in Robinson's medium. The extraction 
method allows DNA to be obtained from both cysts and 
trophzoites. Concentration techniques previously de- 
scribed (FAUST et al., 1938; ALLEN et al., 1970) and used 
by ACUNA-SOTO et al. (1993) lose trophozoites and there- 
fore make the detection of pathogenic E. histolytica less 
likely. Results are obtained within 48 h, which is more 
rapid than culturing followed by isoenzyme charac- 
terization and more informative than microscopy. This 
technique, which might be improved by using the DNA 
extraction method of KATZWINKEL-WLADARSCH et al. 
(1994), is a useful adjunct to microscopy and isoenzyme 
analysis. It is currently being evaluated as a diagnostic 
method in a large scale epidemiological survey covering 
areas endemic for E. histolytica in Colombia. 
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Introduction 
Amebiasis has been regarded as the third cause of 
morbidity and mortality among parasitic diseases in the 
world after malaria and schistosomiasis (1). This fact, 
linked to the growing evidence for the separation of 
invasive and non-invasive Entamoeba histolytica sensu 
lato in two different species (E. histolytica sensu stricto 
and E. dispar respectively), pointed out the need for the 
development of sensitive and specific tools for accurate 
differential diagnosis and the epidemiology of amebiasis 
in endemic and non-endemic areas (2). The PCR-SHELA 
system combines specific DNA amplification and hy- 
bridization steps, together with a colorimetric detection 
of PCR products by ELISA in a robust test where high 
sensitivity and specificity are achieved (3). 
Materials and Methods 
Reference E. histolvtica axenic strains HMI-IMSS, 
200-NIH cultured in TYI-S33 medium, SD 184, Eh 157 
cultured in YI-S medium and polyxenic E. dispar SAW 
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1734 grown in Robinson's medium were used as positive 
controls in the tests. DNA from parasite negative feces 
and water as sample replacement were used as negative 
controls for PCR. Samples were obtained from patients 
attending the centers participating in this study, where 
each fecal sample was examined by direct wet mount in 
saline and Lugol's Iodine, and concentration method 
(fonnol-ether sedimentation or zinc sulfate flotation). 
Cysts and trophozoites were measured and each of those 
positive samples was cultured in Robinson's medium. 
Hexokinase electrophoretic patterns in starch or agarose 
gels were determined when lysates from positive cul- 
tures could be obtained. Additionally, liver abscess ma- 
terial, blood and urine were obtained from one of the 
extra-intestinal invasive cases. All samples were re- 
ferred to the London School of Hygiene and Tropical 
Medicine in order to be tested blindly by PCR-SHELA. 
DNA was extracted from all samples according to the 
protocol previously described by Aguirre et al. (3) where 
the overnight incubation with lysis buffer at 37°C was 
replaced by incubation for 2h at 55°C. The PCR ampli- 
fication of the 25 Kb episomal rDNA from E. histolytica 
and E. dispar- was kept as previously described. How- 
ever, hybridization time to the corresponding internal 
probe was reduced from 90 to 15 min. 
Results and Discussion 
Clinical samples from 14 patients were tested blindly 
by PCR-SHELA for the presence of E. pistol t'tica and E. 
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I'CR-SIII: L; \ Results on clinical Specimens 
SA\1 IT F, Specimen Clinical data \licro: co p:, III 01) I I> (tf) 
4534 lilm)d NT IHM9 
4534 I'm Liscrabscess NeCati\e U. IO1 -IlllllI 
4534 Feces Negate e 47811 -0.111 1 
4534 Urine NT p. (l(3 -ft014 
4534 rum ý< T ((. O II -11.0O), 
1204 Fýcýý 0.031 (1.112-, 
/3/. hmniiris 
1206 Feces Asviuptomatic Negative 0.033 0.034 
1203 Feces Liier amebic E. beanie iica and (l. 6I -O 010 
abscess 3 years E. c oli C\ st,,. 
KIM I). fia, E, l/LS. 
/31. /iQ/1lirti\ 
1 187 Feces Asvmhtonwtic L. histolvtico and 0.757 0.112? 
cyst carrier E. tole cysts. 
131. liominis 
1205 Feces Asymptomatic E. hi. cioli iica and 0.413 0.014 
cyst carrier F_. cnli cysts, 
H/. llOI Mlles 
095 Feces Asymptomatic E. histoli"ticu cysts -0.001 -0.008 
and trophozoitcs 
1096 Feces Asymhtornatic E. hi. c! n/1 tica cysts 0.134 -0.003 
and trophozoites 
822 Feces Dysentery E. hi. stul, vica cysts 0.434 0.017 
and trohhozoites 
675 Feces Salmonellosis E. hi. ciol iica cysts 0.051 0.262 
and Irohhozoites 
1472 Feces Ulcerative colitis Negative a033 0.032 
1079 Pus Hepatic abscess Negative 0.744 0.004 
ANTONY Feces Dysentery Ilematophagous 0.309 (1.030 
WHIT trophozoitcS 
E. hi. viollvica and E. disbar optical densities were determined for eac h sample. 
NT: Not tested. 
Ell OD: EntanIoeha hisio/rtica Optical Dens ity. 
ED OD: Entamncha di. cl)clr Optical Density. 
dispar DNA. Parasite-negative fecal specimens were 
tested as controls (mean OD values 0.029 and 0.03) 1, 
respectively), and titration of cultured trophozoites- 
spiked feces gave a lower detection limit of teil tropho- 
zoites Per gram of feces (data not shown). From 1? fecal 
specimens examined, PCR-SIIELA was able to cor- 
rectly assess 11 and all five positive cultures derived 
front the fecal samples were correctly identified, iTnclud- 
ing the specimen undetected directly from the fecal 
sample. It was also possible to establish a differential 
diautnosis iii a rase of : ulmomi llosis, where cysts mnor- 
ýý ; 
pllologically compatible with E. histoh tic u sense lato 
were detected by microscopy. Pus material from ab- 
scesses is also a good source of DNA for PCR amplifi- 
cation in cases where drainage is indicated. I lowever, it 
was not possible to identify E. histolvtica [)NA from 
blood, Urine Or serum samples from an extraintestinal 
invasive case. In order to improve the sensitivity of the 
system, collaborative work is being carried out together 
with Ackers and colleagues, modifying the [)NA extrac- 
tion step, and also shortening the processing times to 
obtain results within one working div. 
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Culture IlK Ell OD ED OD 
Fast 0.299 0.006 
1095 Fast 0.877 0.006 
1096 Fast 0.229 0.028 
Fast 0.859 0.024 
(75 Slow 0.054 0.239 
2024 Fast 0.422 0.007 
EI I SDI `4 Fast 0.942 -0.009 
Eli 157 Fast 0.863 -0.009 
NIE-i-200 Fast 0.285 0.038 
SAR' 1714 Slow -0.001 0.603 
E. hi. sto/ºvicu and E. dispar optical densities were determined foi 
each specimen. Results on reference strains are included. 
NT: Not tested 
El I OD: Entamuchu histoh'tica Optical Density. 
ED OD: Entaniocba dispar Optical Density. 
In conclusion, the availability of a sensitive and spe- 
cific diagnostic tool permits the rapid simultaneous 
screening of great numbers of samples facilitating future 
worldwide inulticentric studies for the review of the 
epidemiology of amebiasis, where homogeneous ineth- 
odology should be applied. However, it is our view that 
AGUIRRE, MOLINA, BLOTKAMP, ET AL. 
direct microscopy with micrometric measurement and 
concentration methods remain as first hand routine tools 
for the diagnosis of amebiasis. 
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